
<html lang="en"     class="pb-page"  data-request-id="456cc065-0041-4316-90b1-43fd35819c11"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-20;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.8b00141;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4′-Ethynyl-2-fluoro-2′-deoxyadenosine)" /></meta><meta name="dc.Creator" content="François-René  Alexandre" /></meta><meta name="dc.Creator" content="Rachid  Rahali" /></meta><meta name="dc.Creator" content="Houcine  Rahali" /></meta><meta name="dc.Creator" content="Sandra  Guillon" /></meta><meta name="dc.Creator" content="Thierry  Convard" /></meta><meta name="dc.Creator" content="Kerry  Fillgrove" /></meta><meta name="dc.Creator" content="Ming-Tain  Lai" /></meta><meta name="dc.Creator" content="Jean-Christophe  Meillon" /></meta><meta name="dc.Creator" content="Min  Xu" /></meta><meta name="dc.Creator" content="James  Small" /></meta><meta name="dc.Creator" content="Cyril B.  Dousson" /></meta><meta name="dc.Creator" content="Izzat T.  Raheem" /></meta><meta name="dc.Description" content="MK-8591 (4′-ethynyl-2-fluoro-2′-deoxyadenosine) is a novel nucleoside analog that displays a differentiated mechanism of action as a nucleoside reverse transcriptase translocation inhibitor (NRTTI)..." /></meta><meta name="Description" content="MK-8591 (4′-ethynyl-2-fluoro-2′-deoxyadenosine) is a novel nucleoside analog that displays a differentiated mechanism of action as a nucleoside reverse transcriptase translocation inhibitor (NRTTI)..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 28, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00141" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00141" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00141" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00141" /></link>
        
    
    

<title>Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4′-Ethynyl-2-fluoro-2′-deoxyadenosine) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00141" /></meta><meta property="og:title" content="Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4′-Ethynyl-2-fluoro-2′-deoxyadenosine)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0012.jpeg" /></meta><meta property="og:description" content="MK-8591 (4′-ethynyl-2-fluoro-2′-deoxyadenosine) is a novel nucleoside analog that displays a differentiated mechanism of action as a nucleoside reverse transcriptase translocation inhibitor (NRTTI) compared to approved NRTIs. Herein, we describe our recent efforts to explore the impact of structural changes to the properties of MK-8591 through the synthesis and antiviral evaluation of carbocyclic derivatives. Synthesized analogs were evaluated for their antiviral activity, and the corresponding triphosphates were synthesized and evaluated in a biochemical assay. 4′-Ethynyl-G derivative (±)-29 displayed a promising IC50 of 33 nM in a hPBMC cell-based antiviral assay, and its triphosphate (TP), (±)-29-TP, displayed an IC50 of 324 nM in a biochemical RT-polymerase assay. Improved TP anabolite delivery resulting in improved in vitro potency was achieved by preparing the corresponding phosphoramidate prodrug of single enantiomer 29b, with 6-ethoxy G derivative 34b displaying a significantly improved IC50 of 3.0 nM, paving the way for new directions for this novel class of nucleoside analogs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00141"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00141">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00141&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00141&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00141&amp;href=/doi/10.1021/acs.jmedchem.8b00141" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9218-9228</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00824" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00907" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4′-Ethynyl-2-fluoro-2′-deoxyadenosine)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">François-René Alexandre</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">François-René Alexandre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idenix an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</div></div><span class="conrtib-corresp"><strong>*</strong>F.-R.A.: e-mail, <a href="/cdn-cgi/l/email-protection#85e4e9e0fde4ebe1f7e0abe3f7e4ebe6eaecf6abf7e0ebe0c5e2e8e4ece9abe6eae8"><span class="__cf_email__" data-cfemail="8eefe2ebf6efe0eafceba0e8fcefe0ede1e7fda0fcebe0ebcee9e3efe7e2a0ede1e3">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fran%C3%A7ois-Ren%C3%A9++Alexandre">François-René Alexandre</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1396-3757" title="Orcid link">http://orcid.org/0000-0003-1396-3757</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rachid Rahali</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rachid Rahali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idenix an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rachid++Rahali">Rachid Rahali</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Houcine Rahali</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Houcine Rahali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idenix an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Houcine++Rahali">Houcine Rahali</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandra Guillon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandra Guillon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oxeltis, Cap Delta, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Guillon">Sandra Guillon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thierry Convard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thierry Convard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idenix an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Convard">Thierry Convard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kerry Fillgrove</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kerry Fillgrove</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck & Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kerry++Fillgrove">Kerry Fillgrove</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ming-Tain Lai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ming-Tain Lai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck & Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ming-Tain++Lai">Ming-Tain Lai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean-Christophe Meillon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-Christophe Meillon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oxeltis, Cap Delta, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Christophe++Meillon">Jean-Christophe Meillon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Min Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Min Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck & Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Min++Xu">Min Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James Small</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James Small</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck & Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James++Small">James Small</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cyril B. Dousson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cyril B. Dousson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Idenix an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cyril+B.++Dousson">Cyril B. Dousson</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Izzat T. Raheem</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Izzat T. Raheem</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck & Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</div></div><span class="conrtib-corresp"><strong>*</strong>I.T.R.: e-mail, <a href="/cdn-cgi/l/email-protection#5f3625253e2b002d3e373a3a321f323a2d3c34713c3032"><span class="__cf_email__" data-cfemail="721b080813062d00131a17171f321f170011195c111d1f">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Izzat+T.++Raheem">Izzat T. Raheem</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6769-8816" title="Orcid link">http://orcid.org/0000-0002-6769-8816</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00141&amp;href=/doi/10.1021%2Facs.jmedchem.8b00141" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9218–9228</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 28, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 June 2018</li><li><span class="item_label"><b>Published</b> online</span>28 September 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 October 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00141" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00141</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9218%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFran%25C3%25A7ois-Ren%25C3%25A9%2BAlexandre%252C%2BRachid%2BRahali%252C%2BHoucine%2BRahali%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D20%26contentID%3Dacs.jmedchem.8b00141%26title%3DSynthesis%2Band%2BAntiviral%2BEvaluation%2Bof%2BCarbocyclic%2BNucleoside%2BAnalogs%2Bof%2BNucleoside%2BReverse%2BTranscriptase%2BTranslocation%2BInhibitor%2BMK-8591%2B%25284%25E2%2580%25B2-Ethynyl-2-fluoro-2%25E2%2580%25B2-deoxyadenosine%2529%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9228%26publicationDate%3DOctober%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00141"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2088</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00141" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Antiviral Evaluation of Carbocyclic Nucleoside Analogs of Nucleoside Reverse Transcriptase Translocation Inhibitor MK-8591 (4′-Ethynyl-2-fluoro-2′-deoxyadenosine)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;François-René&quot;,&quot;last_name&quot;:&quot;Alexandre&quot;},{&quot;first_name&quot;:&quot;Rachid&quot;,&quot;last_name&quot;:&quot;Rahali&quot;},{&quot;first_name&quot;:&quot;Houcine&quot;,&quot;last_name&quot;:&quot;Rahali&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Guillon&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Convard&quot;},{&quot;first_name&quot;:&quot;Kerry&quot;,&quot;last_name&quot;:&quot;Fillgrove&quot;},{&quot;first_name&quot;:&quot;Ming-Tain&quot;,&quot;last_name&quot;:&quot;Lai&quot;},{&quot;first_name&quot;:&quot;Jean-Christophe&quot;,&quot;last_name&quot;:&quot;Meillon&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Small&quot;},{&quot;first_name&quot;:&quot;Cyril&quot;,&quot;last_name&quot;:&quot;B. Dousson&quot;},{&quot;first_name&quot;:&quot;Izzat&quot;,&quot;last_name&quot;:&quot;T. Raheem&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9218-9228&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00141&quot;},&quot;abstract&quot;:&quot;MK-8591 (4′-ethynyl-2-fluoro-2′-deoxyadenosine) is a novel nucleoside analog that displays a differentiated mechanism of action as a nucleoside reverse transcriptase translocation inhibitor (NRTTI) compared to approved NRTIs. Herein, we describe our recent efforts to explore the impact of structural changes to the properties of MK-8591 through the synthesis and antiviral evaluation of carbocyclic derivatives. Synthesized analogs were evaluated for their antiviral activity, and the corresponding triphosphates were synthesized and evaluated in a biochemical assay. 4′-Ethynyl-G derivative (±)-29 displayed a promising IC50 of 33 nM in a hPBMC cell-based antiviral assay, and its triphosphate (TP), (±)-29-TP, displayed an IC50 of 324 nM in a biochemical RT-polymerase assay. Improved TP anabolite delivery resulting in improved in vitro potency was achieved by preparing the corresponding phosphoramidate prodrug of single enantiomer 29b, with 6-ethoxy G derivative 34b displaying a significantly improved IC50 of 3.0 nM&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00141&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00141" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00141&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00141" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00141&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00141" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00141&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00141&amp;href=/doi/10.1021/acs.jmedchem.8b00141" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00141" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00141" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00141%26sid%3Dliteratum%253Aachs%26pmid%3D30265808%26genre%3Darticle%26aulast%3DAlexandre%26date%3D2018%26atitle%3DSynthesis%2Band%2BAntiviral%2BEvaluation%2Bof%2BCarbocyclic%2BNucleoside%2BAnalogs%2Bof%2BNucleoside%2BReverse%2BTranscriptase%2BTranslocation%2BInhibitor%2BMK-8591%2B%25284%25E2%2580%25B2-Ethynyl-2-fluoro-2%25E2%2580%25B2-deoxyadenosine%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D20%26spage%3D9218%26epage%3D9228%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/jmcmar.2018.61.issue-20/20181025/jmcmar.2018.61.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">MK-8591 (4′-ethynyl-2-fluoro-2′-deoxyadenosine) is a novel nucleoside analog that displays a differentiated mechanism of action as a nucleoside reverse transcriptase translocation inhibitor (NRTTI) compared to approved NRTIs. Herein, we describe our recent efforts to explore the impact of structural changes to the properties of MK-8591 through the synthesis and antiviral evaluation of carbocyclic derivatives. Synthesized analogs were evaluated for their antiviral activity, and the corresponding triphosphates were synthesized and evaluated in a biochemical assay. 4′-Ethynyl-G derivative (±)<b>-29</b> displayed a promising IC<sub>50</sub> of 33 nM in a hPBMC cell-based antiviral assay, and its triphosphate (TP), (±)<b>-29</b>-<b>TP</b>, displayed an IC<sub>50</sub> of 324 nM in a biochemical RT-polymerase assay. Improved TP anabolite delivery resulting in improved in vitro potency was achieved by preparing the corresponding phosphoramidate prodrug of single enantiomer <b>29b</b>, with 6-ethoxy G derivative <b>34b</b> displaying a significantly improved IC<sub>50</sub> of 3.0 nM, paving the way for new directions for this novel class of nucleoside analogs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Reverse transcriptase (RT) is a key enzyme in the human immunodeficiency virus type 1 (HIV-1) replication cycle that converts single-stranded viral RNA into double-stranded DNA that is subsequently integrated into the host genome of infected cells by HIV integrase. RT inhibitors that prevent viral replication are critical components of highly active antiretroviral therapy (HAART).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> They are generally divided into two classes: nucleoside (or nucleotide) reverse transcriptase inhibitors (NRTIs or NtRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> NNRTIs allosterically inhibit reverse transcription upon binding to a hydrophobic site near but distinct from the active site. All NRTIs are pronucleotides that are phosphorylated by host nucleoside and nucleotide kinases to their active triphosphate (TP) forms, which are subsequently incorporated into the elongating viral DNA.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> A common feature of all approved NRTIs (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) is the lack of a 3′-hydroxyl group, which prevents further elongation of the growing DNA strand during the polymerization process, an inhibition mechanism referred to as chain termination. While a number of NRTIs are critical components of highly efficacious current standard-of-care regimens, cellular toxicity and the emergence of mutants that are resistant to the drugs emphasize the need for novel structurally and functionally differentiated nucleosides.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. : Approved NRTIs and NtRTIs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">MK-8591 (4′-ethynyl-2-fluoro-2′-deoxyadenosine), a novel nucleoside analog that possesses a 3′-hydroxyl group, is more potent against wild-type and most clinical drug-resistant HIV strains than any approved nucleoside reverse transcriptase inhibitor (NRTI).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Unlike other NRTIs and due to its unique structure bearing a 4′-ethynyl substituent and a 3′-hydroxy group (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>), MK-8591 has been shown to display multiple novel modes of action, acting in part as a translocation-defective RT inhibitor (NRTTI).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Biochemical mechanistic studies have revealed that MK-8591-TP is a better substrate for RT than its natural substrate dATP. Once incorporated, MK-8591-MP functions either as a de facto chain terminator by preventing RT translocation on the nucleic acid primer possessing the 3′-terminal MK-8591-MP or as a delayed chain terminator, incorporating one incoming deoxynucleoside TP (dNTP) before DNA synthesis stops.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Another novel structural feature of MK-8591 is the 2-fluoro substituent on the adenine nucleobase that renders it highly resistant to metabolism by adenosine deaminase, enabling more efficient uptake and phosphorylation to MK-8591-TP.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> MK-8591-TP has a very long intracellular half-life (>120 h) compared to other NRTIs, imparting the potential for a long duration of action.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Indeed, MK-8591 has displayed an excellent pharmacokinetic profile in preclinical species and in the clinic<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and has been well-tolerated in phase 1 clinical trials. Additionally, driven by its exquisite potency, long intracellular half-life, and high oral bioavailability, MK-8591 has demonstrated robust efficacy in naive patients at oral doses as low as 0.5 mg given once weekly.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. : Chemical Structures of MK-8591 (Left) and Representative 4′-Substituted Carbocyclic Targeted Structures</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As part of a continued discovery effort driven by the further exploration of the structure activity relationship (SAR) of MK-8591 and subsequent structural diversification, we turned our attention to analogs in which the ribose sugar ring was replaced by a carbocycle. The NTP anabolites of carbocyclic nucleoside analogues such as abacavir (ABC, <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) are recognized by and inhibit HIV-RT, and these carbocyclic analogs are established components of antiviral regimens.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Due to their carbocyclic nature, this unique nucleoside analog class is often more chemically robust and metabolically stable toward glycosidases compared to their ribose counterparts, characteristics that could further impart improved pharmacokinetic properties.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Herein, we describe the synthesis and antiviral evaluation of novel carbocyclic analogs of MK-8591.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Syntheses of 4′-substituted carbocyclic nucleoside analogs available in the literature are scarce, and those reported are often long and low-yielding, particularly for our targets of interest.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> To this end, we chose to perform a racemic synthesis of carbocyclic intermediates <b>6</b>–<b>9</b> based on the work of Holy et al. as depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Beginning with substituted malonate derivative <b>1</b>, oxidation was carried out with pyridinium dichromate to afford aldehyde <b>2</b>. Without purification, <b>2</b> was directly engaged in a cyclization reaction in allyl alcohol solvent to afford racemic <b>3</b> as a mixture of cis/trans isomers. The pendant 2-hydroxy group of (±)-<b>3</b> was then protected with a methoxymethyl (MOM) group to provide (±)-<b>4</b>. The ester functionalities were reduced with lithium aluminum hydride, and (±)-<b>5</b> was obtained, still as a cis/trans mixture of isomers in a 1:4 ratio. This resulting prochiral diol was monoprotected with <i>tert</i>-butyldiphenylsilyl chloride (TBDPSCl), producing four isomers, of which two could be isolated by chromatography on silica gel, with <i>trans</i>-(±)-<b>6</b>, obtained in 43% yield, and <i>trans</i>-(±)-<b>7</b> in 12% yield.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Intermediates (±)-<b>6</b> and (±)-<b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PDC, DCM, 0 °C to room temperature, 16 h; (b) NaH, allyl alcohol, 0 °C to room temperature, 16 h, 22% (over 2 steps); (c) dimethoxymethane, Tf<sub>2</sub>O, room temperature, 1 h, 57%; (d) LiAlH<sub>4</sub>, THF, 0 °C, then reflux, 90 min, 92%; (e) TBDPSCl, imidazole, DMAP, DCM, 0 °C to room temperature, 16 h; (±)-<b>6</b> (43%), (±)-<b>7</b> (12%); (±)-<b>8</b> and (±)-<b>9</b> not isolated.</p></p></figure><div class="NLM_p">The corresponding relative stereochemistry of (±)-<b>6</b> and (±)-<b>7</b> was assigned by COSY and NOESY NMR experiments and was in accordance with closely related structures described in the literature.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In (±)-<b>6</b> and (±)-<b>7</b>, as indicated by the NOESY NMR spectra (<a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>), a strong correlation between H-2 and 1-C<u class="uu">H</u><sub><u class="uu">2</u></sub>OTBDPS indicated that the 1-CH<sub>2</sub>OTBDPS and 2-OMOM were trans to one another in both compounds. A separate weaker correlation between H-2 and H-4 indicated that the 2-OMOM and 4-O-allyl groups were cis to one another in (±)-<b>7</b>, while the absence of such a correlation in (±)-<b>6</b> indicated that these groups were trans. The cis isomers (±)-<b>8</b> and (±)-<b>9</b> could not be separated at this stage and were not used further in the synthesis.</div><figure id="cht3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. : Primary NOESY NMR Correlations (Red Arrows) in (±)-<b>6</b> and (±)-<b>7</b> Used for Stereochemical Assignment</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Alcohol (±)-<b>6</b> was functionalized at its 4′ position as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. First, oxidation of the free hydroxyl group to the corresponding aldehyde with Dess–Martin periodinane provided (±)-<b>10</b> in good yield. The aldehyde (±)-<b>10</b> was next transformed into the corresponding ethynyl derivative (±)-<b>11</b> through Seyferth–Gilbert homologation or converted to the 4′-cyano derivative (±)-<b>14</b> through a two-step sequence involving hydroxylamine formation followed by dehydration. Next, allyl deprotection was carried out with Pd(PPh<sub>3</sub>)<sub>4</sub> in the presence of barbituric acid in methanol<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> to afford (±)<b>-12</b> and (±)<b>-15</b>. Finally, (±)<b>-12</b> was converted to (±)<b>-13</b> and (±)<b>-15</b> was converted to (±)<b>-16</b> by inverting the stereochemistry of the hydroxyl using a Mitsunobu reaction followed by hydrolysis of the pendant phenyl ester. Alternatively, the same reaction sequence could be carried out beginning with (±)-<b>7</b> obtained previously, to produce additional (±)-<b>13</b> and (±)-<b>16</b> and eliminating the final Mitsunobu inversion.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Alcohols (±)-<b>13</b> and (±)-<b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Dess–Martin periodinane, DCM, room temperature, 16 h, 76%; (b) Seyferth–Gilbert reagent, K<sub>2</sub>CO<sub>3</sub>, MeOH, room temperature, 16 h, 78%; (c) (1) hydroxylamine, pyridine, EtOH, 2 h; (2) Burgess reagent, toluene, 1 h, 78% (over 2 steps); (d) Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, MeOH, room temperature, 16 h, 89%; (e) (1) benzoic acid, PPh<sub>3</sub>, DIAD, THF (quant), 16 h; (2) NaOH, MeOH, 2 h, 80% (over 2 steps) for (±)<b>-13</b>, 66% (over 2 steps) for (±)<b>-16</b>.</p></p></figure><div class="NLM_p">Starting from alcohol intermediates (±)<b>-13</b> and (±)<b>-16</b>, final carbocyclic nucleosides derivatives bearing various bases were synthesized as depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Protected bases were coupled to (±)<b>-13</b> and (±)<b>-16</b> using a standard Mitsunobu process. The resulting compounds were subjected to desilylation using TBAF in the presence of AcOH in THF to afford 5′-OH carbocyclic nucleoside analogs, which were purified and characterized at this stage. The final racemic nucleoside analogs were obtained in good yields by a subsequent deprotection of the MOM protecting group using TFA, followed by either deprotection of the nucleobase or amination of the nucleobase at the purine 6-position using ammonia in methanol or 1,4-dioxane.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2′-Deoxycarbocyclic Nucleosides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) N3-Bz-thymine, PPh<sub>3</sub>, DIAD, THF, −41 °C to room temperature, 16 h; (b) 2-fluoro-6-chloropurine or 2,6-dichloropurine, DIAD, THF, −41 °C to room temperature, 16 h; (c) N2-Ac-6-ODPC-guanine, DIAD, THF, −41 °C to room temperature, 16 h; (d) TBAF, AcOH, THF, room temperature, 24 −48 h, 45% (over 2 steps) for (±<b>-17</b>, 33% (over 2 steps) for (±)<b>-18</b>, 56% (over 2 steps) for (±)<b>-21</b>, 78% (over 2 steps) for (±)<b>-22</b>, 42% (over 2 steps) for (±)<b>-23</b>, 74% (over 2 steps) for (±)<b>-27</b>, 54% (over 2 steps) for (±)<b>-28</b>; (e) TFA, DCM, rt, 16 h; (f) 7 N NH<sub>3</sub> in MeOH, sealed tube, room temperature, 16 h, 56% (over 2 steps) for (±)<b>-19</b>, 27% (over 2 steps) for (±)<b>-20</b>, 73% (over 2 steps) for (±)<b>-29</b>, 26% (over 2 steps) for (±)<b>-30</b>; (g) NH<sub>3</sub> in 1,4-dioxane, sealed tube, 50 °C, 16 h, 19% (over 2 steps) for (±)<b>-24</b>, 27% (over 2 steps) for (±)<b>-25</b>, 10% (over 2 steps) for (±)<b>-26</b>.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47773" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47773" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The antiviral activity of our novel nucleoside analogs against wild-type HIV-1 was evaluated in a cell-based assay in HIV-1 infected human peripheral blood mononuclear cells (hPBMCs),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and the results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Among the 4′-ethynyl series, thymine (T) derivative (±)<b>-19</b> showed no activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 3), adenosine (A) derivatives (±)<b>-24</b> and (±)<b>-25</b> were modestly active in the midnanomolar range (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entries 4 and 5), while guanine (G) analogs were most potent, with (±)<b>-29</b> displaying an IC<sub>50</sub> of 33 nM. Analogs in the 4′-cyano series were significantly less potent than the 4′-ethynyl series (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entries 7–9), with the most potent compound in this series being G analog (±)<b>-30</b> with an IC<sub>50</sub> of 1.15 μM, significantly less potent than (±)<b>-29</b>. Importantly, all compounds displayed no measurable cellular toxicity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure and in Vitro Activity of 2′-Deoxycarbocyclic Nucleosides against Wild-Type HIV-1-Infected hPBMCs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">base</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CC<sub>50</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">MK-8591</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.00021</td><td class="colsep0 rowsep0" align="char" char=".">>4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">3TC</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.171</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">(±)-<b>19</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="char" char=".">>2.10</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">(±)-<b>24</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2FA</td><td class="colsep0 rowsep0" align="char" char=".">0.201</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">(±)<b>-25</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2ClA</td><td class="colsep0 rowsep0" align="char" char=".">0.232</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">(±)<b>-29</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="char" char=".">0.033</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">(±)<b>-20</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="char" char=".">>2.10</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">(±)-<b>26</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2FA</td><td class="colsep0 rowsep0" align="char" char=".">>2.10</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">(±)-<b>30</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="char" char=".">1.15</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left"><b>29a</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="char" char=".">>2.10</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"><b>29b</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left"><b>34a</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">GOEt</td><td class="colsep0 rowsep0" align="char" char=".">0.382</td><td class="colsep0 rowsep0" align="char" char=".">>4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left"><b>34b</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">GOEt</td><td class="colsep0 rowsep0" align="char" char=".">0.0030</td><td class="colsep0 rowsep0" align="char" char=".">>42.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values were determined in 10% NHS in a single-cycle HIV replication assay in hPBMCs.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">CC<sub>50</sub> values were determined in 10% NHS condition in an MT4 cell line (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf" class="ext-link">Supporting Information</a> for details).</p></div></div></div><div class="NLM_p">The most potent G derivative (±)<b>-29</b> was resolved into its constituent enantiomers via chiral supercritical fluid chromatography (SFC) (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) to afford <b>29a</b> (faster eluting isomer) and <b>29b</b> (slower eluting isomer). The two enantiomers were then evaluated in the cell-based antiviral assay, and only <b>29b</b> retained antiviral activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 11). On the basis of these results, we attributed the potent <b>29b</b> to be the <span class="smallcaps smallerCapital">d</span>-series (1<i>S</i>,3<i>R</i>,4<i>R</i>) and <b>29a</b> to be the <span class="smallcaps smallerCapital">l</span>-series (1<i>R</i>,3<i>S</i>,4<i>S</i>), a hypothesis that was consistent with a modeling study of their corresponding TPs described later in this manuscript.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. : Chiral Separation of (±)-<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chiral SFC separation, CHIRALCEL OD-H column, mobile phase CO<sub>2</sub>/MeOH; faster eluting isomer <b>29a</b> and slower eluting isomer <b>29b</b>.</p></p></figure><div class="NLM_p">In addition to the in vitro evaluation of the parent nucleoside analogs, the corresponding TPs were synthesized using known methods<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and were evaluated in a biochemical HIV-1 RT polymerase (RT-Pol) assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The results were in accordance with the trend observed in the cell-based assay, with G analogs (±)<b>-29-TP</b> and (±)<b>-30-TP</b> being potent inhibitors of HIV RT, superior to the corresponding A derivatives. The T derivatives (±)<b>-19-TP</b> and (±)<b>-20-TP</b> displayed IC<sub>50</sub>’s of 114 nM and 523 nM, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entries 1 and 5), while their corresponding nucleosides were inactive in the cell-based assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Interestingly, compared to MK-8591-TP, carbocyclic analog <b>24-TP</b>, which also bears a 2-fluoroadenine base (2FA), displayed an 13-fold higher IC<sub>50</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, entry 2).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure and in Vitro Activity of 2′-Deoxycarbocyclic Nucleoside Triphosphates against Wild-Type HIV-1 RT</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0011.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">base</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">(±)-<b>19</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">0.114</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">(±)-<b>24</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2FA</td><td class="colsep0 rowsep0" align="left">3.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">(±)-<b>25</b>-T<b>P</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2ClA</td><td class="colsep0 rowsep0" align="left">20.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">(±)-<b>29</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">0.324</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">(±)-<b>20</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">0.523</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">(±)-<b>26</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2FA</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">(±)-<b>30</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">0.444</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">MK-8591-TP</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.263</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">3TC-TP</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.015</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">HIV reverse transcriptase polymerase assay (RT-Pol). IC<sub>50</sub> values were determined by nonlinear four-parameter curve fitting (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf" class="ext-link">Supporting Information</a> for details).</p></div></div></div><div class="NLM_p">In order to rationalize the observed potency differences between MK-8591-TP and <b>24-TP</b>, a computational modeling study of these TPs bound in the RT polymerase active site was undertaken (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf" class="ext-link">Supporting Information</a> for details). In this process, lowest energy 3D conformations of the TP ligands, within a 45 kcal/mol range between the lowest and the highest energy conformation, were first generated using the Discovery Studio Catalyst (Biovia) software package. Next, the minimized TP ligand geometries were flexibly mapped to a previously generated and validated pharmacophore model using the same software package. If no solution was found, two fixed points of the pharmacophore model were sequentially allowed to be unconstrained, and the calculation was repeated. A maximum of 10 conformations, based on the best calculated fit, were kept. These were then docked into the available complex of HIV RT polymerase protein, primer, template, and 2 Mg<sup>2+</sup> ions (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1rtd">1rtd</a><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>), and their geometries were optimized using the CHARMm force field while keeping most components of the complex fixed except for specific residues. Next, simulated annealing of the ligand/enzyme complexes was performed using CDOCKER. The resulting complexes were relaxed by energy minimization using the CHARMm force field while keeping other parts of the complex fixed. Finally, ligand geometries from the minimized complexes were remapped to the pharmacophore model, keeping the 3D coordinates of the ligand fixed, and the fit values were calculated. These scores were used to evaluate the quality of the modeled structures. At this final stage only the highest fit value conformation was kept, with these solutions depicted in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> for several TPs.</div><figure id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Computational models illustrating the primary interactions of MK-8591-TP (A), (1<i>S</i>,3<i>R</i>,4<i>R</i>)-<b>24-TP</b> (B), (1<i>S</i>,3<i>R</i>,4<i>R</i>)-<b>29-TP</b> (C), and (1<i>R</i>,3<i>S</i>,4<i>S</i>)-<b>29-TP</b> (D) in the polymerase active site of HIV-1 RT/DNA. NTPs are colored by atom type. Template is displayed in yellow. Primer is displayed in pink. RT amino acids are displayed in in cyan, and metal ions are displayed in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The primary interactions of MK-8591-TP and (1<i>S</i>,3<i>R</i>,4<i>R</i>)-<b>24-TP</b> are shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B, respectively. We assumed that the active enantiomer of (±)<b>-24-TP</b> would be the (1<i>S</i>,3<i>R</i>,4<i>R</i>)-<b>24-TP</b>, corresponding to the configuration of a <span class="smallcaps smallerCapital">d</span>-nucleoside as no solution for the other enantiomer (1<i>R</i>,3<i>S</i>,4<i>S</i>)-<b>24-TP</b> could be found in the previously described pharmacophore model computational mapping study. In this precatalytic complex of RT bound to the dideoxyguanosine (ddG) terminated double-stranded DNA, MK-8591-TP adopts a C-3′ endo ring conformation (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), displays Watson–Crick base pairing interactions, and shows strong hydrophobic interactions of the 4′-ethynyl with Phe160 (π–σ), Tyr115 (π-alkyl), Met184 (alkyl), and Ala114 (alkyl). In the case of (1<i>S</i>,3<i>R</i>,4<i>R</i>)-<b>24-TP</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B), which has a flat ring conformation, base pairing is of the Hoogsteen type with the 2-fluoroadenine ring system adopting a syn conformation. The interactions with the carbocyclic ring are less numerous and less efficient than those for MK-8591-TP, with the 4′-ethynyl making a weaker interaction with Phe160 (<i>d</i> = 4.41 Å as compared to <i>d</i> = 2.79 Å for MK-8591-TP) and no interaction with Ala114. These observations suggest that (1<i>S</i>,3<i>R</i>,4<i>R</i>)-<b>24-TP</b> is less favorably bound to the RT compared to MK-8591-TP. Unlike (±)<b>-24-TP</b>, (±)<b>-29-TP</b> is a potent inhibitor of the HIV RT polymerase and adopts a C-3′ endo ring conformation. The corresponding modeling study (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C) performed on (1<i>S</i>,3<i>R</i>,4<i>R</i>)-<b>29-TP</b> shows a binding mode similar to MK-8591-TP, with Watson–Crick base pairing interactions (losing only interaction with Gly-152), strong hydrophobic interactions with 4′-ethynyl, and presence of the metal (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, in green) in an optimal distance to the ddG 3′-OH of the primer.</div><div class="NLM_p">To validate our assumption that the active nucleoside analog enantiomer <b>29b</b> does indeed bear the (1<i>S</i>,3<i>R</i>,4<i>R</i>) configuration, we also modeled the TP derivative of the inactive enantiomer <b>29a</b> in RT (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). Interestingly, and in support of our assignment, this triphosphate displayed fewer interactions with the protein with longer distances between the 4′-ethynyl and Tyr115 and Phe160, as well as no interactions with Ala114 and Met184. Furthermore, the distance from the metal chelating the α-phosphate to the 3′-OH of the primer was 3.78 Å, which renders the likelihood of the further polymerization less favorable.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Having gained a better understanding of the structure and active site binding interactions of our novel carbocyclic nucleoside analogs, we chose to evaluate the in vivo pharmacokinetics of <b>29b</b> as a leading representative of this new class. Pharmacokinetic parameters obtained in male Sprague-Dawley rats after intravenous (iv, 1 mg/kg) and oral (po, 2 mg/kg) administration are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, compared to MK-8591. After oral administration, <b>29b</b> exhibited an excellent oral bioavailability of 91%, good oral exposure, and a moderate plasma clearance (32.4 mL min<sup>–1</sup> kg<sup>–1</sup>) and half-life (9.8 h). These data provided early confidence in the in vivo performance of this class.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Rat Pharmacokinetic Profile of MK-8591 and <b>29b</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">route<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–∞</sub> (μM·h)</th><th class="colsep0 rowsep0" align="center">Cl (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MK-8591</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29b</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.82</td><td class="colsep0 rowsep0" align="left">32.4</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">3.30</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">91</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Intravenous (iv) arm formulated in 50:50 DMSO/saline; oral (po) arm formulated in 0.5% methylcellulose (aq).</p></div></div></div><div class="NLM_p">In order to improve the in vitro cellular potency of the 4′ethynyl-G carbocyclic series, a prodrug approach was investigated. Prodrugs have historically been employed in the nucleoside space to directly deliver a masked monophosphate into target cells rather than the nucleoside itself, expediting the route to the triphosphate form by bypassing the commonly rate-determining first phosphorylation step.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As a benchmark prodrug, we chose to synthesize the <span class="smallcaps smallerCapital">l</span>-Ala phosphoramidate, 6-ethoxyguanine derivative. In this prodrug class, it is well established that the isopropyl ester is cleaved intracellularly by cathepsin A, and the resulting carboxylic acid is subsequently degraded to the monophosphate over a sequence of three steps.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Upon liberation of the free monophosphate, the 2-amino-6-ethoxypurine is transformed to a G by intracellular adenosine deaminase.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">The 2-amino-6-ethoxypurine intermediate (±)<b>-32</b> was synthesized in a manner similar to carbocyclic nucleoside (±)<b>-29</b> via a Mitsunobu coupling followed by subsequent deprotections (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). The pendant phosphoramidate was installed using commercially available isopropyl ((<i>S</i>)-(perfluorophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate in the presence of <i>tert</i>-butylmagnesium chloride in THF.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The diastereomeric mixture obtained was deprotected at the 3′-OH and then separated by chiral SFC to afford <b>34a</b> and <b>34b</b>. In the hPBMC cell-based antiviral assay, <b>34b</b> was identified as the active enantiomer (3.0 nM), 127-fold more active than <b>34a</b> (382 nM). Gratifyingly, compared to our lead parent nucleoside analog <b>29b</b>, the corresponding phosphoramidate prodrug <b>34b</b> provided an 8-fold improvement in activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entries 11, 12, and 13). Upon the basis of these exciting preliminary results, we anticipate this improvement in the in vitro potency should result in improved TP delivery in vivo, and efforts are focused toward optimizing our NMP delivery to this end.</div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis and Chiral Separation of Phosphoramidate Prodrugs <b>34a</b> and <b>34b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) N2-CO<sup><i>i</i></sup>Pr-6-ODPC-guanine, DIAD, THF, −41 °C to room temperature, 16 h, 50%; (b) TBAF, AcOH, THF, room temperature, 16 h, 98%; (c) KOH, MeOH, room temperature, 0 °C, 16 h, 66%; (d) isopropyl ((<i>S</i>)-(perfluorophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate, <sup><i>t</i></sup>BuMgCl 1 M in THF, 0 °C to rt, 16 h, 82%; (e) TFA, DCM, room temperature, then 0 °C, 2.5 h, 57%; (f) chiral SFC separation, CHIRALPAK AD-H column, mobile phase CO<sub>2</sub>/MeOH; faster eluting isomer <b>34a</b> (28%) and slower eluting isomer <b>34b</b> (30%).</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have synthesized and evaluated a series of novel carbocyclic analogs of MK-8591. Prepared racemates were resolved, and the stereochemistry of the active analogs was postulated to be from the (1<i>S</i>,3<i>R</i>,4<i>R</i>) series. This hypothesis was further supported by a computational modeling study and was in line with corresponding in vitro potency data. NTP anabolites from this class exhibit potent inhibitory activity against HIV-1 RT similar to MK-8591-TP. In addition, lead carbocyclic derivatives display potent inhibitory activity in a hPBMC cell-based antiviral assay, although in a higher range compared to the exceptional potency of MK-8591. These results demonstrate that the highly conserved ribose moiety can be replaced by a carbocyclic backbone to open up new structural space. Compared to MK-8591, lead compound <b>29b</b> displayed a good overall PK profile in rat with improved plasma clearance and half-life. A prodrug strategy was interrogated in order to further improve in vitro potency, and an 8-fold improvement in cellular IC<sub>50</sub> was obtained by employing a phosphoramidate prodrug. This early result validated the prodrug strategy for this promising new class of nucleosides, and additional studies exploring this approach will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of Representative Carbocyclic Nucleosides</h3><div class="NLM_p last">The syntheses of <b>29a</b>, <b>29b</b>, <b>34a</b>, and <b>34b</b> are described in this section, while the syntheses of all other compounds presented in this manuscript are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General</h4><div class="NLM_p last">All reactions were performed with reagent-grade materials under an atmosphere of nitrogen. Solvents were reagent-grade or better. Evaporation of the solvents was carried out in a rotary evaporator in vacuo. Thin layer chromatography (TLC) was performed on precoated aluminum sheets of silica gel 60 F254 (Merck, 60F-254), visualization of products being accomplished by UV absorbance at 254 nm; column chromatography was performed on silica gel (15–45 μm, 40–63 μm, or spheric silica prepacked cartridges) using a Biotage flash chromatography apparatus (Isolera). <sup>1</sup>H (400 MHz) and <sup>31</sup>P (162 MHz) NMR spectra were acquired on a Bruker AVANCE II 400 MHz spectrometer using DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> as solvents. Chemical shifts (δ) are quoted in parts per million (ppm) referenced to the residual solvent peak (DMSO-<i>d</i><sub>6</sub> set at 2.49 ppm or CDCl<sub>3</sub> set at 7.26 ppm). <sup>13</sup>C (176 MHz) NMR data were acquired on a Bruker AVANCE III HD 700 MHz NMR spectrometer equipped with a 1.7 mm HCN TCI MicroCryoProbe using CD<sub>3</sub>OD as solvent. Chemical shifts (δ) are quoted in parts per million (ppm) referenced to the residual solvent peak (CD<sub>3</sub>OD set at 49.15 ppm). The accepted abbreviations are as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet. Low-resolution LC mass spectra (LR UPLCMS) were recorded on a WATERS unit [Acquity UPLC, SQD2 (ESCI source)] using a reverse phase analytical column, CORTECS UPLC C18 1.6 μm, 2.1 mm × 30 mm for standard methods and ACQUITY UPLC HSST3 1.8 μm, 2.1 mm × 30 mm for polar methods. The compound to be analyzed was eluted using a linear gradient of 5–95% acetonitrile in water with 0.05% formic acid programmed over a 1.7 min period with a flow rate of 0.7 mL/min. Purity of all compounds was determined to be >95% by analytical LC–MS system consisting of an Agilent 6140 quadrupole LC/MS platform with PDA detector. The column for standard methods was Purospher STAR RP-18 end-capped 2 μm, Hibar HR 50-2.1, the column temperature was 60 °C, the flow rate was 0.8 mL/min, and injection volume was 0.5–5 μL. UV detection was in the range 210–400 nm. The mobile phase consisted of solvent A (water plus 0.05% formic acid) and solvent B (acetonitrile plus 0.05% formic acid) with different gradients for two different methods: (1) starting with 98% solvent A changing to 100% solvent B over 1.8 min, maintained for 0.8 min; (2) starting with 98% solvent A changing to 100% solvent B over 5.8 min, maintained for 0.3 min. Preparative HPLC was performed on a Gilson system 233XL with 735 (Unipoint). The column was a Waters XBridge Prep C18 5 μm OBD, dimension 30 mm × 250 mm. The mobile phase consisted of mixture of acetonitrile/ammonium carbonate 0.02 N (3–15% over 70 min or 3–30% over 50 min). Flow rates were maintained at 50 mL/min, the injection volume was 1000 μL, and the UV detection range was 260 nm. Chiral preparative chromatography was conducted on CHIRALCEL OD-H or CHIRALPAK AD-H columns (Daicel Chemical Industries, Ltd.) with desired isocratic solvent systems identified on chiral analytical chromatography under supercritical fluid (SFC) conditions.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Procedures. (±)-<i>cis</i>- and (±)-<i>trans</i>-(4-(Allyloxy)-2-(methoxymethoxy)cyclopentane-1,1-diyl)dimethanol (±)-<b>5</b></h3><div class="NLM_p"><i>Step a:</i> To a solution of dimethyl (<i>Z</i>)-2-(4-hydroxybut-2-en-1-yl)malonate<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (40 g, 0.198 mol) in DCM (800 mL) cooled at 0 °C was added portionwise pyridinium dichromate (126.5 g, 0.336 mol). The reaction mixture was stirred at room temperature for 16 h, filtered on silica gel eluting with EtOAc, and then concentrated in vacuo. The crude dimethyl (<i>Z</i>)-2-(4-oxobut-2-en-1-yl)malonate (±)-<b>2</b> was used in the subsequent step without further purification.</div><div class="NLM_p"><i>Step b:</i> To allyl alcohol (700 mL) was slowly added sodium hydride (60% in oil, 5 g, 0.124 mol) at 0 °C. The reaction mixture was stirred at room temperature for 1 h. To this reaction mixture was added dropwise a solution of crude (±)-<b>2</b> (35.4 g, 0.177 mol) in allyl alcohol (190 mL). The reaction mixture was stirred at room temperature for 16 h. The reaction was quenched with addition of acetic acid until pH = 7, and then the reaction mixture was concentrated in vacuo. The crude residue was dissolved in EtOAc and water, the organic layer was separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with a saturated NaHCO<sub>3</sub> solution and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude residue was purified by gradient elution on SiO<sub>2</sub> (PE/EtOAc: 0–70%) to afford (±)-<i>cis</i>- and (±)-<i>trans</i>-diallyl-4-(allyloxy)-2-hydroxycyclopentane-1,1-dicarboxylate (±)-<b>3</b> (13.7 g, 22%).</div><div class="NLM_p"><i>Step c:</i> To a solution of (±)-<b>3</b> (13.7 g, 44 mmol) in dimethoxymethane (560 mL) was added dropwise triflic acid (3.1 mL, 35 mmol). The reaction mixture was stirred at room temperature for 1 h and then poured into a saturated NaHCO<sub>3</sub> solution and extracted twice with DCM. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The crude residue was purified by gradient elution on SiO<sub>2</sub> (PE/EtOAc: 0–100%) to afford (±)-<i>cis</i>- and (±)-<i>trans</i>-diallyl-4-(allyloxy)-2-(methoxymethoxy)cyclopentane-1,1-dicarboxylate (±)-<b>4</b> (8.94 g, 57%).</div><div class="NLM_p last"><i>Step d:</i> To a solution of (±)-<b>4</b> (8.94 g, 25 mmol) in THF (70 mL), cooled at 0 °C was added dropwise LiAlH<sub>4</sub> at 0 °C. The reaction mixture was stirred at reflux for 90 min and then cooled to 0 °C, quenched with dropwise addition of water, and diluted with EtOAc. The resulting reaction mixture was filtered on Celite and washed with water and EtOAc. The organic layer was dried, filtered, and concentrated in vacuo. The crude residue was purified by gradient elution on SiO<sub>2</sub> (DCM/MeOH: 0–10%) to afford the expected compound (±)-<b>5</b> (5.66 g, 92%) as a mixture of isomer. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 5.91–5.81 (m, 1H), 5.24–5.19 (m, 1H), 5.12–5.08 (m, 1H), 4.58–4.51 (m, 3H), 4.17–4.12 (m, 1H), 3.99–3.93 (m, 1.5H), 3.88–3.79 (m, 2.5H), 3.45–3.35 (m, 2H), 3.33–3.24 (m, 2H), 3.23 (s, 3H), 2.30–2.23 (m, 0.2H), 1.95–1.84 (m, 2.4H), 1.79–1.74 (m, 0.2H), 1.65–1.53 (m, 0.4H), 1.40–1.35 (m, 0.8H).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> ((1<i>S</i>,2<i>S</i>,4<i>R</i>)- and ((1<i>R</i>,2<i>R</i>,4<i>S</i>)-4-(Allyloxy)-1-(((<i>tert</i>-butyldiphenylsilyl)oxy)methyl)-2-(methoxymethoxy)cyclopentyl)methanol (±)-<b>6</b> and ((1<i>R</i>,2<i>R</i>,4<i>R</i>)- and (1<i>S</i>,2<i>S</i>,4<i>S</i>)-4-(Allyloxy)-1-(((<i>tert</i>-butyldiphenylsilyl)oxy)methyl)-2-(methoxymethoxy)cyclopentyl)methanol (±)-<b>7</b></h3><div class="NLM_p last">To a solution of compound (±)-<b>5</b> (5.75 g, 23.35 mmol) in DCM (280 mL) at 0 °C were added imidazole (1.91 g, 28.0 mmol), DMAP (0.28 g, 2.33 mmol), and <i>tert</i>-butyldiphenylchlorosilane (7.28 mL, 28.0 mmol). The reaction mixture was stirred from 0 °C to room temperature for 3 h and at room temperature for 16 h. The reaction mixture was then diluted with EtOAc (500 mL) and washed with a 1 M HCl solution (500 mL), water (500 mL), and brine (500 mL). The organic layer was dried over sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by gradient elution on SiO<sub>2</sub> (PE/Et<sub>2</sub>O: 0–70%) to afford the expected compounds (±)-<b>6</b> (4.86 g, 43%), (±)-<b>7</b> (1.416 g, 12%) and a mixture of isomers (±)-<b>8</b> and (±)-<b>9</b> (5.0 g, 44%). Compound (±)-<b>6</b>: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 7.66–7.61 (m, 4H), 7.48–7.40 (m, 6H), 5.87–5.77 (m, 1H), 5.20–5.15 (m, 1H), 5.09–5.05 (m, 1H), 4.55 (d, <i>J</i> = 6.62 Hz, 1H), 4.53 (d, <i>J</i> = 6.62 Hz, 1H), 4.29 (t, <i>J</i> = 4.97 Hz, 1H), 4.14 (t, <i>J</i> = 6.55 Hz, 1H), 3.99–3.93 (m, 1H), 3.84–3.82 (m, 2H), 3.62–3.52 (m, 2H), 3.53–3.43 (m, 2H), 3.21 (s, 3H), 1.99–1.85 (m, 3H), 1.53–1.49 (m, 1H), 1.01 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> = 507.8 (MNa<sup>+</sup>). Compound (±)-<b>7</b>: <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 7.68–7.60 (m, 4H), 7.49–7.41 (m, 6H), 5.91–5.82 (m, 1H), 5.25–5.20 (m, 1H), 5.13–5.09 (m, 1H), 4.55 (d, <i>J</i> = 6.62 Hz, 1H), 4.50 (d, <i>J</i> = 6.62 Hz, 1H), 4.26 (t, <i>J</i> = 4.95 Hz, 1H), 4.04–3.99 (m, 1H), 3.88–3.78 (m, 3H), 3.49–3.48 (m, 4H), 3.21 (s, 3H), 2.31–2.24 (m, 1H), 1.95–1.86 (m, 1H), 1.68–1.60 (m, 2H), 1.01 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> = 507.6 (MNa<sup>+</sup>).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (1<i>S</i>,2<i>S</i>,4<i>R</i>)- and (1<i>R</i>,2<i>R</i>,4<i>S</i>)-4-(Allyloxy)-1-(((<i>tert</i>-butyldiphenylsilyl)oxy)methyl)-2-(methoxymethoxy)cyclopentane-1-carbaldehyde (±)-<b>10</b></h3><div class="NLM_p last">To a solution of compound (±)-<b>6</b> (2.68 g, 5.53 mmol) in DCM (40 mL) under nitrogen was added Dess–Martin periodinane (4.69 g, 11.06 mmol) dissolved in DCM (40 mL). The reaction mixture was stirred at room temperature for 16 h. The resulting reaction mixture was partially concentrated in vacuo (2/3), and the compound was purified by gradient elution on SiO<sub>2</sub> (PE/Et<sub>2</sub>O: 0–70%) to afford the expected compound (±)-<b>10</b> (2.67 g, 76%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 9.66 (s, 1H), 7.61–7.59 (m, 4H), 7.50–7.41 (m, 6H), 5.86–5.76 (m, 1H), 5.20–5.15 (m, 1H), 5.11–5.07 (m, 1H), 4.53 (d, <i>J</i> = 6.79 Hz, 1H), 4.50 (d, <i>J</i> = 6.79 Hz, 1H), 4.22 (t, <i>J</i> = 6.79 Hz, 1H), 4.12 (d, <i>J</i> = 9.78 Hz, 1H), 4.06–4.01 (m, 1H), 3.85–3.84 (m, 2H), 3.72 (d, <i>J</i> = 9.78 Hz, 1H), 3.17 (s, 3H), 2.44–2.39 (m, 1H), 2.02–1.96 (m, 1H), 1.85–1.78 (m, 1H), 1.70–1.66 (m, 1H), 0.98 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> = 505.5 (MNa<sup>+</sup>).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (((1<i>S</i>,2<i>S</i>,4<i>R</i>)- and (1<i>R</i>,2<i>R</i>,4<i>S</i>)-4-(Allyloxy)-1-ethynyl-2-(methoxymethoxy)cyclopentyl)methoxy)(<i>tert</i>-butyl)diphenylsilane (±)-<b>11</b></h3><div class="NLM_p last">To a solution of compound (±)-<b>10</b> (3.24 g, 6.71 mmol) in MeOH (192 mL) under nitrogen was added potassium carbonate (2.78 g, 20.14 mmol). The reaction mixture was stirred at 0 °C, and then dimethyl(1-diazo-2-oxopropyl)phosphonate (2.015 mL, 13.42 mmol) was added dropwise under nitrogen. The reaction mixture was stirred at room temperature for 16 h and then concentrated in vacuo. The crude residue was purified by gradient elution on SiO<sub>2</sub> (PE/Et<sub>2</sub>O: 0–70%) to afford the expected compound (±)-<b>11</b> (3.21 g, 78%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 7.66–7.61 (m, 4H), 7.50–7.42 (m, 6H), 5.88–5.79 (m, 1H), 5.22–5.17 (m, 1H), 5.11–5.08 (m, 1H), 4.59 (s, 2H), 4.16 (t, <i>J</i> = 7.49 Hz, 1H), 4.08–4.03 (m, 1H), 3.86–3.84 (m, 2H), 3.66 (d, <i>J</i> = 9.76 Hz, 1H), 3.60 (d, <i>J</i> = 9.76 Hz, 1H), 3.22 (s, 3H), 3.02 (s, 1H), 2.15–2.10 (m, 1H), 1.99–1.96 (m, 2H), 1.93–1.89 (m, 1H), 1.02 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> = 501.5 (MNa<sup>+</sup>).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (1<i>R</i>,3<i>S</i>,4<i>S</i>)- and (1<i>S</i>,3<i>R</i>,4<i>R</i>)-3-(((<i>tert</i>-Butyldiphenylsilyl)oxy)methyl)-3-ethynyl-4-(methoxymethoxy)cyclopentan-1-ol (±)-<b>12</b></h3><div class="NLM_p last">To a solution of compound (±)-<b>11</b> (2.50 g, 5.22 mmol) in MeOH (11.5 mL) were added 1,3-dimethylbarbituric acid (1.631 g, 10.45 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (302 mg, 0.261 mmol) at room temperature. The reaction mixture was stirred at room temperature for 16 h and then concentrated in vacuo and directly purified by gradient elution on SiO<sub>2</sub> (PE/Et<sub>2</sub>O: 0–100%) to afford the expected compound (±)-<b>12</b> (1.98 g, 87%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 7.67–7.62 (m, 4H), 7.50–7.42 (m, 6H), 4.75–4.74 (m, 1H), 4.60 (d, <i>J</i> = 6.69 Hz, 1H), 4.57 (d, <i>J</i> = 6.69 Hz, 1H), 4.27–4.25 (m, 1H), 4.19 (t, <i>J</i> = 7.40 Hz, 1H), 3.66–3.60 (m, 2H), 3.22 (s, 3H), 2.97 (s, 1H), 2.13–2.08 (m, 1H), 2.01–1.93 (m, 1H), 1.87–1.81 (m, 1H), 1.79–1.75 (m, 1H), 1.02 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> = 461.4 (MNa<sup>+</sup>).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (1<i>S</i>,3<i>S</i>,4<i>S</i>)- and (1<i>R</i>,3<i>R</i>,4<i>R</i>)-3-(((<i>tert</i>-Butyldiphenylsilyl)oxy)methyl)-3-ethynyl-4-(methoxymethoxy)cyclopentan-1-ol (±)-<b>13</b></h3><div class="NLM_p last">To a suspension of PPh<sub>3</sub> (2.368 g, 9.03 mmol) in Et<sub>2</sub>O (60 mL) under nitrogen at 0 °C was added DIAD (1.778 mL, 9.03 mmol). This reaction mixture was stirred at 0 °C for 30 min. The resulting mixture was added to a solution of compound (±)-<b>12</b> (1.98 g, 4.51 mmol) and benzoic acid (1.103 g, 9.03 mmol) in Et<sub>2</sub>O (60 mL) at 0 °C. The reaction mixture was stirred at room temperature for 16 h and then concentrated in vacuo. A solution of 1% NaOH in MeOH (23 mL) was added, and the reaction mixture was stirred for 2 h. EtOAc (250 mL) was added followed by a 1 M HCl solution (250 mL). The aqueous layer was extracted twice with EtOAc, and the combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to afford the title compound (±)-<b>13</b> (1.581 g, 80%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 7.64–7.60 (m, 4H), 7.51–7.42 (m, 6H), 4.80–4.74 (m, 1H), 4.60–4.56 (m, 2H), 4.05–3.98 (m, 1H), 3.95–3.92 (m, 1H), 3.57 (d, <i>J</i> = 9.92 Hz, 1H), 3.46 (d, <i>J</i> = 9.92 Hz, 1H), 3.22 (s, 3H), 2.99 (s, 1H), 2.29–2.18 (m, 2H), 1.77–1.65 (m, 2H), 1.01 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> = 461.4 (MNa<sup>+</sup>).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Acetamido-9-((1<i>R</i>,3<i>S</i>,4<i>S</i>)- and (1<i>S</i>,3<i>R</i>,4<i>R</i>)-3-Ethynyl-3-(hydroxymethyl)-4-(methoxymethoxy)cyclopentyl)-9<i>H</i>-purin-6-yl Diphenylcarbamate (±)-<b>27</b></h3><div class="NLM_p"><i>Step a:</i> PPh<sub>3</sub> (0.718 g, 3 equiv) was suspended in anhydrous THF (15 mL) under nitrogen and cooled to 0 °C using an ice bath. Then DIAD (0.503 mL, 2.8 equiv) was added dropwise, and the reaction mixture was stirred 30 min. The resulting mixture was added to a solution of (±)-<b>13</b> (400 mg, 0.912 mmol) and 2-acetamido-9<i>H</i>-purin-6-yl-diphenylcarbamate (0.531 g, 1.5 equiv) in anhydrous THF (15 mL) at −41 °C (N<sub>2</sub>/acetonitrile bath). The reaction mixture was stirred at −41 °C for 2 h, then at room temperature for 16 h. The reaction mixture was concentrated in vacuo, then the crude residue was purified by gradient elution on SiO<sub>2</sub> (PE/Et<sub>2</sub>O: 0–10%) to afford the intermediate 2-acetamido-9-((1<i>R</i>,3<i>S</i>,4<i>S</i>)- and (1<i>S</i>,3<i>R</i>,4<i>R</i>)-3-(((<i>tert</i>-butyldiphenylsilyl)oxy)methyl)-3-ethynyl-4-(methoxymethoxy)cyclopentyl)-9<i>H</i>-purin-6-yl diphenylcarbamate (0.545 g) contaminated with DIAD-H<sub>2</sub>, which was used in the subsequent step without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 10.68 (s, 1H), 8.50 (s, 1H), 7.64–7.30 (m, 20H), 5.27–5.18 (m, 1H), 4.71–4.66 (m, 3H), 3.83 (d, <i>J</i> = 9.72 Hz, 1H), 3.77 (d, <i>J</i> = 9.72 Hz, 1H), 3.22 (s, 3H), 3.19 (s, 1H), 2.58–2.54 (m, 2H), 2.42–2.32 (m, 2H), 2.13 (s, 3H), 0.98 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> = 807.5 (MH<sup>–</sup>).</div><div class="NLM_p last"><i>Step b:</i> To a solution of product from step a in anhydrous THF (11 mL) and acetic acid (0.190 mL, 3.37 mmol) was added TBAF (1.35 mL, 1.35 mmol). The reaction mixture was stirred 16 h. Solvents were removed in vacuo, and the crude residue was purified by gradient elution on SiO<sub>2</sub> (DCM/MeOH: 0–5%) to afford (±)-<b>27</b> (384 mg, 74%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 10.70 (s, 1H), 8.54 (s, 1H), 7.50–7.31 (m, 10H), 5.25–5.12 (m, 2H), 4.69 (d, <i>J</i> = 6.63 Hz, 1H), 4.64 (d, <i>J</i> = 6.63 Hz, 1H), 4.45 (t, <i>J</i> = 7.22 Hz, 1H), 3.61–3.54 (m, 2H), 3.28 (s, 3H), 3.11 (s, 1H), 2.46–2.41 (m, 1H), 2.36–2.29 (m, 3H), 2.22 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> = 571.7 (MH<sup>+</sup>).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Amino-9-((1<i>R</i>,3<i>S</i>,4<i>S</i>)- and (1<i>S</i>,3<i>R</i>,4<i>R</i>)-3-ethynyl-4-hydroxy-3-(hydroxymethyl)cyclopentyl)-1,9-dihydro-6<i>H</i>-purin-6-one (±)-<b>29</b></h3><div class="NLM_p"><i>Step a</i>: (±)-<b>27</b> (0.235 g, 0.412 mmol) was dissolved in DCM (8.8 mL), and TFA (1.2 mL, 40 equiv) was added. The reaction mixture was stirred at room temperature for 16 h, then solvents were removed in vacuo. The product <i>N</i>-(9-((1<i>R</i>,3<i>S</i>,4<i>S</i>)- and (1<i>S</i>,3<i>R</i>,4<i>R</i>)-3-ethynyl-4-hydroxy-3-(hydroxymethyl)cyclopentyl)-6-oxo-6,9-dihydro-1<i>H</i>-purin-2-yl)acetamide was used in the subsequent step without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 12.01 (s, 1H), 11.68 (s, 1H), 8.15 (s, 1H), 5.10–5.03 (m, 3H), 4.31–4.27 (m, 1H), 3.54 (brs, 2H), 3.08 (s, 1H), 2.29–2.21 (m, 2H), 2.11–2.06 (m, 2H), 2.22 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> = 332.3 (MH<sup>+</sup>).</div><div class="NLM_p last"><i>Step b:</i> To a solution of the product of step a in MeCN (10 mL) was added a 7 N ammonia solution in MeOH (2.9 mL, 20.6 mmol). The reaction mixture was stirred at 50 °C for 16 h. The reaction mixture was then concentrated in vacuo, and the crude residue was triturated in a mixture water/MeCN (1:1), filtered, and washed with water/MeCN (1:1), MeCN, and pentane to afford the title compound (±)-<b>29</b> (119 mg, 73%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 10.55 (s, 1H), 7.81 (s, 1H), 6.44 (brs, 2H), 5.01 (t, <i>J</i> = 5.82 Hz, 1H), 4.98–4.91 (m, 2H), 4.29–4.24 (m, 1H), 3.56–3.48 (m, 2H), 3.04 (s, 1H), 2.22–2.11 (m, 3H), 2.08–2.02 (m, 1H); <sup>13</sup>C NMR (CD<sub>3</sub>OD, 176 MHz) δ (ppm) 159.45, 154.93, 152.89, 138.34, 118.08, 84.98, 74.93, 73.55, 66.03, 52.51, 51.32, 40.54, 39.40; MS (ESI) <i>m</i>/<i>z</i> = 290.4 (MH<sup>+</sup>). The two enantiomers of compound (±)-<b>29</b> were separated by preparative chiral SFC with the following conditions. Column: CHIRALCEL OD-H, 2 cm × 25 cm, 5 μm. Mobile phase A: CO<sub>2</sub>. Mobile phase B: MeOH. Gradient: 30% B in 6 min. Flow rate: 60 mL/min. Detector: UV 254 nm. The process afforded isomer <b>29a</b> (faster eluting, <i>t</i><sub>R</sub> = 1.76 min; MS (ESI) <i>m</i>/<i>z</i> = 290.2 (MH<sup>+</sup>)) and isomer <b>29b</b> (slower eluting, <i>t</i><sub>R</sub> = 2.22 min; MS (ESI) <i>m</i>/<i>z</i> = 290.2 (MH<sup>+</sup>)).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-{6-Ethoxy-9-[(1<i>R</i>,3<i>S</i>,4<i>S</i>)- and (1<i>S</i>,3<i>R</i>,4<i>R</i>)-3-Ethynyl-3-(hydroxymethyl)-4-(methoxymethoxy)cyclopentyl]-9<i>H</i>-purin-2-yl}-2-methylpropanamide (±)-<b>31</b></h3><div class="NLM_p"><i>Step a</i>: PPh<sub>3</sub> (1.658 g, 3 equiv) was suspended in anhydrous THF (60 mL) under N<sub>2</sub> and then cooled to 0 °C using an ice bath. DIAD (1.193 g, 2.8 equiv) was added dropwise, and the reaction mixture was stirred for 30 min. The resulting mixture was added to a solution of (±)-<b>13</b> (0.924 g, 2.107 mmol) and <i>N</i>-(6-ethoxy-9<i>H</i>-purin-2-yl)isobutyramide (0.788 g, 1.5 equiv) in anhydrous THF (60 mL) at −41 °C (N<sub>2</sub>/acetonitrile bath). The reaction mixture was stirred at −41 °C for 2 h and then warmed to room temperature for 16 h. Solvent was removed in vacuo, and the crude residue was purified by gradient elution on SiO<sub>2</sub> (DCM/MeOH: 0–10%) to afford 9-[(2<i>R</i>,4<i>S</i>,5<i>R</i>) and (2<i>S</i>,4<i>R</i>,5<i>S</i>)-5-[[<i>tert</i>-butyl(diphenyl)silyl]oxymethyl]-5-ethynyl-4-(methoxymethoxy)tetrahydrofuran-2-yl]-6-ethoxypurin-2-amine (0.706 g) contaminated with DIAD-H<sub>2</sub>. It was used in the subsequent step without further purification. MS (ESI) <i>m</i>/<i>z</i> = 670.4 (MH<sup>+</sup>).</div><div class="NLM_p last"><i>Step b</i>: To the product from step a dissolved in anhydrous THF (15 mL) and acetic acid (0.3 mL, 5.22 mmol) was added a solution of TBAF 1 M in THF (2.09 mL, 2.09 mmol). The reaction mixture was stirred at room temperature for 16 h. Solvents were removed in vacuo, and the crude residue was purified by gradient elution on SiO<sub>2</sub> (DCM/MeOH: 0–10%) to afford (±)-<b>31</b> (440 mg, 49% 2 steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 10.31 (s, 1H), 8.32 (s, 1H), 5.21–5.13 (m, 1H), 5.10 (t, <i>J</i> = 5.96 Hz, 1H), 4.69 (d, <i>J</i> = 6.62 Hz, 1H), 4.65 (d, <i>J</i> = 6.62 Hz, 1H), 4.57 (q, <i>J</i> = 7.06 Hz, 2H), 4.45 (t, <i>J</i> = 7.06 Hz, 1H), 3.62–3.54 (m, 2H), 3.28 (s, 3H), 3.10 (s, 1H), 2.98–2.91 (m, 1H), 2.41–2.22 (m, 4H), 1.40 (t, <i>J</i> = 7.06 Hz, 3H), 1.09 (d, <i>J</i> = 6.83 Hz, 6H); MS (ESI) <i>m</i>/<i>z</i> = 432.8 (MH<sup>+</sup>).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> [(1<i>S</i>,2<i>S</i>,4<i>R</i>)- and (1<i>R</i>,2<i>R</i>,4<i>S</i>)-4-(2-Amino-6-ethoxy-9<i>H</i>-purin-9-yl)-1-ethynyl-2-(methoxymethoxy)cyclopentyl]methanol (±)-<b>32</b></h3><div class="NLM_p last">A solution of potassium hydroxide (629 mg, 11.22 mmol) in MeOH (12 mL) was added to compound (±)-<b>31</b> (440 mg, 1.02 mmol). The reaction mixture was stirred at room temperature for 6 h and at 0 °C for 16 h and then quenched with acetic acid (0.701 mL, 12.24 mmol). The reaction mixture was concentrated in vacuo, and the crude residue purified by gradient elution on SiO<sub>2</sub> (DCM/MeOH: 0–10%) to afford (±)-<b>32</b> (212 mg, 66%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 7.99 (s, 1H), 6.39 (brs, 2H), 5.16 (t, <i>J</i> = 5.77 Hz, 1H), 5.10–5.01 (m, 1H), 4.67 (d, <i>J</i> = 6.69 Hz, 1H), 4.63 (d, <i>J</i> = 6.69 Hz, 1H), 4.44 (q, <i>J</i> = 7.01 Hz, 2H), 4.31–4.28 (m, 1H), 3.59–3.51 (m, 2H), 3.28 (s, 3H), 3.09 (s, 1H), 2.32–2.14 (m, 4H), 1.35 (t, <i>J</i> = 7.01 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> = 362.6 (MH<sup>+</sup>).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Propan-2-yl <i>N</i>-[(<i>S</i>)-{[(1<i>R</i>,2<i>R</i>,4<i>S</i>)-4-(2-Amino-6-ethoxy-9<i>H</i>-purin-9-yl)-1-ethynyl-2-(methoxymethoxy)cyclopentyl]methoxy}(phenoxy)phosphoryl]-<span class="smallcaps smallerCapital">l</span>-alaninate <b>33a</b> and Propan-2-yl <i>N</i>-[(<i>S</i>)-{[(1<i>S</i>,2<i>S</i>,4<i>R</i>)-4-(2-Amino-6-ethoxy-9<i>H</i>-purin-9-yl)-1-ethynyl-2-(methoxymethoxy)cyclopentyl]methoxy}(phenoxy)phosphoryl]-<span class="smallcaps smallerCapital">l</span>-alaninate <b>33b</b></h3><div class="NLM_p last">To a solution of compound (±)-<b>32</b> (240 mg, 0.66 mmol) in THF (10 mL) at 0 °C under nitrogen was added a 1 M solution of <i>tert</i>-butylmagnesium chloride in THF (1.66 mL, 1.66 mmol). The reaction mixture was stirred at 0 °C for 5 min, and then a solution of isopropyl ((<i>S</i>)-(perfluorophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate (331 mg, 0.731 mmol) in THF (10 mL) was added dropwise at 0 °C. The reaction mixture was allowed to warm slowly to room temperature and stirred at room temperature for 16 h. The resulting reaction mixture was diluted with EtOAc and washed with a saturated NH<sub>4</sub>Cl solution and brine. The organic layer was dried, filtered and concentrated in vacuo. The crude residue was purified by gradient elution on SiO<sub>2</sub> (DCM/MeOH: 0–10%) to afford the product a mixture of diastereomers <b>33a</b> and <b>33b</b> (344 mg, 82%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm) 7.94 (s, 0.5H), 7.93 (0.5H), 7.37–7.32 (m, 2H), 7.23–7.21 (m, 2H), 7.18–7.13 (m, 1H), 6.41–6.40 (m, 2H), 6.09–6.01 (m, 1H), 5.12–5.03 (m, 1H), 4.89–4.79 (m, 1H), 4.67–4.62 (m, 2H), 4.45 (q, <i>J</i> = 6.98 Hz, 2H), 4.34–4.07 (m, 3H), 3.86–3.78 (m, 1H), 3.28 (s, 1.5H), 3.275 (s, 1.5H), 3.24 (s, 0.5H), 3.23 (s, 0.5H), 2.40–2.11 (m, 4H), 1.35 (t, <i>J</i> = 6.98 Hz, 3H), 1.24–1.22 (m, 3H), 1.16–1.10 (m, 6H); <sup>31</sup>P NMR (DMSO-<i>d</i><sub>6</sub>, 162 MHz) δ (ppm) 3.26 (s, 0.5P), 3.15 (0.5P); MS (ESI) <i>m</i>/<i>z</i> = 631.4 (MH<sup>+</sup>).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Propan-2-yl <i>N</i>-[(<i>S</i>)-{[(1<i>R</i>,2<i>R</i>,4<i>S</i>)-4-(2-Amino-6-ethoxy-9<i>H</i>-purin-9-yl)-1-ethynyl-2-hydroxycyclopentyl]methoxy}(phenoxy)phosphoryl]-<span class="smallcaps smallerCapital">l</span>-alaninate <b>34a</b> and Propan-2-yl <i>N</i>-[(<i>S</i>)-{[(1<i>S</i>,2<i>S</i>,4<i>R</i>)-4-(2-Amino-6-ethoxy-9<i>H</i>-purin-9-yl)-1-ethynyl-2-hydroxycyclopentyl]methoxy}(phenoxy)phosphoryl]-<span class="smallcaps smallerCapital">l</span>-alaninate <b>34b</b></h3><div class="NLM_p last">To a solution of a mixture of diastereomers <b>33a</b> and <b>33b</b> (270 mg, 0.43 mmol) in DCM (5 mL) at 10 °C was added TFA (0.99 mL, 12.84 mmol). The reaction mixture was stirred between 10 and 25 °C for 2 h and at 0 °C for 2.5 h and then concentrated. The crude residue was purified by gradient elution on SiO<sub>2</sub> (DCM/MeOH: 0–4%) to afford the title compound as a mixture of diastereomers <b>34a</b> and <b>34b</b> (145 mg, 57%). <sup>31</sup>P NMR (DMSO-<i>d</i><sub>6</sub>, 162 MHz) δ (ppm) 3.34 (s, 0.4P), 3.28 (0.6P); MS (ESI) <i>m</i>/<i>z</i> = 587.8 (MH<sup>+</sup>). The two diastereomers <b>34a</b> and <b>34b</b> (139 mg) were separated by preparative chiral SFC with the following conditions. Column: CHIRALPAK AD-H, 2 cm × 25 cm, 5 μm. Mobile phase A: CO<sub>2</sub>. Mobile phase B: <sup><i>i</i></sup>PrOH. Gradient: 30% B in 8 min. Flow rate: 60 mL/min. Detector: UV 220 nm. The process afford <b>34a</b> and <b>34b</b>. Diastereomer <b>34a</b> (40 mg, 28%): faster eluting, <i>t</i><sub>R</sub> = 3.22 min; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm) 7.44 (s, 1H), 7.30–7.27 (m, 2H), 7.23–7.22 (m, 2H), 7.17–7.14 (m, 1H), 5.18 (brs, 2H), 5.08–5.02 (m, 2H), 4.53 (q, <i>J</i> = 7.31 Hz, 2H), 4.48–4.46 (m, 1H), 4.44–4.42 (m, 1H), 4.38–4.35 (m, 1H), 4.08–4.00 (m, 3H), 2.51–2.46 (m, 1H), 2.41 (s, 1H), 2.40–2.39 (m, 2H), 2.37–2.32 (m, 1H), 1.45 (t, <i>J</i> = 7.31 Hz, 3H), 1.405 (d, <i>J</i> = 6.83 Hz, 3H), 1.25 (d, <i>J</i> = 5.85 Hz, 3H), 1.24 (d, <i>J</i> = 5.85 Hz, 3H); <sup>13</sup>C NMR (CD<sub>3</sub>OD, 176 MHz) δ (ppm) 174.2, 162.0, 161.1, 154.3, 151.9, 138.3, 129.4, 124.8, 120.1, 115.3, 83.2, 74.6, 72.2, 68.8, 68.4, 61.9, 52.2, 51.0, 50.2, 38.8, 37.4, 20.5, 19.1, 13.4; <sup>31</sup>P NMR (CDCl<sub>3</sub>, 243 MHz) δ (ppm) 3.21 (s, 1P); MS (ESI) <i>m</i>/<i>z</i> = 587.6 (MH<sup>+</sup>). Diastereomer <b>34b</b> (42 mg, 30%): slower eluting, <i>t</i><sub>R</sub> = 5.37 min; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm) 7.52 (s, 1H), 7.33–7.30 (m, 2H), 7.25–7.21 (m, 2H), 7.18–7.15 (m, 1H), 5.24 (brs, 2H), 5.12–4.99 (m, 2H), 4.66–4.63 (m, 1H), 4.55–4.52 (m, 3H), 4.47–4.45 (m, 1H), 4.38–4.35 (m, 1H), 4.03–3.99 (m, 1H), 3.77–3.71 (m, 1H), 2.62–2.58 (m, 1H), 2.46–2.43 (m, 1H), 2.42 (s, 1H), 2.40–2.36 (m, 1H), 2.33–2.29 (m, 1H), 1.45 (t, <i>J</i> = 6.83 Hz, 3H), 1.39 (d, <i>J</i> = 6.83 Hz, 3H), 1.225 (d, <i>J</i> = 5.85 Hz, 3H), 1.22 (d, <i>J</i> = 5.85 Hz, 3H); <sup>13</sup>C NMR (CD<sub>3</sub>OD, 176 MHz) δ (ppm) 174.3, 162.3, 161.4, 154.4, 151.8, 139.7, 130.6, 126.1, 121.4, 115.6, 82.7, 75.9, 73.5, 73.4, 70.1, 69.8, 65.8, 52.4, 51.5, 49.9, 40.2, 21.9, 21.8, 20.3, 14.7; <sup>31</sup>P NMR (CDCl<sub>3</sub>, 243 MHz) δ (ppm) 2.88 (s, 1P); MS (ESI) <i>m</i>/<i>z</i> = 587.6 (MH<sup>+</sup>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00141" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00141" class="ext-link">10.1021/acs.jmedchem.8b00141</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">All experimental procedures, characterization data for new compounds, in vitro experimental protocols, and details on computational modeling (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for compounds <b>19</b>, <b>20</b>, <b>24</b>–<b>26</b>, <b>29b</b>, <b>30</b>, <b>34a</b>, and <b>34b</b> and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf">jm8b00141_si_001.pdf (441.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_002.csv">jm8b00141_si_002.csv (0.7 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00141" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">François-René Alexandre</span> - <span class="hlFld-Affiliation affiliation">Idenix
an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1396-3757" title="Orcid link">http://orcid.org/0000-0003-1396-3757</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ddbcb1b8a5bcb3b9afb8f3bbafbcb3beb2b4aef3afb8b3b89dbab0bcb4b1f3beb2b0"><span class="__cf_email__" data-cfemail="7d1c1118051c13190f18531b0f1c131e12140e530f1813183d1a101c1411531e1210">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Izzat T. Raheem</span> - <span class="hlFld-Affiliation affiliation">Merck
& Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6769-8816" title="Orcid link">http://orcid.org/0000-0002-6769-8816</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b9d0c3c3d8cde6cbd8d1dcdcd4f9d4dccbdad297dad6d4"><span class="__cf_email__" data-cfemail="6d0417170c19321f0c050808002d00081f0e06430e0200">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachid Rahali</span> - <span class="hlFld-Affiliation affiliation">Idenix
an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Houcine Rahali</span> - <span class="hlFld-Affiliation affiliation">Idenix
an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Guillon</span> - <span class="hlFld-Affiliation affiliation">Oxeltis, Cap Delta, 1682 Rue de la Valsière, 34189 Montpellier Cedex
4, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Convard</span> - <span class="hlFld-Affiliation affiliation">Idenix
an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kerry Fillgrove</span> - <span class="hlFld-Affiliation affiliation">Merck
& Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming-Tain Lai</span> - <span class="hlFld-Affiliation affiliation">Merck
& Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Christophe Meillon</span> - <span class="hlFld-Affiliation affiliation">Oxeltis, Cap Delta, 1682 Rue de la Valsière, 34189 Montpellier Cedex
4, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Xu</span> - <span class="hlFld-Affiliation affiliation">Merck
& Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Small</span> - <span class="hlFld-Affiliation affiliation">Merck
& Co., Inc., P.O. Box 4, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cyril B. Dousson</span> - <span class="hlFld-Affiliation affiliation">Idenix
an MSD Company, Cap Gamma, 1682 Rue de la Valsière, 34189 Montpellier Cedex 4, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>F.-R.A. and I.T.R. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3351-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30442" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30442" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank colleagues at Idenix and Merck & Co, Inc., Kenilworth, NJ, U.S., for their help and assistance during this project. Dr. John Sanders and Dr. Jay Grobler are gratefully acknowledged for support preparing this manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the plasma concentration–time curve</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichoromethane</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DPC</td><td class="NLM_def"><p class="first last">diphenylcarbamoyl</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">HAART</td><td class="NLM_def"><p class="first last">highly active antiretroviral therapy</p></td></tr><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">Me</td><td class="NLM_def"><p class="first last">methyl</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MOM</td><td class="NLM_def"><p class="first last">methoxymethyl</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors in the Treatment of HIV Infections (AIDS)</span>. In  <i>Advances in Pharmacology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>, Ed.;  <i>Antiviral Agents</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Oxford. U.K.</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">67</span>, pp  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-405880-4.00009-3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2FB978-0-12-405880-4.00009-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=317-358&author=E.+De+Clercqauthor=E.+De+Clercq&title=Advances+in+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-405880-4.00009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-405880-4.00009-3%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520Nucleoside%2520Reverse%2520Transcriptase%2520Inhibitors%252C%2520Nonnucleoside%2520Reverse%2520Transcriptase%2520Inhibitors%252C%2520and%2520Protease%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520HIV%2520Infections%2520%2528AIDS%2529%26btitle%3DAdvances%2520in%2520Pharmacology%26aulast%3DDe%2BClercq%26aufirst%3DE.%26btitle%3DAntiviral%2520Agents%26pub%3DAcademic%2520Press%26date%3D2013%26volume%3D67%26spage%3D317%26epage%3D358%26doi%3D10.1016%2FB978-0-12-405880-4.00009-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">A 40-Year Journey in Search of Selective Antiviral Chemotherapy*</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-010510-100228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1146%2Fannurev-pharmtox-010510-100228" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1-24&issue=1&author=E.+De+Clercq&title=A+40-Year+Journey+in+Search+of+Selective+Antiviral+Chemotherapy*&doi=10.1146%2Fannurev-pharmtox-010510-100228"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010510-100228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010510-100228%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DA%252040-Year%2520Journey%2520in%2520Search%2520of%2520Selective%2520Antiviral%2520Chemotherapy%252A%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2011%26volume%3D51%26issue%3D1%26spage%3D1%26epage%3D24%26doi%3D10.1146%2Fannurev-pharmtox-010510-100228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Anusha, N. P.</span></span> <span> </span><span class="NLM_article-title">Antiretroviral Strategies for Treatment of HIV</span>. <i>J. Antivirals Antiretrovirals</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.4172/jaa.1000036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.4172%2Fjaa.1000036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=55-59&author=N.+P.+Anusha&title=Antiretroviral+Strategies+for+Treatment+of+HIV&doi=10.4172%2Fjaa.1000036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.4172%2Fjaa.1000036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252Fjaa.1000036%26sid%3Dliteratum%253Aachs%26aulast%3DAnusha%26aufirst%3DN.%2BP.%26atitle%3DAntiretroviral%2520Strategies%2520for%2520Treatment%2520of%2520HIV%26jtitle%3DJ.%2520Antivirals%2520Antiretrovirals%26date%3D2011%26volume%3D3%26spage%3D55%26epage%3D59%26doi%3D10.4172%2Fjaa.1000036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tressler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godfrey, C.</span></span> <span> </span><span class="NLM_article-title">NRTI Backbone in HIV Treatment</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2051</span>– <span class="NLM_lpage">2062</span>, <span class="refDoi"> DOI: 10.2165/11640830-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.2165%2F11640830-000000000-00000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2051-2062&issue=16&author=R.+Tresslerauthor=C.+Godfrey&title=NRTI+Backbone+in+HIV+Treatment&doi=10.2165%2F11640830-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.2165%2F11640830-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11640830-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DTressler%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DC.%26atitle%3DNRTI%2520Backbone%2520in%2520HIV%2520Treatment%26jtitle%3DDrugs%26date%3D2012%26volume%3D72%26issue%3D16%26spage%3D2051%26epage%3D2062%26doi%3D10.2165%2F11640830-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudinot, F. D.</span></span> <span> </span><span class="NLM_article-title">Development and Optimization of Anti-HIV Nucleoside Analogs and Prodrugs: A Review of Their Cellular Pharmacology, Structure-Activity Relationships and Pharmacokinetics</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(99)00023-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2FS0169-409X%2899%2900023-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=117-151&issue=1&author=X.+Tanauthor=C.+K.+Chuauthor=F.+D.+Boudinot&title=Development+and+Optimization+of+Anti-HIV+Nucleoside+Analogs+and+Prodrugs%3A+A+Review+of+Their+Cellular+Pharmacology%2C+Structure-Activity+Relationships+and+Pharmacokinetics&doi=10.1016%2FS0169-409X%2899%2900023-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2899%2900023-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252899%252900023-X%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DX.%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DBoudinot%26aufirst%3DF.%2BD.%26atitle%3DDevelopment%2520and%2520Optimization%2520of%2520Anti-HIV%2520Nucleoside%2520Analogs%2520and%2520Prodrugs%253A%2520A%2520Review%2520of%2520Their%2520Cellular%2520Pharmacology%252C%2520Structure-Activity%2520Relationships%2520and%2520Pharmacokinetics%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1999%26volume%3D39%26issue%3D1%26spage%3D117%26epage%3D151%26doi%3D10.1016%2FS0169-409X%2899%2900023-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kukhanova, M. K.</span></span> <span> </span><span class="NLM_article-title">Anti-HIV Nucleoside Drugs: A Retrospective View into the Future</span>. <i>Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">768</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1134/S002689331206012X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1134%2FS002689331206012X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKhur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=768-779&issue=6&author=M.+K.+Kukhanova&title=Anti-HIV+Nucleoside+Drugs%3A+A+Retrospective+View+into+the+Future&doi=10.1134%2FS002689331206012X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HIV nucleoside drugs: A retrospective view into the future</span></div><div class="casAuthors">Kukhanova, M. K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology (Moscow, Russian Federation, English Edition)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">768-779</span>CODEN:
                <span class="NLM_cas:coden">MOLBBJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-8933</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica</span>)
        </div><div class="casAbstract">The review considers the design of antiretroviral drugs based on nucleoside analogs.  Approx. 30 drugs have been approved for treating HIV-infected patients over the past 25 years.  Seven nucleoside drugs act as HIV reverse transcriptase (RT) inhibitors and are clin. used in combination with inhibitors of other viral enzymes, integrase and protease, and nonnucleoside inhibitors of HIV RT.  Toxicity of nucleoside drugs and the possibility to obtain safe anti-HIV drugs by constructing their depot forms are discussed.  The results of developing anti-HIV drugs in Russia are described.  The future prospects of anti-HIV research are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRN48RNKXZwrVg90H21EOLACvtfcHk0liMmx0cHRpkXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKhur%252FM&md5=74c46def86147882225a75a6beacd355</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1134%2FS002689331206012X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS002689331206012X%26sid%3Dliteratum%253Aachs%26aulast%3DKukhanova%26aufirst%3DM.%2BK.%26atitle%3DAnti-HIV%2520Nucleoside%2520Drugs%253A%2520A%2520Retrospective%2520View%2520into%2520the%2520Future%26jtitle%3DMol.%2520Biol.%26date%3D2012%26volume%3D46%26issue%3D6%26spage%3D768%26epage%3D779%26doi%3D10.1134%2FS002689331206012X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lionne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, B.</span></span> <span> </span><span class="NLM_article-title">Intracellular Metabolism of Nucleoside/Nucleotide Analogues: a Bottleneck to Reach Active Drugs on HIV Reverse Transcriptase</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.2174/1389200217666151210141903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.2174%2F1389200217666151210141903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=26651972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsVGgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=237-252&author=A.+Vargaauthor=C.+Lionneauthor=B.+Roy&title=Intracellular+Metabolism+of+Nucleoside%2FNucleotide+Analogues%3A+a+Bottleneck+to+Reach+Active+Drugs+on+HIV+Reverse+Transcriptase&doi=10.2174%2F1389200217666151210141903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular Metabolism of Nucleoside/Nucleotide Analogues: a Bottleneck to Reach Active Drugs on HIV Reverse Transcriptase</span></div><div class="casAuthors">Varga, Andrea; Lionne, Corinne; Roy, Beatrice</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-252</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Background: To date, the most effective way to treat HIV is to use a highly active antiretroviral therapy (HAART) that combines three or more different drugs.  The usual regimen consists of two nucleoside reverse transcriptase inhibitors and either a protease inhibitor, a non-nucleoside reverse transcriptase inhibitor, or an integrase strand transfer inhibitor.  Due to the emerging resistance against the nucleoside analogs in use, there is a continuous need for the development of such therapeutic mols. with different structural features.  Objectives: In this review, we would like to summarize the state of knowledge of the antiretroviral nucleoside analogs intracellular metab.  Indeed, these mols. have to be phosphorylated in the cell, a process that is often a bottleneck, to produce their pharmacol. active triphosphorylated forms.  These forms can be used by the HIV reverse transcriptase.  Because they lack a 3'-hydroxyl group, they block further extension of the viral DNA, and finally lead to early chain termination.  Several kinases can act on the phosphorylation of these drugs; most of them have low nucleoside/nucleotide specificity.  On the other hand, there are also nucleotidases in the cell, which can reverse the phosphorylation process, thus shifting the equil. from the active triphosphorylated state to the non-active (not-, mono- or di-phosphorylated) states of these analogs.  Conclusion: Here, we would like to bring to the attention of the medicinal chemists that they have to take into account the limitation of the intracellular phosphorylation machinery when designing new nucleoside analog drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5v8upNgY8grVg90H21EOLACvtfcHk0lioeI3RnJq89A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsVGgu7k%253D&md5=589ddeaaf5282d1e27e65842839a8ad1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1389200217666151210141903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200217666151210141903%26sid%3Dliteratum%253Aachs%26aulast%3DVarga%26aufirst%3DA.%26aulast%3DLionne%26aufirst%3DC.%26aulast%3DRoy%26aufirst%3DB.%26atitle%3DIntracellular%2520Metabolism%2520of%2520Nucleoside%252FNucleotide%2520Analogues%253A%2520a%2520Bottleneck%2520to%2520Reach%2520Active%2520Drugs%2520on%2520HIV%2520Reverse%2520Transcriptase%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2016%26volume%3D17%26spage%3D237%26epage%3D252%26doi%3D10.2174%2F1389200217666151210141903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, W. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Toxicity of Nrti Antiviral Drugs: An Integrated Cellular Perspective</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">822</span>, <span class="refDoi"> DOI: 10.1038/nrd1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1038%2Fnrd1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=14526384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslarsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=812-822&issue=10&author=W.+Lewisauthor=B.+J.+Dayauthor=W.+C.+Copeland&title=Mitochondrial+Toxicity+of+Nrti+Antiviral+Drugs%3A+An+Integrated+Cellular+Perspective&doi=10.1038%2Fnrd1201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective</span></div><div class="casAuthors">Lewis, William; Day, Brian J.; Copeland, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">812-822</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral therapy (HAART) regimes based on nucleoside reverse transcriptase inhibitors (NRTIs) have revolutionized the treatment of AIDS in recent years.  Although HAART can successfully suppress viral replication in the long term, it is not without significant toxicity, which can seriously compromise treatment effectiveness.  A major toxicity that has been recognized for more than a decade is NRTI-related mitochondrial toxicity, which manifests as serious side effects such as hepatic failure and lactic acidosis.  However, a lack of understanding of the mechanisms underlying mitochondrial toxicity has hampered efforts to develop novel drugs with better side-effect profiles.  This review characterizes the pharmacol. mechanisms and pathways that are involved in mitochondrial dysfunction caused by NRTIs, and suggests opportunities for future pharmacol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSLd33wOAwYLVg90H21EOLACvtfcHk0lioeI3RnJq89A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslarsbo%253D&md5=e027a725c00f135731b9dbb041ae986f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1201%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26aulast%3DCopeland%26aufirst%3DW.%2BC.%26atitle%3DMitochondrial%2520Toxicity%2520of%2520Nrti%2520Antiviral%2520Drugs%253A%2520An%2520Integrated%2520Cellular%2520Perspective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26issue%3D10%26spage%3D812%26epage%3D822%26doi%3D10.1038%2Fnrd1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michailidis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.3390/v2020606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.3390%2Fv2020606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=20376302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFWms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=606-638&issue=2&author=K.+Singhauthor=B.+Marchandauthor=K.+A.+Kirbyauthor=E.+Michailidisauthor=S.+G.+Sarafianos&title=Structural+Aspects+of+Drug+Resistance+and+Inhibition+of+HIV-1+Reverse+Transcriptase&doi=10.3390%2Fv2020606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural aspects of drug resistance and inhibition of HIV-1 Reverse Transcriptase</span></div><div class="casAuthors">Singh, Kamalendra; Marchand, Bruno; Kirby, Karen A.; Michailidis, Eleftherios; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">606-638</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  HIV-1 Reverse Transcriptase (HIV-1 RT) has been the target of numerous approved anti-AIDS drugs that are key components of Highly Active Anti-Retroviral Therapies (HAART).  It remains the target of extensive structural studies that continue unabated for almost twenty years.  The crystal structures of wild-type or drug-resistant mutant HIV RTs in the unliganded form or in complex with substrates and/or drugs have offered valuable glimpses into the enzyme's folding and its interactions with DNA and dNTP substrates, as well as with nucleos(t)ide reverse transcriptase inhibitor (NRTI) and non-nucleoside reverse transcriptase inhibitor (NNRTIs) drugs.  These studies have been used to interpret a large body of biochem. results and have paved the way for innovative biochem. expts. designed to elucidate the mechanisms of catalysis and drug inhibition of polymerase and RNase H functions of RT.  In turn, the combined use of structural biol. and biochem. approaches has led to the discovery of novel mechanisms of drug resistance and has contributed to the design of new drugs with improved potency and ability to suppress multi-drug resistant strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqmEOrS-tfLVg90H21EOLACvtfcHk0lhhHyrgwRELVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFWms70%253D&md5=315c778aba130ec51e869377a5835009</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.3390%2Fv2020606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv2020606%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520Aspects%2520of%2520Drug%2520Resistance%2520and%2520Inhibition%2520of%2520HIV-1%2520Reverse%2520Transcriptase%26jtitle%3DViruses%26date%3D2010%26volume%3D2%26issue%3D2%26spage%3D606%26epage%3D638%26doi%3D10.3390%2Fv2020606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohrui, H.</span></span> <span> </span><span class="NLM_article-title">A New Paradigm for Developing Antiviral Drugs Exemplified by the Development of Supremely High Anti-HIV Active EFdA</span>. <i>J. Antivirals Antiretrovirals</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.4172/jaa.1000092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.4172%2Fjaa.1000092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=32-39&author=H.+Ohrui&title=A+New+Paradigm+for+Developing+Antiviral+Drugs+Exemplified+by+the+Development+of+Supremely+High+Anti-HIV+Active+EFdA&doi=10.4172%2Fjaa.1000092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A new paradigm for developing antiviral drugs exemplified by the development of supremely high anti-HIV active EFdA</span></div><div class="casAuthors">Ohrui, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antivirals & Antiretrovirals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">032-039, 8</span>CODEN:
                <span class="NLM_cas:coden">JAAOC9</span>;
        ISSN:<span class="NLM_cas:issn">1948-5964</span>.
    
            (<span class="NLM_cas:orgname">OMICS Publishing Group</span>)
        </div><div class="casAbstract">The fundamental concept for developing anti-viral modified nucleoside was proposed.  An idea to use 4'-C-substituted-2'-deoxynucleoside derivs. based on the fundamental concept was also proposed to solve the problems of the existing highly active antiretroviral therapy (HAART).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo_5svxCGj9rVg90H21EOLACvtfcHk0lhhHyrgwRELVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gtrvJ&md5=7e268939ef2368fb0b324fd4ce6b7029</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4172%2Fjaa.1000092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252Fjaa.1000092%26sid%3Dliteratum%253Aachs%26aulast%3DOhrui%26aufirst%3DH.%26atitle%3DA%2520New%2520Paradigm%2520for%2520Developing%2520Antiviral%2520Drugs%2520Exemplified%2520by%2520the%2520Development%2520of%2520Supremely%2520High%2520Anti-HIV%2520Active%2520EFdA%26jtitle%3DJ.%2520Antivirals%2520Antiretrovirals%26date%3D2014%26volume%3D6%26spage%3D32%26epage%3D39%26doi%3D10.4172%2Fjaa.1000092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Salie, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michailidis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of HIV Inhibition by Translocation-Defective RT Inhibitor 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine (EFdA)</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">9274</span>– <span class="NLM_lpage">9279</span>, <span class="refDoi"> DOI: 10.1073/pnas.1605223113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1073%2Fpnas.1605223113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=27489345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=9274-9279&author=Z.+L.+Salieauthor=K.+A.+Kirbyauthor=E.+Michailidisauthor=B.+Marchandauthor=K.+Singhauthor=L.+C.+Rohanauthor=E.+N.+Kodamaauthor=H.+Mitsuyaauthor=M.+A.+Parniakauthor=S.+G.+Sarafianos&title=Structural+Basis+of+HIV+Inhibition+by+Translocation-Defective+RT+Inhibitor+4%E2%80%B2-Ethynyl-2-Fluoro-2%E2%80%B2-Deoxyadenosine+%28EFdA%29&doi=10.1073%2Fpnas.1605223113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)</span></div><div class="casAuthors">Salie, Zhe Li; Kirby, Karen A.; Michailidis, Eleftherios; Marchand, Bruno; Singh, Kamalendra; Rohan, Lisa C.; Kodama, Eiichi N.; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">9274-9279</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) is the most potent nucleoside analog inhibitor of HIV reverse transcriptase (RT).  It retains a 3'-OH yet acts as a chain-terminating agent by diminishing translocation from the pretranslocation nucleotide-binding site (N site) to the posttranslocation primer-binding site (P site).  Also, facile misincorporation of EFdA-monophosphate (MP) results in difficult-to-extend mismatched primers.  To understand the high potency and unusual inhibition mechanism of EFdA, we solved RT crystal structures (resolns. from 2.4 to 2.9 Å) that include inhibition intermediates (i) before inhibitor incorporation (catalytic complex, RT/DNA/EFdA-triphosphate), (ii) after incorporation of EFdA-MP followed by dT-MP (RT/DNAEFdA-MPSUP°P/SUP°buldT-MPSUP°N/SUP°), or (iii) after incorporation of two EFdA-MPs (RT/DNAEFdA-MPSUP°P/SUP°bulEFdA-MPSUP°N/SUP°); (iv) the latter was also solved with EFdA-MP mismatched at the N site (RT/DNAEFdA-MPSUP°P/SUP°bulEFdA-MPtSUP°N/SUP°).  We report that the inhibition mechanism and potency of EFdA stem from interactions of its 4'-ethynyl at a previously unexploited conserved hydrophobic pocket in the polymerase active site.  The high resoln. of the catalytic complex structure revealed a network of ordered water mols. at the polymerase active site that stabilize enzyme interactions with nucleotide and DNA substrates.  Finally, decreased translocation results from favorable interactions of primer-terminating EFdA-MP at the pretranslocation site and unfavorable posttranslocation interactions that lead to obsd. localized primer distortions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-6y_9SBl-hbVg90H21EOLACvtfcHk0lhhHyrgwRELVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygt73K&md5=f3668fe0d312877907006a44549d1520</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1605223113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1605223113%26sid%3Dliteratum%253Aachs%26aulast%3DSalie%26aufirst%3DZ.%2BL.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DRohan%26aufirst%3DL.%2BC.%26aulast%3DKodama%26aufirst%3DE.%2BN.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520Basis%2520of%2520HIV%2520Inhibition%2520by%2520Translocation-Defective%2520RT%2520Inhibitor%25204%25E2%2580%25B2-Ethynyl-2-Fluoro-2%25E2%2580%25B2-Deoxyadenosine%2520%2528EFdA%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D9274%26epage%3D9279%26doi%3D10.1073%2Fpnas.1605223113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Michailidis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawani, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine Triphosphate, a Translocation-Defective Reverse Transcriptase Inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">35681</span>– <span class="NLM_lpage">35691</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.036616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1074%2Fjbc.M109.036616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=19837673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=35681-35691&author=E.+Michailidisauthor=B.+Marchandauthor=E.+N.+Kodamaauthor=K.+Singhauthor=M.+Matsuokaauthor=K.+A.+Kirbyauthor=E.+M.+Ryanauthor=A.+M.+Sawaniauthor=E.+Nagyauthor=N.+Ashidaauthor=H.+Mitsuyaauthor=M.+A.+Parniakauthor=S.+G.+Sarafianos&title=Mechanism+of+Inhibition+of+HIV-1+Reverse+Transcriptase+by+4%E2%80%B2-Ethynyl-2-Fluoro-2%E2%80%B2-Deoxyadenosine+Triphosphate%2C+a+Translocation-Defective+Reverse+Transcriptase+Inhibitor&doi=10.1074%2Fjbc.M109.036616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor</span></div><div class="casAuthors">Michailidis, Eleftherios; Marchand, Bruno; Kodama, Eiichi N.; Singh, Kamlendra; Matsuoka, Masao; Kirby, Karen A.; Ryan, Emily M.; Sawani, Ali M.; Nagy, Eva; Ashida, Noriyuki; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">35681-35691</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleoside reverse transcriptase inhibitors (NRTIs) are employed in first line therapies for the treatment of human immunodeficiency virus (HIV) infection.  They generally lack a 3'-hydroxyl group, and thus when incorporated into the nascent DNA they prevent further elongation.  The authors show that 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA), a nucleoside analog that retains a 3'-hydroxyl moiety, inhibited HIV-1 replication in activated peripheral blood mononuclear cells with an EC50 of 0.05 nM, a potency several orders of magnitude better than any of the current clin. used NRTIs.  This exceptional antiviral activity stems in part from a mechanism of action that is different from approved NRTIs.  Reverse transcriptase (RT) can use EFdA-5'-triphosphate (EFdA-TP) as a substrate more efficiently than the natural substrate, dATP.  Importantly, despite the presence of a 3'-hydroxyl, the incorporated EFdA monophosphate (EFdA-MP) acted mainly as a de facto terminator of further RT-catalyzed DNA synthesis because of the difficulty of RT translocation on the nucleic acid primer possessing 3'-terminal EFdA-MP.  EFdA-TP is thus a translocation-defective RT inhibitor (TDRTI).  This diminished translocation kept the primer 3'-terminal EFdA-MP ideally located to undergo phosphorolytic excision.  However, net phosphorolysis was not substantially increased, because of the apparently facile reincorporation of the newly excised EFdA-TP.  The authors' mol. modeling studies suggest that the 4'-ethynyl fits into a hydrophobic pocket defined by RT residues Ala 114, Tyr-115, Phe 160, and Met 184 and the aliph. chain of Asp 185.  These interactions, which contribute to both enhanced RT utilization of EFdA-TP and difficulty in the translocation of 3'-terminal EFdA-MP primers, underlie the mechanism of action of this potent antiviral nucleoside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSzybzRvJFz7Vg90H21EOLACvtfcHk0lgPSAfqAEuuWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurfI&md5=af4d7c768df0bc42d8a058bd7fd7e993</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.036616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.036616%26sid%3Dliteratum%253Aachs%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DKodama%26aufirst%3DE.%2BN.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DM.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DRyan%26aufirst%3DE.%2BM.%26aulast%3DSawani%26aufirst%3DA.%2BM.%26aulast%3DNagy%26aufirst%3DE.%26aulast%3DAshida%26aufirst%3DN.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DMechanism%2520of%2520Inhibition%2520of%2520HIV-1%2520Reverse%2520Transcriptase%2520by%25204%25E2%2580%25B2-Ethynyl-2-Fluoro-2%25E2%2580%25B2-Deoxyadenosine%2520Triphosphate%252C%2520a%2520Translocation-Defective%2520Reverse%2520Transcriptase%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D35681%26epage%3D35691%26doi%3D10.1074%2Fjbc.M109.036616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohgo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, M.</span></span> <span> </span><span class="NLM_article-title">2′-Deoxy-4′-<i>C</i>-ethynyl-2-halo-adenosines Active against Drug-Resistant Human Immunodeficiency Virus Type 1 Variants</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2410</span>– <span class="NLM_lpage">2420</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2008.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2Fj.biocel.2008.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=18487070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVaguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=2410-2420&author=A.+Kawamotoauthor=E.+Kodamaauthor=S.+G.+Sarafianosauthor=Y.+Sakagamiauthor=S.+Kohgoauthor=K.+Kitanoauthor=N.+Ashidaauthor=Y.+Iwaiauthor=H.+Hayakawaauthor=H.+Nakataauthor=H.+Mitsuyaauthor=E.+Arnoldauthor=M.+Matsuoka&title=2%E2%80%B2-Deoxy-4%E2%80%B2-C-ethynyl-2-halo-adenosines+Active+against+Drug-Resistant+Human+Immunodeficiency+Virus+Type+1+Variants&doi=10.1016%2Fj.biocel.2008.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">2'-Deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants</span></div><div class="casAuthors">Kawamoto, Atsushi; Kodama, Eiichi; Sarafianos, Stefan G.; Sakagami, Yasuko; Kohgo, Satoru; Kitano, Kenji; Ashida, Noriyuki; Iwai, Yuko; Hayakawa, Hiroyuki; Nakata, Hirotomo; Mitsuya, Hiroaki; Arnold, Eddy; Matsuoka, Masao</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2410-2420</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">One of the formidable challenges in therapy of infections by human immunodeficiency virus (HIV) is the emergence of drug-resistant variants that attenuate the efficacy of highly active antiretroviral therapy (HAART).  We have recently introduced 4'-ethynyl-nucleoside analogs as nucleoside reverse transcriptase inhibitors (NRTIs) that could be developed as therapeutics for treatment of HIV infections.  In this study, we present 2'-deoxy-4'-C-ethynyl-2-fluoroadenosine (EFdA), a second generation 4'-ethynyl inhibitor that exerted highly potent activity against wild-type HIV-1 (EC50 ∼ 0.07 nM).  EFdA retains potency toward many HIV-1 resistant strains, including the multi-drug resistant clone HIV-1A62V/V75I/F77L/F116Y/q151M.  The selectivity index of EFdA (cytotoxicity/inhibitory activity) is more favorable than all approved NRTIs used in HIV therapy.  Furthermore, EFdA efficiently inhibited clin. isolates from patients heavily treated with multiple anti-HIV-1 drugs.  EFdA appears to be primarily phosphorylated by the cellular 2'-deoxycytidine kinase (dCK) because: (a) the antiviral activity of EFdA was reduced by the addn. of dC, which competes nucleosides phosphorylated by the dCK pathway, (b) the antiviral activity of EFdA was significantly reduced in dCK-deficient HT-1080/Ara-Cr cells, but restored after dCK transduction.  Further, unlike other dA analogs, EFdA is completely resistant to degrdn. by adenosine deaminase.  Moderate decrease in susceptibility to EFdA is conferred by a combination of three RT mutations (I142V, T165R, and M184V) that result in a significant decrease of viral fitness.  Mol. modeling anal. suggests that the M184V/I substitutions may reduce anti-HIV activity of EFdA through steric hindrance between its 4'-ethynyl moiety and the V/I184 β-branched side chains.  The present data suggest that EFdA, is a promising candidate for developing as a therapeutic agent for the treatment of individuals harboring multi-drug resistant HIV variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1x9Q0xUpKX7Vg90H21EOLACvtfcHk0lj01xwwWno7Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVaguro%253D&md5=69039c735ae8e2f42c73c085f5ba87a3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DA.%26aulast%3DKodama%26aufirst%3DE.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DSakagami%26aufirst%3DY.%26aulast%3DKohgo%26aufirst%3DS.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DAshida%26aufirst%3DN.%26aulast%3DIwai%26aufirst%3DY.%26aulast%3DHayakawa%26aufirst%3DH.%26aulast%3DNakata%26aufirst%3DH.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DMatsuoka%26aufirst%3DM.%26atitle%3D2%25E2%2580%25B2-Deoxy-4%25E2%2580%25B2-C-ethynyl-2-halo-adenosines%2520Active%2520against%2520Drug-Resistant%2520Human%2520Immunodeficiency%2520Virus%2520Type%25201%2520Variants%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2008%26volume%3D40%26spage%3D2410%26epage%3D2420%26doi%3D10.1016%2Fj.biocel.2008.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphey-Corb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyaundi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didier, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span> <span> </span><span class="NLM_article-title">Response of Simian Immunodeficiency Virus to the Novel Nucleoside Reverse Transcriptase Inhibitor 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine in Vitro and in Vivo</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4707</span>– <span class="NLM_lpage">4712</span>, <span class="refDoi"> DOI: 10.1128/AAC.00723-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1128%2FAAC.00723-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=4707-4712&author=M.+Murphey-Corbauthor=P.+Rajakumarauthor=H.+Michaelauthor=J.+Nyaundiauthor=P.+J.+Didierauthor=A.+B.+Reeveauthor=H.+Mitsuyaauthor=S.+G.+Sarafianosauthor=M.+A.+Parniak&title=Response+of+Simian+Immunodeficiency+Virus+to+the+Novel+Nucleoside+Reverse+Transcriptase+Inhibitor+4%E2%80%B2-Ethynyl-2-Fluoro-2%E2%80%B2-Deoxyadenosine+in+Vitro+and+in+Vivo&doi=10.1128%2FAAC.00723-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FAAC.00723-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00723-12%26sid%3Dliteratum%253Aachs%26aulast%3DMurphey-Corb%26aufirst%3DM.%26aulast%3DRajakumar%26aufirst%3DP.%26aulast%3DMichael%26aufirst%3DH.%26aulast%3DNyaundi%26aufirst%3DJ.%26aulast%3DDidier%26aufirst%3DP.%2BJ.%26aulast%3DReeve%26aufirst%3DA.%2BB.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26atitle%3DResponse%2520of%2520Simian%2520Immunodeficiency%2520Virus%2520to%2520the%2520Novel%2520Nucleoside%2520Reverse%2520Transcriptase%2520Inhibitor%25204%25E2%2580%25B2-Ethynyl-2-Fluoro-2%25E2%2580%25B2-Deoxyadenosine%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D4707%26epage%3D4712%26doi%3D10.1128%2FAAC.00723-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> MK-8591 with Doravirine and Lamivudine
in Participants
Infected with Human Immunodeficiency Virus Type 1 (MK-8591-011). <a href="https://clinicaltrials.gov/ct2/show/NCT03272347" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03272347</a> (accessed July 17, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MK-8591+with+Doravirine+and+Lamivudine%0Ain+Participants%0AInfected+with+Human+Immunodeficiency+Virus+Type+1+%28MK-8591-011%29.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03272347+%28accessed+July+17%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Grobler, J.</span>; <span class="NLM_string-name">Friedman, E.</span>; <span class="NLM_string-name">Barrett, S. E.</span>; <span class="NLM_string-name">Wood, S. L.</span>; <span class="NLM_string-name">Ankrom, W.</span>; <span class="NLM_string-name">Fillgrove, K. L.</span>; <span class="NLM_string-name">Lai, M.-T.</span>; <span class="NLM_string-name">Gindy, M.</span>; <span class="NLM_string-name">Iwamoto, M.</span>; <span class="NLM_string-name">Hazuda, D. J.</span></span> <span> </span><span class="NLM_article-title">Long-Acting Oral and Parenteral Dosing of MK-8591 for HIV Treatment or Prophylaxis</span>. Presented at the CROI, Boston, MA, U.S., <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Grobler&author=E.+Friedman&author=S.+E.+Barrett&author=S.+L.+Wood&author=W.+Ankrom&author=K.+L.+Fillgrove&author=M.-T.+Lai&author=M.+Gindy&author=M.+Iwamoto&author=D.+J.+Hazuda&title=Long-Acting+Oral+and+Parenteral+Dosing+of+MK-8591+for+HIV+Treatment+or+Prophylaxis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGrobler%26aufirst%3DJ.%26atitle%3DLong-Acting%2520Oral%2520and%2520Parenteral%2520Dosing%2520of%2520MK-8591%2520for%2520HIV%2520Treatment%2520or%2520Prophylaxis%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, R. P.</span>; <span class="NLM_string-name">Schürmann, D.</span>; <span class="NLM_string-name">Rudd, D. J.</span>; <span class="NLM_string-name">Levine, V.</span>; <span class="NLM_string-name">Fox-Bosetti, S.</span>; <span class="NLM_string-name">Zhang, S.</span>; <span class="NLM_string-name">Robberechts, M.</span>; <span class="NLM_string-name">Huser, A.</span>; <span class="NLM_string-name">Hazuda, D. J.</span>; <span class="NLM_string-name">Iwamoto, M.</span>; <span class="NLM_string-name">Grobler, J. A.</span></span> <span> </span><span class="NLM_article-title">Single Doses as Low as 0.5 mg of the Novel NRTTI MK-8591 Suppress HIV for at Least Seven Days</span>. Presented at the IAS, Paris, France, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+P.+Matthews&author=D.+Sch%C3%BCrmann&author=D.+J.+Rudd&author=V.+Levine&author=S.+Fox-Bosetti&author=S.+Zhang&author=M.+Robberechts&author=A.+Huser&author=D.+J.+Hazuda&author=M.+Iwamoto&author=J.+A.+Grobler&title=Single+Doses+as+Low+as+0.5+mg+of+the+Novel+NRTTI+MK-8591+Suppress+HIV+for+at+Least+Seven+Days"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DR.%2BP.%26atitle%3DSingle%2520Doses%2520as%2520Low%2520as%25200.5%2520mg%2520of%2520the%2520Novel%2520NRTTI%2520MK-8591%2520Suppress%2520HIV%2520for%2520at%2520Least%2520Seven%2520Days%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nyaku, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiwo, B. O.</span></span> <span> </span><span class="NLM_article-title">Long-Acting Antiretrovirals: Where Are We Now?</span>. <i>Curr. HIV/AIDS Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1007/s11904-017-0353-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1007%2Fs11904-017-0353-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=28303548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A280%3ADC%252BC1cznt1Smtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=63-71&author=A.+N.+Nyakuauthor=S.+G.+Kellyauthor=B.+O.+Taiwo&title=Long-Acting+Antiretrovirals%3A+Where+Are+We+Now%3F&doi=10.1007%2Fs11904-017-0353-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Long-Acting Antiretrovirals: Where Are We now?</span></div><div class="casAuthors">Nyaku Amesika N; Kelly Sean G; Taiwo Babafemi O; Taiwo Babafemi O</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV/AIDS reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">63-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Current HIV treatment options require daily use of combination antiretroviral drugs.  Many persons living with HIV experience treatment fatigue and suboptimal adherence as a result.  Long-acting antiretroviral drugs are being developed to expand options for HIV treatment.  Here, we review the agents in development, and evaluate data from recent clinical trials.  In addition, we anticipate challenges to successful widespread use of long-acting antiretrovirals.  RECENT FINDINGS:  Parenteral nanosuspensions of cabotegravir and rilpivirine, and dapivirine vaginal ring are the farthest in clinical development.  Long-acting modalities in earlier development stages employ drug-loaded implants, microparticles, or targeted mutagenesis, among other innovations.  Long-acting antiretroviral drugs promise new options for HIV prevention and treatment, and ways to address poor adherence and treatment fatigue.  Further studies will identify the long-acting agents or combinations that are suitable for routine use.  Creative solutions will be needed for anticipated implementation challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKP8arQFIJ-uRS7coPn-RtfW6udTcc2eahlkLtj9ykY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cznt1Smtg%253D%253D&md5=d78bfa6bd94a1f4df4b5e19062d0ea05</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1007%2Fs11904-017-0353-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11904-017-0353-0%26sid%3Dliteratum%253Aachs%26aulast%3DNyaku%26aufirst%3DA.%2BN.%26aulast%3DKelly%26aufirst%3DS.%2BG.%26aulast%3DTaiwo%26aufirst%3DB.%2BO.%26atitle%3DLong-Acting%2520Antiretrovirals%253A%2520Where%2520Are%2520We%2520Now%253F%26jtitle%3DCurr.%2520HIV%252FAIDS%2520Rep.%26date%3D2017%26volume%3D14%26spage%3D63%26epage%3D71%26doi%3D10.1007%2Fs11904-017-0353-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, C. M.</span></span> <span> </span><span class="NLM_article-title">Abacavir: A Review of its Clinical Potential in Patients with HIV Infection</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.2165/00003495-200060020-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.2165%2F00003495-200060020-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10983741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslWgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=447-479&author=P.+S.+Herveyauthor=C.+M.+Perry&title=Abacavir%3A+A+Review+of+its+Clinical+Potential+in+Patients+with+HIV+Infection&doi=10.2165%2F00003495-200060020-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Abacavir A review of its clinical potential in patients with HIV infection</span></div><div class="casAuthors">Hervey, Pauline S.; Perry, Caroline M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">447-479</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 108 refs.  Abacavir is a carbocyclic 2'-deoxyguanosine nucleoside analog.  It is metabolized intracellularly to a 2'-deoxyguanosine nucleoside analog which competitively inhibits HIV reverse transcriptase and terminates proviral DNA chain extension.  In double-blind trials in antiretroviral therapy-experienced or -naive patients, redns. in HIV RNA levels were greater and more prolonged in patients receiving abacavir in combination with other antiretroviral drugs than in those receiving placebo in combination with the same agents.  Furthermore, abacavir in combination with lamivudine and zidovudine reduced viral load to below detectable levels in a proportion of patients, and to a similar extent to the protease inhibitor indinavir in combination with lamivudine and zidovudine.  Greatest viral load redns. were seen in antiretroviral therapy-naive patients.  Preliminary results suggest that the viral suppression achieved with a protease inhibitor plus 2 nucleoside reverse transcriptase inhibitors (NRTIs) can be maintained as effectively with abacavir in combination with 2 NRTIs as it can be by continuing the protease inhibitor-contg. treatment regimen.  Initial virol. data from studies of combination regimens including abacavir and protease inhibitors appear promising but larger controlled trials are required to confirm these observations.  Nausea is the most frequently reported adverse event in patients receiving abacavir-contg. combination therapy.  Adverse events tend to be reported most frequently soon after starting treatment; the majority of events are mild or moderate in intensity and transient.  Other adverse events reported in >5% of patients include vomiting, malaise and fatigue, headache, diarrhea, sleep disorders, cough, anorexia and rash.  A major cause of abacavir treatment discontinuation is the development of a hypersensitivity reaction which has been reported in 3 to 5% of patients.  The reaction usually occurs within 6 wk of commencing treatment, shows evidence of multiorgan system involvement and typically includes fever and/or rash.  Symptoms resolve rapidly after discontinuation of treatment.  Continuing treatment or rechallenge can result in more severe symptoms, life-threatening hypotension and even death.  Abacavir used in combination with other antiretroviral drugs effectively reduces viral load in both adults and children with HIV infection.  Although these responses are greatest in individuals with little or no previous antiretroviral treatment, useful responses agree still sometimes achieved in heavily pretreated individuals.  Abacavir in combination with lamivudine and zidovudine provides a simple and convenient dosage regimen which is generally well tolerated, able to produce sustained suppression of viral replication and has the advantage of sparing other classes of antiretroviral drugs for subsequent use.  This triple combination represents an alternative antiretroviral regimen for patients intolerant to protease inhibitors or those wishing to retain the option of protease inhibitors for later use.  Further clin. studies are needed to define the activity of abacavir in combination with protease inhibitors and non-nucleoside reverse transcriptase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHo1d2XSPQqLVg90H21EOLACvtfcHk0lisHeXpn-9YLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslWgurw%253D&md5=062632cb422b7897073fa86cc3874fc8</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.2165%2F00003495-200060020-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200060020-00015%26sid%3Dliteratum%253Aachs%26aulast%3DHervey%26aufirst%3DP.%2BS.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26atitle%3DAbacavir%253A%2520A%2520Review%2520of%2520its%2520Clinical%2520Potential%2520in%2520Patients%2520with%2520HIV%2520Infection%26jtitle%3DDrugs%26date%3D2000%26volume%3D60%26spage%3D447%26epage%3D479%26doi%3D10.2165%2F00003495-200060020-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pakes, G. E.</span></span> <span> </span><span class="NLM_article-title">A Review of the Pharmacokinetis of Abacavir</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.2165/00003088-200847060-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.2165%2F00003088-200847060-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=18479171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1ehsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=351-371&author=G.+J.+Yuenauthor=S.+Wellerauthor=G.+E.+Pakes&title=A+Review+of+the+Pharmacokinetis+of+Abacavir&doi=10.2165%2F00003088-200847060-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the pharmacokinetics of abacavir</span></div><div class="casAuthors">Yuen, Geoffrey J.; Weller, Steve; Pakes, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">351-371</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Abacavir is a carbocyclic 2'-deoxyguanosine nucleoside reverse transcriptase inhibitor that is used as either a 600-mg once-daily or 300-mg twice-daily regimen exclusively in the treatment of HIV infection.  Abacavir is rapidly absorbed after oral administration, with peak concns. occurring 0.63-1 h after dosing.  The abs. bioavailability of abacavir is approx. 83%.  Abacavir pharmacokinetics are linear and dose-proportional over the range of 300-1200 mg/day.  To date, one study has assessed the steady-state pharmacokinetics of abacavir following a 600-mg once-daily regimen, and reported a geometric mean steady-state abacavir peak concn. of 3.85 μg/mL.  Although this concn. is higher than the steady-state abacavir peak concn. reported following a 300-mg twice-daily regimen (0.88-3.19 μg/mL, depending on the study), the geometric mean steady-state abacavir exposure over 24 h was similar following these regimens.  Coadministration with food has no significant effect on abacavir exposure; therefore, abacavir may be administered with or without food.  The apparent vol. of distribution of abacavir after i.v. administration is approx. 0.86 ± 0.15 L/kg, suggesting that abacavir is distributed to extravascular spaces.  Binding to plasma proteins is about 50% and is independent of the plasma abacavir concn.  Abacavir is extensively metabolized by the liver; less than 2% is excreted as unchanged drug in the urine.  Abacavir is primarily metabolized via two pathways, uridine diphosphate glucuronyltransferase and alc. dehydrogenase, resulting in the inactive glucuronide metabolite (361W94, ∼36% of the dose recovered in the urine) and the inactive carboxylate metabolite (2269W93, ∼30% of the dose recovered in the urine).  The remaining 15% of abacavir equiv. found in the urine are minor metabolites, each less than 2% of the total dose.  Faecal elimination accounts for about 16% of the dose.  The terminal elimination half-life of abacavir is approx. 1.5 h.  The antiviral effect of abacavir is due to its intracellular anabolite, carbovir-triphosphate (CBV-TP).  When assessed by validated high-performance liq. chromatog. electrospray ionization tandem mass spectrometry, CBV-TP has been shown to have a long elimination half-life (>20 h), supporting once-daily dosing.  The mean CBV-TP trough concns. do not differ following abacavir 600-mg once-daily and 300-mg twice-daily regimens.  Limited data are available for abacavir in subjects with renal dysfunction or hepatic impairment.  Abacavir pharmacokinetics in HIV-infected subjects with end-stage renal disease were found to be no different from those obsd. in healthy adults; this finding was consistent with the kidney being a minor route of abacavir elimination.  A study of abacavir pharmacokinetics in hepatically impaired adults (Child-Pugh score of 5-6) showed that the abacavir area under the plasma concn.-time curve and elimination half-life were 89% and 58% greater, resp., suggesting that the daily dose of abacavir should be reduced in patients with mild hepatic impairment (Child-Pugh score of 5-6).  Abacavir pharmacokinetics have not been studied in patients with higher Child-Pugh scores.  Abacavir is not significantly metabolized by cytochrome P 450 (CYP) enzymes, nor does it inhibit these enzymes.  Therefore, clin. significant drug interactions between abacavir and drugs metabolized by CYP enzymes are unlikely.  The potential for drug interactions is no different when abacavir is used as a once-daily regimen vs. a twice-daily regimen.  No clin. significant drug interactions have been obsd. between recommended doses of abacavir and lamivudine, zidovudine, alc. (ethanol) or methadone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoqL_LBoD9FbVg90H21EOLACvtfcHk0lisHeXpn-9YLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1ehsrw%253D&md5=1f8910ab20febad83100819dd725613a</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.2165%2F00003088-200847060-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200847060-00001%26sid%3Dliteratum%253Aachs%26aulast%3DYuen%26aufirst%3DG.%2BJ.%26aulast%3DWeller%26aufirst%3DS.%26aulast%3DPakes%26aufirst%3DG.%2BE.%26atitle%3DA%2520Review%2520of%2520the%2520Pharmacokinetis%2520of%2520Abacavir%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2008%26volume%3D47%26spage%3D351%26epage%3D371%26doi%3D10.2165%2F00003088-200847060-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Rawal, R.
K.</span>; <span class="NLM_string-name">Chu, C. K.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Carbocyclic Nucleosides: Synthesis and Biological Activity</span>. In  <i>Medicinal Chemistry of Nucleic Acids</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-H.</span>, <span class="NLM_string-name">Xi, Z.</span>, <span class="NLM_string-name">Chattopadhyaya, J.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2011</span>; Chapter 1, pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1002/9781118092804.ch1</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1002%2F9781118092804.ch1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1-100&author=J.+Wang&author=R.%0AK.+Rawal&author=C.+K.+Chuauthor=L.-H.+Zhang&author=Z.+Xi&author=J.+Chattopadhyaya&title=Medicinal+Chemistry+of+Nucleic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2F9781118092804.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118092804.ch1%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DRecent%2520Advances%2520in%2520Carbocyclic%2520Nucleosides%253A%2520Synthesis%2520and%2520Biological%2520Activity%26btitle%3DMedicinal%2520Chemistry%2520of%2520Nucleic%2520Acids%26aulast%3DZhang%26aufirst%3DL.-H.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2011%26spage%3D1%26epage%3D100%26doi%3D10.1002%2F9781118092804.ch1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. K.</span></span> <span> </span><span class="NLM_article-title">Enantiomeric synthesis of carbocyclic D-4′-<i>C</i>-methylribonucleosides as Potential Antiviral Agents</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3304</span>– <span class="NLM_lpage">3314</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2006.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2Fj.tetasy.2006.12.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=3304-3314&author=P.+Liuauthor=A.+Sharonauthor=C.+K.+Chu&title=Enantiomeric+synthesis+of+carbocyclic+D-4%E2%80%B2-C-methylribonucleosides+as+Potential+Antiviral+Agents&doi=10.1016%2Fj.tetasy.2006.12.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2006.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2006.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DSharon%26aufirst%3DA.%26aulast%3DChu%26aufirst%3DC.%2BK.%26atitle%3DEnantiomeric%2520synthesis%2520of%2520carbocyclic%2520D-4%25E2%2580%25B2-C-methylribonucleosides%2520as%2520Potential%2520Antiviral%2520Agents%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2006%26volume%3D17%26spage%3D3304%26epage%3D3314%26doi%3D10.1016%2Fj.tetasy.2006.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, O.
H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. H.</span></span> <span> </span><span class="NLM_article-title">Efficient Synthesis of Novel Carbocyclic Nucleosides via Sequential Claisen Rearrangement and Ring-Closing Metathesis</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6399</span>– <span class="NLM_lpage">6402</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(02)01384-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2FS0040-4039%2802%2901384-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=6399-6402&author=O.%0AH.+Koauthor=J.+H.+Hong&title=Efficient+Synthesis+of+Novel+Carbocyclic+Nucleosides+via+Sequential+Claisen+Rearrangement+and+Ring-Closing+Metathesis&doi=10.1016%2FS0040-4039%2802%2901384-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2901384-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252901384-9%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DO.%2BH.%26aulast%3DHong%26aufirst%3DJ.%2BH.%26atitle%3DEfficient%2520Synthesis%2520of%2520Novel%2520Carbocyclic%2520Nucleosides%2520via%2520Sequential%2520Claisen%2520Rearrangement%2520and%2520Ring-Closing%2520Metathesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D6399%26epage%3D6402%26doi%3D10.1016%2FS0040-4039%2802%2901384-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antiviral Activity of Novel 2′,4′-Doubly Branched Carbocyclic Nucleosides</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">822</span>, <span class="refDoi"> DOI: 10.1081/NCN-120039252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1081%2FNCN-120039252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=15281369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFGntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=813-822&author=A.+Kimauthor=J.+H.+Hong&title=Synthesis+and+Antiviral+Activity+of+Novel+2%E2%80%B2%2C4%E2%80%B2-Doubly+Branched+Carbocyclic+Nucleosides&doi=10.1081%2FNCN-120039252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antiviral Activity of Novel 2',4'-Doubly Branched Carbocyclic Nucleosides</span></div><div class="casAuthors">Kim, Aihong; Hong, Joon Hee</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">813-822</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A series of 2' and 4'-doubly branched carbocyclic nucleosides, e.g. I, were synthesized as antiviral agents starting from simple acyclic ketone derivs.  The required 4'-quaternary carbon was constructed using Claisen rearrangement.  In addn., the installation of a Me group in the 2'-position was accomplished using a Grignard carbonyl addn. of iso-propenyl-magnesium bromide.  Bis-vinyl was successfully cyclized using a Grubbs' catalyst II.  Natural bases (adenine, cytosine) were efficiently coupled by using Pd(0) catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouP1mZul3u27Vg90H21EOLACvtfcHk0lhzP9Tyqmfang"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFGntbc%253D&md5=a6c27a9b885cdfbde8cf1d3b32c40040</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1081%2FNCN-120039252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-120039252%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%2BH.%26atitle%3DSynthesis%2520and%2520Antiviral%2520Activity%2520of%2520Novel%25202%25E2%2580%25B2%252C4%25E2%2580%25B2-Doubly%2520Branched%2520Carbocyclic%2520Nucleosides%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2004%26volume%3D23%26spage%3D813%26epage%3D822%26doi%3D10.1081%2FNCN-120039252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. H.</span></span> <span> </span><span class="NLM_article-title">Novel Synthesis of 4′C-Aryl-Branched Acyclic Nucleoside Using [3,3]-Sigmatropic Rearrangement</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1781</span>– <span class="NLM_lpage">1788</span>, <span class="refDoi"> DOI: 10.1081/NCN-120023272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1081%2FNCN-120023272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=14533881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFelurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=1781-1788&author=G.+H.+Baikauthor=B.+Y.+Chungauthor=C.-H.+Ohauthor=J.-H.+Choauthor=O.+H.+Koauthor=J.+H.+Hong&title=Novel+Synthesis+of+4%E2%80%B2C-Aryl-Branched+Acyclic+Nucleoside+Using+%5B3%2C3%5D-Sigmatropic+Rearrangement&doi=10.1081%2FNCN-120023272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12dR"><div class="casContent"><span class="casTitleNuber">12d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Synthesis of 4'C-Aryl-Branched Acyclic Nucleoside Using [3,3]-Sigmatropic Rearrangement</span></div><div class="casAuthors">Baik, Gun Ha; Chung, Bong Young; Oh, Chang-Hyun; Cho, Jung-Hyuck; Ko, Ok Hyun; Hong, Joon Hee</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1781-1788</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A very efficient synthetic route for prepg. a novel 4'-C-aryl branched-1',2'-seco-2',3'-dideoxy-2',3'-didehydro-nucleoside is described.  Mesylate I was successfully synthesized via a Horner-Wadsworth-Emmons reaction and a [3,3]sigmatropic rearrangement, with which an adenine base was coupled by nucleophilic substitution conditions (K2CO3, 18-Crown-6, DMF) to give the target nucleoside II.  This study aimed to synthesize novel classes of nucleosides, which are hybrids of branched carbocyclic and 1',2'-seco-acyclic nucleoside analogs showing marginal anti-HIV activity.  An antiviral assay of the synthesized nucleoside II against HIV-1, HSV-1, HSV-2, and HCMV was performed.  However, no significant antiviral activity or cytotoxicity up to 100 pM was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXyXqiyncFtbVg90H21EOLACvtfcHk0lhzP9Tyqmfang"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFelurg%253D&md5=e3bb8dddf5611b31dedb220e5ad2cf52</span></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1081%2FNCN-120023272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-120023272%26sid%3Dliteratum%253Aachs%26aulast%3DBaik%26aufirst%3DG.%2BH.%26aulast%3DChung%26aufirst%3DB.%2BY.%26aulast%3DOh%26aufirst%3DC.-H.%26aulast%3DCho%26aufirst%3DJ.-H.%26aulast%3DKo%26aufirst%3DO.%2BH.%26aulast%3DHong%26aufirst%3DJ.%2BH.%26atitle%3DNovel%2520Synthesis%2520of%25204%25E2%2580%25B2C-Aryl-Branched%2520Acyclic%2520Nucleoside%2520Using%2520%255B3%252C3%255D-Sigmatropic%2520Rearrangement%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2003%26volume%3D22%26spage%3D1781%26epage%3D1788%26doi%3D10.1081%2FNCN-120023272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kumamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haraguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitanda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutschman, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of (±)-4′-Ethynyl and 4′-Cyano Carbocyclic Analogues of Stavudine (d4T)</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1081/NCN-51900</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1081%2FNCN-51900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=15822615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFWgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=73-83&author=H.+Kumamotoauthor=K.+Haraguchiauthor=H.+Tanakaauthor=T.+Nitandaauthor=M.+Babaauthor=G.+E.+Dutschmanauthor=Y.-C.+Chengauthor=K.+Kato&title=Synthesis+of+%28%C2%B1%29-4%E2%80%B2-Ethynyl+and+4%E2%80%B2-Cyano+Carbocyclic+Analogues+of+Stavudine+%28d4T%29&doi=10.1081%2FNCN-51900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12eR"><div class="casContent"><span class="casTitleNuber">12e</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (±)-4'-ethynyl and 4'-cyano carbocyclic analogs of stavudine (d4T)</span></div><div class="casAuthors">Kumamoto, Hiroki; Haraguchi, Kazuhiro; Tanaka, Hiromichi; Nitanda, Takao; Baba, Masanori; Dutschman, Ginger E.; Cheng, Yung-Chi; Kato, Keisuke</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The synthesis of (±)-4'-ethynyl (I) and 4'-cyano (II) carbocyclic analogs of the anti-HIV agent stavudine (d4T) is reported.  The carbocyclic unit was constructed from readily available β-keto ester.  The ethynyl or cyano group of I and II were prepd., after the introduction of thymine base, by manipulation of the ester function.  Evaluation of the anti-HIV activity of I and II was also carried out, but ultimately did not inhibit the virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxE3RQWy4fgrVg90H21EOLACvtfcHk0lhzP9Tyqmfang"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFWgtrY%253D&md5=6875892c6d555799610e441a67fb81ec</span></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1081%2FNCN-51900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-51900%26sid%3Dliteratum%253Aachs%26aulast%3DKumamoto%26aufirst%3DH.%26aulast%3DHaraguchi%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DNitanda%26aufirst%3DT.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DDutschman%26aufirst%3DG.%2BE.%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DKato%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520%2528%25C2%25B1%2529-4%25E2%2580%25B2-Ethynyl%2520and%25204%25E2%2580%25B2-Cyano%2520Carbocyclic%2520Analogues%2520of%2520Stavudine%2520%2528d4T%2529%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2005%26volume%3D24%26spage%3D73%26epage%3D83%26doi%3D10.1081%2FNCN-51900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyasaka, T.</span></span> <span> </span><span class="NLM_article-title">Enantio- and Diastereoselective Synthesis of 4′-α-Substituted Carbocyclic Nucleosides</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1016/S0957-4166(98)00065-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2FS0957-4166%2898%2900065-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=911-914&author=K.+Katoauthor=H.+Suzukiauthor=H.+Tanakaauthor=T.+Miyasaka&title=Enantio-+and+Diastereoselective+Synthesis+of+4%E2%80%B2-%CE%B1-Substituted+Carbocyclic+Nucleosides&doi=10.1016%2FS0957-4166%2898%2900065-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2898%2900065-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252898%252900065-2%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DMiyasaka%26aufirst%3DT.%26atitle%3DEnantio-%2520and%2520Diastereoselective%2520Synthesis%2520of%25204%25E2%2580%25B2-%25CE%25B1-Substituted%2520Carbocyclic%2520Nucleosides%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1998%26volume%3D9%26spage%3D911%26epage%3D914%26doi%3D10.1016%2FS0957-4166%2898%2900065-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a Novel Conformationally Locked Carbocyclic Nucleoside Ring System</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1021/ol034326z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol034326z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=1665-1668&author=H.+S.+Kimauthor=K.+A.+Jacobson&title=Synthesis+of+a+Novel+Conformationally+Locked+Carbocyclic+Nucleoside+Ring+System&doi=10.1021%2Fol034326z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=10.1021%2Fol034326z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol034326z%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520of%2520a%2520Novel%2520Conformationally%2520Locked%2520Carbocyclic%2520Nucleoside%2520Ring%2520System%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D1665%26epage%3D1668%26doi%3D10.1021%2Fol034326z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneller, S. W.</span></span> <span> </span><span class="NLM_article-title">A Practical Synthetic Route to 4′-Alkylaristeromycin Derivatives: 4′-Methylaristeromycin</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">4057</span>– <span class="NLM_lpage">4059</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.03.188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2Fj.tetlet.2006.03.188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=4057-4059&author=K.-Q.+Yinauthor=S.+W.+Schneller&title=A+Practical+Synthetic+Route+to+4%E2%80%B2-Alkylaristeromycin+Derivatives%3A+4%E2%80%B2-Methylaristeromycin&doi=10.1016%2Fj.tetlet.2006.03.188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12h&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.03.188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.03.188%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DK.-Q.%26aulast%3DSchneller%26aufirst%3DS.%2BW.%26atitle%3DA%2520Practical%2520Synthetic%2520Route%2520to%25204%25E2%2580%25B2-Alkylaristeromycin%2520Derivatives%253A%25204%25E2%2580%25B2-Methylaristeromycin%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D4057%26epage%3D4059%26doi%3D10.1016%2Fj.tetlet.2006.03.188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hřebabecký, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masojídková, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Carba Analogues of Deoxy-4-<i>C</i>-(Hydroxymethyl)-Pentofuranoses, Intermediates in the Synthesis of Carbocyclic Nucleosides</span>. <i>Collect. Czech. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2044</span>– <span class="NLM_lpage">2064</span>, <span class="refDoi"> DOI: 10.1135/cccc19982044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1135%2Fcccc19982044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADyaK1MXislah" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=2044-2064&author=H.+H%C5%99ebabeck%C3%BDauthor=M.+Masoj%C3%ADdkov%C3%A1author=A.+Hol%C3%BD&title=Synthesis+of+Carba+Analogues+of+Deoxy-4-C-%28Hydroxymethyl%29-Pentofuranoses%2C+Intermediates+in+the+Synthesis+of+Carbocyclic+Nucleosides&doi=10.1135%2Fcccc19982044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of carba analogs of deoxy-4-C-(hydroxymethyl)pentofuranoses, intermediates in the synthesis of carbocyclic nucleosides</span></div><div class="casAuthors">Hrebabecky, Hubert; Masojidkova, Milena; Holy, Antonin</div><div class="citationInfo"><span class="NLM_cas:title">Collection of Czechoslovak Chemical Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2044-2064</span>CODEN:
                <span class="NLM_cas:coden">CCCCAK</span>;
        ISSN:<span class="NLM_cas:issn">0010-0765</span>.
    
            (<span class="NLM_cas:orgname">Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic</span>)
        </div><div class="casAbstract">Racemic di-Me 4-methoxy-, diallyl 4-allyloxy- and di-Me 4-(ethylsulfanyl)-2-hydroxycyclopentane-1,1-dicarboxylates were prepd. by base-catalyzed addn. of methanol, allyl alc. and ethylsulfane, resp., to di-Me (4-oxobut-2-en-1-yl)malonate.  Deallylation afforded the 4-hydroxycyclopentanes.  Redn. with lithium aluminum hydride gave the corresponding 4-substituted 2,2-bis(hydroxymethyl)cyclopentanols.  Di-Me (2S,3S,4R)-, (2R,3S,4R)-3-benzyloxy-4-formyloxy-2-hydroxycyclopentane-1,1-dicarboxylates and di-Me (2S,3S,4R)-, (2R,3S,4R)-3-benzyloxy-2-benzoyloxy-4-methoxycyclopentane-1,1-dicarboxylates were synthesized starting from D-glucose.  Redn. of di-Me cyclopentane-1,1-dicarboxylates with lithium aluminum hydride, benzoylation of the formed hydroxy derivs., hydrogenolysis of benzyl groups, conversion of the liberated hydroxy groups into dithiocarbonates and their redn. with tributylstannane afforded, after removal of the protecting groups, (2R,4R)-1,1-bis(hydroxymethyl)-4-methoxycyclopentan-2-ol and (3R,4R)-1,1-bis(hydroxymethyl)-4-methoxycyclopentan-3-ol.  Redn. of a mixt. of esters gave (2R,3R)-2-benzyloxy-5-(hydroxymethyl)hexane-1,3,6-triol as the major product and (2R,3S,4R)-3-benzyloxy-1,1-bis(hydroxymethyl)cyclopentane-2,4-diol as the minor product.  The latter was converted into (3R,4R)-1,1-bis(hydroxymethyl)cyclopentane-3,4-diol.  3-Deoxycarba analogs arose by migration of benzoyl group in the prepn. of the dithiocarbonates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO0ofU6nG-n7Vg90H21EOLACvtfcHk0lh2txGuTeMQMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislah&md5=4a018bf0f734229636c47b1861350b52</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1135%2Fcccc19982044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1135%252Fcccc19982044%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C5%2599ebabeck%25C3%25BD%26aufirst%3DH.%26aulast%3DMasoj%25C3%25ADdkov%25C3%25A1%26aufirst%3DM.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520Carba%2520Analogues%2520of%2520Deoxy-4-C-%2528Hydroxymethyl%2529-Pentofuranoses%252C%2520Intermediates%2520in%2520the%2520Synthesis%2520of%2520Carbocyclic%2520Nucleosides%26jtitle%3DCollect.%2520Czech.%2520Chem.%2520Commun.%26date%3D1998%26volume%3D63%26spage%3D2044%26epage%3D2064%26doi%3D10.1135%2Fcccc19982044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, Y.</span></span> <span> </span><span class="NLM_article-title">Remarkable Solvent Effect on Pd(0)-Catalyzed Deprotection of Allyl Ethers Using Barbituric Acid Derivatives: Application to Selective and Successive Removal of Allyl, Methallyl, and Prenyl Ethers</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3132</span>, <span class="refDoi"> DOI: 10.1055/s-2007-992352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1055%2Fs-2007-992352" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=3131-3132&issue=20&author=H.+Tsukamotoauthor=T.+Suzukiauthor=Y.+Kondo&title=Remarkable+Solvent+Effect+on+Pd%280%29-Catalyzed+Deprotection+of+Allyl+Ethers+Using+Barbituric+Acid+Derivatives%3A+Application+to+Selective+and+Successive+Removal+of+Allyl%2C+Methallyl%2C+and+Prenyl+Ethers&doi=10.1055%2Fs-2007-992352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-992352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-992352%26sid%3Dliteratum%253Aachs%26aulast%3DTsukamoto%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKondo%26aufirst%3DY.%26atitle%3DRemarkable%2520Solvent%2520Effect%2520on%2520Pd%25280%2529-Catalyzed%2520Deprotection%2520of%2520Allyl%2520Ethers%2520Using%2520Barbituric%2520Acid%2520Derivatives%253A%2520Application%2520to%2520Selective%2520and%2520Successive%2520Removal%2520of%2520Allyl%252C%2520Methallyl%252C%2520and%2520Prenyl%2520Ethers%26jtitle%3DSynlett%26date%3D2007%26volume%3D2007%26issue%3D20%26spage%3D3131%26epage%3D3132%26doi%3D10.1055%2Fs-2007-992352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>See <span class="NLM_ext-link">Supporting Information</span>. A full manuscript reviewing the details of this
assay is forthcoming (<span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.-T.</span></span>; <span class="NLM_etal"></span> Manuscript in preparation).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Supporting+Information.+A+full+manuscript+reviewing+the+details+of+this%0Aassay+is+forthcoming+%28Lai%2C+M.-T.%3B+Manuscript+in+preparation%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DM.-T." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caton-Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Convenient Synthesis of Nucleoside 5′-Triphosphates for RNA Transcription</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">8142</span>– <span class="NLM_lpage">8144</span>, <span class="refDoi"> DOI: 10.1039/c1cc12201k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1039%2Fc1cc12201k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=8142-8144&author=J.+Caton-Williamsauthor=L.+Linauthor=M.+Smithauthor=Z.+Huang&title=Convenient+Synthesis+of+Nucleoside+5%E2%80%B2-Triphosphates+for+RNA+Transcription&doi=10.1039%2Fc1cc12201k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2Fc1cc12201k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cc12201k%26sid%3Dliteratum%253Aachs%26aulast%3DCaton-Williams%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DConvenient%2520Synthesis%2520of%2520Nucleoside%25205%25E2%2580%25B2-Triphosphates%2520for%2520RNA%2520Transcription%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D8142%26epage%3D8144%26doi%3D10.1039%2Fc1cc12201k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1rtd">1rtd</a> was used as a starting point for modeling efforts. This complex contains HXB2 RT, which was also used for the program’s RT-Pol assay and therefore provided an optimal starting point. Prior to docking ligands of interest, NTP was removed and primer was modified to align with the ligand being modeled. See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>385</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">713</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.10.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2Fj.jmb.2008.10.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=19022262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=693-713&author=S.+G.+Sarafianosauthor=B.+Marchandauthor=K.+Dasauthor=D.+Himmelauthor=M.+A.+Parniakauthor=S.+H.+Hughesauthor=E.+Arnold&title=Structure+and+Function+of+HIV-1+Reverse+Transcriptase%3A+Molecular+Mechanisms+of+Polymerization+and+Inhibition&doi=10.1016%2Fj.jmb.2008.10.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of HIV-1 reverse transcriptase: Molecular mechanisms of polymerization and inhibition</span></div><div class="casAuthors">Sarafianos, Stefan G.; Marchand, Bruno; Das, Kalyan; Himmel, Daniel M.; Parniak, Michael A.; Hughes, Stephen H.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-713</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The rapid replication of the HIV-1 virus and errors made during viral replication cause the virus to evolve rapidly in patients, making the problems of vaccine development and drug therapy particularly challenging.  In the absence of an effective vaccine, drugs are the only useful treatment.  Anti-HIV drugs work; so far drug therapy has saved more than 3 × 106 yr of life.  Unfortunately, HIV-1 virus develops resistance to all of the available drugs.  Although a no. of useful anti-HIV drugs have been approved for use in patients, the problems assocd. with drug toxicity and the development of resistance means that the search for new drugs is an ongoing process.  The 3 viral enzymes, reverse transcriptase (RT), integrase (IN), and protease (PR) are all good drug targets.  Two distinct types of RT inhibitors, both of which block the polymerase activity of RT, have been approved to treat HIV-1 infections, nucleoside analogs (NRTIs) and non-nucleosides (NNRTIs), and there are promising leads for compds. that either block the RNase H activity or block the polymerase in other ways.  A better understanding of the structure and function(s) of RT and of the mechanism(s) of inhibition can be used to generate better drugs; in particular, drugs that are effective against the current drug-resistant strains of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrnqshyZtC7Vg90H21EOLACvtfcHk0linpDfANlpM4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sltw%253D%253D&md5=e26f178e629a36f6e248a879057021a2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.071%26sid%3Dliteratum%253Aachs%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DHimmel%26aufirst%3DD.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520and%2520Function%2520of%2520HIV-1%2520Reverse%2520Transcriptase%253A%2520Molecular%2520Mechanisms%2520of%2520Polymerization%2520and%2520Inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D693%26epage%3D713%26doi%3D10.1016%2Fj.jmb.2008.10.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaix, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Périgaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyrottes, S.</span></span> <span> </span><span class="NLM_article-title">Recent Trends in Nucleotide Synthesis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">7854</span>– <span class="NLM_lpage">7897</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSju77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=7854-7897&author=B.+Royauthor=A.+Depaixauthor=C.+P%C3%A9rigaudauthor=S.+Peyrottes&title=Recent+Trends+in+Nucleotide+Synthesis&doi=10.1021%2Facs.chemrev.6b00174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Trends in Nucleotide Synthesis</span></div><div class="casAuthors">Roy, Beatrice; Depaix, Anais; Perigaud, Christian; Peyrottes, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7854-7897</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Focusing on the recent literature (since 2000), this review outlines the main synthetic approaches for the prepn. of 5'-mono-, 5'-di-, and 5'-triphosphorylated nucleosides, also known as nucleotides, as well as several derivs., namely, cyclic nucleotides and dinucleotides, dinucleoside 5',5'-polyphosphates, sugar nucleotides, and nucleolipids.  Endogenous nucleotides and their analogs can be obtained enzymically, which is often restricted to natural substrates, or chem.  In chem. synthesis, protected or unprotected nucleosides can be used as the starting material, depending on the nature of the reagents selected from P(III) or P(V) species.  Both soln.-phase and solid-support syntheses have been developed and are reported here.  Although a considerable amt. of research has been conducted in this field, further work is required because chemists are still faced with the challenge of developing a universal methodol. that is compatible with a large variety of nucleoside analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsGkv8t1I_7bVg90H21EOLACvtfcHk0linpDfANlpM4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSju77E&md5=b193e68126504cd6442f532aead446e2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00174%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DB.%26aulast%3DDepaix%26aufirst%3DA.%26aulast%3DP%25C3%25A9rigaud%26aufirst%3DC.%26aulast%3DPeyrottes%26aufirst%3DS.%26atitle%3DRecent%2520Trends%2520in%2520Nucleotide%2520Synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D7854%26epage%3D7897%26doi%3D10.1021%2Facs.chemrev.6b00174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolstykh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micolochick Steuer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiritu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Activation of PSI-7851 and its Diastereoisomer PSI-7977</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">34337</span>– <span class="NLM_lpage">34347</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.161802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1074%2Fjbc.M110.161802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=20801890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGktb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=34337-34347&author=E.+Murakamiauthor=T.+Tolstykhauthor=H.+Baoauthor=C.+Niuauthor=H.+M.+Micolochick+Steuerauthor=D.+Baoauthor=W.+Changauthor=C.+Espirituauthor=S.+Bansalauthor=A.+M.+Lamauthor=M.+J.+Ottoauthor=M.+J.+Sofiaauthor=P.+A.+Furman&title=Mechanism+of+Activation+of+PSI-7851+and+its+Diastereoisomer+PSI-7977&doi=10.1074%2Fjbc.M110.161802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977</span></div><div class="casAuthors">Murakami, Eisuke; Tolstykh, Tatiana; Bao, Haiying; Niu, Congrong; Steuer, Holly M. Micolochick; Bao, Donghui; Chang, Wonsuk; Espiritu, Christine; Bansal, Shalini; Lam, Angela M.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">34337-34347</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A phosphoramidate prodrug of 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate, PSI-7851, demonstrates potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo.  PSI-7851 is a mixt. of two diastereoisomers, PSI-7976 and PSI-7977, with PSI-7977 being the more active inhibitor of HCV RNA replication in the HCV replicon assay.  To inhibit the HCV NS5B RNA-dependent RNA polymerase, PSI-7851 must be metabolized to the active triphosphate form.  The first step, hydrolysis of the carboxyl ester by human cathepsin A (CatA) and/or carboxylesterase 1 (CES1), is a stereospecific reaction.  Western blot anal. showed that CatA and CES1 are both expressed in primary human hepatocytes.  However, expression of CES1 is undetectable in clone A replicon cells.  Studies with inhibitors of CatA and/or CES1 indicated that CatA is primarily responsible for hydrolysis of the carboxyl ester in clone A cells, although in primary human hepatocytes, both CatA and CES1 contribute to the hydrolysis.  Hydrolysis of the ester is followed by a putative nucleophilic attack on the phosphorus by the carboxyl group resulting in the spontaneous elimination of phenol and the prodn. of an alaninyl phosphate metabolite, PSI-352707, which is common to both isomers.  The removal of the amino acid moiety of PSI-352707 is catalyzed by histidine triad nucleotide-binding protein 1 (Hint1) to give the 5'-monophosphate form, PSI-7411.  SiRNA-mediated Hint1 knockdown studies further indicate that Hint1 is, at least in part, responsible for converting PSI-352707 to PSI-7411.  PSI-7411 is then consecutively phosphorylated to the diphosphate, PSI-7410, and to the active triphosphate metabolite, PSI-7409, by UMP-CMP kinase and nucleoside diphosphate kinase, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3SPaB9Whp17Vg90H21EOLACvtfcHk0lgzRhLryzJNIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGktb7O&md5=28287a5f7547ab85158f594cd5fb1cd0</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.161802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.161802%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DMechanism%2520of%2520Activation%2520of%2520PSI-7851%2520and%2520its%2520Diastereoisomer%2520PSI-7977%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D34337%26epage%3D34347%26doi%3D10.1074%2Fjbc.M110.161802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Derudas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanpouille, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuigan, C.</span></span> <span> </span><span class="NLM_article-title">The Application of Phosphoramidate Protide Technology to Acyclovir Confers Anti-HIV Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5520</span>– <span class="NLM_lpage">5530</span>, <span class="refDoi"> DOI: 10.1021/jm9007856</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9007856" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlSgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5520-5530&author=M.+Derudasauthor=D.+Cartaauthor=A.+Brancaleauthor=C.+Vanpouilleauthor=A.+Liscoauthor=L.+Margolisauthor=J.+Balzariniauthor=C.+McGuigan&title=The+Application+of+Phosphoramidate+Protide+Technology+to+Acyclovir+Confers+Anti-HIV+Inhibition&doi=10.1021%2Fjm9007856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">The Application of Phosphoramidate Protide Technology to Acyclovir Confers Anti-HIV Inhibition</span></div><div class="casAuthors">Derudas, Marco; Carta, Davide; Brancale, Andrea; Vanpouille, Christophe; Lisco, Andrea; Margolis, Leonid; Balzarini, Jan; McGuigan, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5520-5530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, it has been reported that phosphorylated acyclovir (ACV) inhibits human immunodeficiency virus type 1 (HIV-1) reverse transcriptase in a cell-free system.  To deliver phosphorylated ACV inside cells, ACV monophosphorylated derivs., i.e. I, using ProTide technol. were designed.  It was found that the L-alanine derived ProTides show anti-HIV activity at noncytotoxic concns.; ester and aryl variation was tolerated.  ACV ProTides with other amino acids, other than L-phenylalanine, showed no detectable activity against HIV in cell culture.  The inhibitory activity of the prodrugs against herpes simplex virus (HSV) types -1 and -2 and thymidine kinase-deficient HSV-1 revealed different structure-activity relationships but was again consistent with successful nucleoside kinase bypass.  Enzymic and mol. modeling studies have been performed in order to better understand the antiviral behavior of these compds.  ProTides showing diminished carboxypeptidase lability translated to poor anti-HIV agents and vice versa, so the assay became predictive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOQcvyBNhrB7Vg90H21EOLACvtfcHk0lgzRhLryzJNIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlSgtbc%253D&md5=164dd951a4a2234895cb4da8b01fdaa1</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm9007856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9007856%26sid%3Dliteratum%253Aachs%26aulast%3DDerudas%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DD.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DVanpouille%26aufirst%3DC.%26aulast%3DLisco%26aufirst%3DA.%26aulast%3DMargolis%26aufirst%3DL.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DThe%2520Application%2520of%2520Phosphoramidate%2520Protide%2520Technology%2520to%2520Acyclovir%2520Confers%2520Anti-HIV%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5520%26epage%3D5530%26doi%3D10.1021%2Fjm9007856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolstykh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span> <span> </span><span class="NLM_article-title">Metabolic Activation of the Anti-Hepatitis C Virus Nucleotide Prodrug PSI-352938</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3767</span>– <span class="NLM_lpage">3775</span>, <span class="refDoi"> DOI: 10.1128/AAC.00530-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1128%2FAAC.00530-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=22526308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2isLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3767-3775&author=C.+Niuauthor=T.+Tolstykhauthor=H.+Baoauthor=Y.+Parkauthor=D.+Babusisauthor=A.+M.+Lamauthor=S.+Bansalauthor=J.+Duauthor=W.+Changauthor=P.+G.+Reddyauthor=H.-R.+Zhangauthor=J.+Woolleyauthor=L.-Q.+Wangauthor=P.+B.+Chaoauthor=A.+S.+Rayauthor=M.+J.+Ottoauthor=M.+J.+Sofiaauthor=P.+A.+Furmanauthor=E.+Murakami&title=Metabolic+Activation+of+the+Anti-Hepatitis+C+Virus+Nucleotide+Prodrug+PSI-352938&doi=10.1128%2FAAC.00530-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938</span></div><div class="casAuthors">Niu, Congrong; Tolstykh, Tatiana; Bao, Haiying; Park, Yeojin; Babusis, Darius; Lam, Angela M.; Bansal, Shalini; Du, Jinfa; Chang, Wonsuk; Reddy, P. Ganapati; Zhang, Hai-Ren; Woolley, Joseph; Wang, Li-Quan; Chao, Piyun B.; Ray, Adrian S.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.; Murakami, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3767-3775</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">PSI-352938 is a novel cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine-5'-monophosphate with potent anti-HCV activity.  In order to inhibit the NS5B RNA-dependent RNA polymerase, PSI-352938 must be metabolized to the active triphosphate form, PSI-352666.  During in vitro incubations with PSI-352938, significantly larger amts. of PSI-352666 were formed in primary hepatocytes than in clone A hepatitis C virus (HCV) replicon cells.  Metab. and biochem. assays were performed to define the mol. mechanism of PSI-352938 activation.  The first step, removal of the iso-Pr group on the 3',5'-cyclic phosphate moiety, was found to be cytochrome P 450 (CYP) 3A4 dependent, with other CYP isoforms unable to catalyze the reaction.  The second step, opening of the cyclic phosphate ring, was catalyzed by phosphodiesterases (PDEs) 2A1, 5A, 9A, and 11A4, all known to be expressed in the liver.  The role of these enzymes in the activation of PSI-352938 was confirmed in primary human hepatocytes, where prodrug activation was reduced by inhibitors of CYP3A4 and PDEs.  The third step, removal of the O6-Et group on the nucleobase, was shown to be catalyzed by adenosine deaminase-like protein 1.  The resulting monophosphate was consecutively phosphorylated to the diphosphate and to the triphosphate PSI-352666 by guanylate kinase 1 and nucleoside diphosphate kinase, resp.  In addn., formation of nucleoside metabolites was obsd. in primary hepatocytes, and ecto-5'-nucleotidase was able to dephosphorylate the monophosphate metabolites.  Since CYP3A4 is highly expressed in the liver, the CYP3A4-dependent metab. of PSI-352938 makes it an effective liver-targeted prodrug, in part accounting for the potent antiviral activity obsd. clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNZgd5L-S6a7Vg90H21EOLACvtfcHk0livqk-oJWYSnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2isLk%253D&md5=368e11bad1e84484953d392df3e9aaa5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FAAC.00530-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00530-12%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DWoolley%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.-Q.%26aulast%3DChao%26aufirst%3DP.%2BB.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DMurakami%26aufirst%3DE.%26atitle%3DMetabolic%2520Activation%2520of%2520the%2520Anti-Hepatitis%2520C%2520Virus%2520Nucleotide%2520Prodrug%2520PSI-352938%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3767%26epage%3D3775%26doi%3D10.1128%2FAAC.00530-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapati Reddy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachakonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">8311</span>– <span class="NLM_lpage">8319</span>, <span class="refDoi"> DOI: 10.1021/jo201492m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo201492m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ags77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=8311-8319&author=B.+S.+Rossauthor=P.+Ganapati+Reddyauthor=H.-R.+Zhangauthor=S.+Rachakondaauthor=M.+J.+Sofia&title=Synthesis+of+Diastereomerically+Pure+Nucleotide+Phosphoramidates&doi=10.1021%2Fjo201492m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates</span></div><div class="casAuthors">Ross, Bruce S.; Ganapati Reddy, P.; Zhang, Hai-Ren; Rachakonda, Suguna; Sofia, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8311-8319</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prodrugs of therapeutic nucleoside monophosphates masked as phosphoramidate derivs. have become an increasingly important class of antiviral drugs in pharmaceutical research for delivering nucleotides in vitro and in vivo.  Conventionally, phosphoramidate derivs. are prepd. as a mixt. of two diastereomers.  We report a class of stable phosphoramidate reagents contg. an amino acid ester and two phenolic groups, one unsubstituted and the other with electron-withdrawing substituents.  The reagents can be isolated as single diastereomers and reacted with the 5'-hydroxyl group of nucleosides through selective nucleophilic displacement of the substituted phenol to prep. single diastereomer phosphoramidate products.  This method has been used to prep. the HCV clin. candidate PSI-7977 I in high yield and high diastereomeric purity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgDGdlH3gLa7Vg90H21EOLACvtfcHk0livqk-oJWYSnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ags77F&md5=747a893daa7d9c4784cc29619d05ab81</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo201492m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo201492m%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DGanapati%2BReddy%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520of%2520Diastereomerically%2520Pure%2520Nucleotide%2520Phosphoramidates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2011%26volume%3D76%26spage%3D8311%26epage%3D8319%26doi%3D10.1021%2Fjo201492m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d','cit1e'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c','cit9d'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c','cit12d','cit12e','cit12f','cit12g','cit12h'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':[],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tommy Lussier, Amarender Manchoju, Gang Wang, Starr Dostie, Scott Foster, Philippe Mochirian, Michel Prévost, <span class="NLM_string-name hlFld-ContribAuthor">Yvan Guindon</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective Synthesis of Arabino- and Ribo-like Nucleoside Analogues Bearing a Stereogenic C3′ All-Carbon Quaternary Center. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (24)
                                     , 16055-16067. <a href="https://doi.org/10.1021/acs.joc.9b02550" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02550%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDiastereoselective%252BSynthesis%252Bof%252BArabino-%252Band%252BRibo-like%252BNucleoside%252BAnalogues%252BBearing%252Ba%252BStereogenic%252BC3%2525E2%252580%2525B2%252BAll-Carbon%252BQuaternary%252BCenter%26aulast%3DLussier%26aufirst%3DTommy%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19092019%26date%3D27112019%26date%3D15112019%26volume%3D84%26issue%3D24%26spage%3D16055%26epage%3D16067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Kang</span>, <span class="hlFld-ContribAuthor ">Qi‐Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Gui‐Rong  Qu</span>, <span class="hlFld-ContribAuthor ">Hai‐Ming  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">The Enantioselective Synthesis of Chiral Carbocyclic Nucleosides via Palladium‐Catalyzed Asymmetric Allylic Amination of Alicyclic MBH Adducts with Purines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (10)
                                     , 1955-1960. <a href="https://doi.org/10.1002/adsc.202000088" title="DOI URL">https://doi.org/10.1002/adsc.202000088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000088%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DThe%252BEnantioselective%252BSynthesis%252Bof%252BChiral%252BCarbocyclic%252BNucleosides%252Bvia%252BPalladium%2525E2%252580%252590Catalyzed%252BAsymmetric%252BAllylic%252BAmination%252Bof%252BAlicyclic%252BMBH%252BAdducts%252Bwith%252BPurines%26aulast%3DKang%26aufirst%3DBo%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D10%26spage%3D1955%26epage%3D1960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enzo  Tramontano</span>, <span class="hlFld-ContribAuthor ">Bart  Tarbet</span>, <span class="hlFld-ContribAuthor ">Jessica R.  Spengler</span>, <span class="hlFld-ContribAuthor ">Katherine  Seley-Radtke</span>, <span class="hlFld-ContribAuthor ">Chris  Meier</span>, <span class="hlFld-ContribAuthor ">Robert  Jordan</span>, <span class="hlFld-ContribAuthor ">Zlatko  Janeba</span>, <span class="hlFld-ContribAuthor ">Brian  Gowen</span>, <span class="hlFld-ContribAuthor ">Brian  Gentry</span>, <span class="hlFld-ContribAuthor ">José A.  Esté</span>, <span class="hlFld-ContribAuthor ">Mike  Bray</span>, <span class="hlFld-ContribAuthor ">Graciela  Andrei</span>, <span class="hlFld-ContribAuthor ">Luis M.  Schang</span>. </span><span class="cited-content_cbyCitation_article-title">Meeting report: 32nd International Conference on Antiviral Research. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2019,</strong> <em>169 </em>, 104550. <a href="https://doi.org/10.1016/j.antiviral.2019.104550" title="DOI URL">https://doi.org/10.1016/j.antiviral.2019.104550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2019.104550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2019.104550%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DMeeting%252Breport%25253A%252B32nd%252BInternational%252BConference%252Bon%252BAntiviral%252BResearch%26aulast%3DTramontano%26aufirst%3DEnzo%26date%3D2019%26volume%3D169%26spage%3D104550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. : Approved NRTIs and NtRTIs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. : Chemical Structures of MK-8591 (Left) and Representative 4′-Substituted Carbocyclic Targeted Structures</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Intermediates (±)-<b>6</b> and (±)-<b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PDC, DCM, 0 °C to room temperature, 16 h; (b) NaH, allyl alcohol, 0 °C to room temperature, 16 h, 22% (over 2 steps); (c) dimethoxymethane, Tf<sub>2</sub>O, room temperature, 1 h, 57%; (d) LiAlH<sub>4</sub>, THF, 0 °C, then reflux, 90 min, 92%; (e) TBDPSCl, imidazole, DMAP, DCM, 0 °C to room temperature, 16 h; (±)-<b>6</b> (43%), (±)-<b>7</b> (12%); (±)-<b>8</b> and (±)-<b>9</b> not isolated.</p></p></figure><figure data-id="cht3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. : Primary NOESY NMR Correlations (Red Arrows) in (±)-<b>6</b> and (±)-<b>7</b> Used for Stereochemical Assignment</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Alcohols (±)-<b>13</b> and (±)-<b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Dess–Martin periodinane, DCM, room temperature, 16 h, 76%; (b) Seyferth–Gilbert reagent, K<sub>2</sub>CO<sub>3</sub>, MeOH, room temperature, 16 h, 78%; (c) (1) hydroxylamine, pyridine, EtOH, 2 h; (2) Burgess reagent, toluene, 1 h, 78% (over 2 steps); (d) Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, MeOH, room temperature, 16 h, 89%; (e) (1) benzoic acid, PPh<sub>3</sub>, DIAD, THF (quant), 16 h; (2) NaOH, MeOH, 2 h, 80% (over 2 steps) for (±)<b>-13</b>, 66% (over 2 steps) for (±)<b>-16</b>.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2′-Deoxycarbocyclic Nucleosides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) N3-Bz-thymine, PPh<sub>3</sub>, DIAD, THF, −41 °C to room temperature, 16 h; (b) 2-fluoro-6-chloropurine or 2,6-dichloropurine, DIAD, THF, −41 °C to room temperature, 16 h; (c) N2-Ac-6-ODPC-guanine, DIAD, THF, −41 °C to room temperature, 16 h; (d) TBAF, AcOH, THF, room temperature, 24 −48 h, 45% (over 2 steps) for (±<b>-17</b>, 33% (over 2 steps) for (±)<b>-18</b>, 56% (over 2 steps) for (±)<b>-21</b>, 78% (over 2 steps) for (±)<b>-22</b>, 42% (over 2 steps) for (±)<b>-23</b>, 74% (over 2 steps) for (±)<b>-27</b>, 54% (over 2 steps) for (±)<b>-28</b>; (e) TFA, DCM, rt, 16 h; (f) 7 N NH<sub>3</sub> in MeOH, sealed tube, room temperature, 16 h, 56% (over 2 steps) for (±)<b>-19</b>, 27% (over 2 steps) for (±)<b>-20</b>, 73% (over 2 steps) for (±)<b>-29</b>, 26% (over 2 steps) for (±)<b>-30</b>; (g) NH<sub>3</sub> in 1,4-dioxane, sealed tube, 50 °C, 16 h, 19% (over 2 steps) for (±)<b>-24</b>, 27% (over 2 steps) for (±)<b>-25</b>, 10% (over 2 steps) for (±)<b>-26</b>.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. : Chiral Separation of (±)-<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chiral SFC separation, CHIRALCEL OD-H column, mobile phase CO<sub>2</sub>/MeOH; faster eluting isomer <b>29a</b> and slower eluting isomer <b>29b</b>.</p></p></figure><figure data-id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Computational models illustrating the primary interactions of MK-8591-TP (A), (1<i>S</i>,3<i>R</i>,4<i>R</i>)-<b>24-TP</b> (B), (1<i>S</i>,3<i>R</i>,4<i>R</i>)-<b>29-TP</b> (C), and (1<i>R</i>,3<i>S</i>,4<i>S</i>)-<b>29-TP</b> (D) in the polymerase active site of HIV-1 RT/DNA. NTPs are colored by atom type. Template is displayed in yellow. Primer is displayed in pink. RT amino acids are displayed in in cyan, and metal ions are displayed in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/medium/jm-2018-00141u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis and Chiral Separation of Phosphoramidate Prodrugs <b>34a</b> and <b>34b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-20/acs.jmedchem.8b00141/20181019/images/large/jm-2018-00141u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00141&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) N2-CO<sup><i>i</i></sup>Pr-6-ODPC-guanine, DIAD, THF, −41 °C to room temperature, 16 h, 50%; (b) TBAF, AcOH, THF, room temperature, 16 h, 98%; (c) KOH, MeOH, room temperature, 0 °C, 16 h, 66%; (d) isopropyl ((<i>S</i>)-(perfluorophenoxy)(phenoxy)phosphoryl)-<span class="smallcaps smallerCapital">l</span>-alaninate, <sup><i>t</i></sup>BuMgCl 1 M in THF, 0 °C to rt, 16 h, 82%; (e) TFA, DCM, room temperature, then 0 °C, 2.5 h, 57%; (f) chiral SFC separation, CHIRALPAK AD-H column, mobile phase CO<sub>2</sub>/MeOH; faster eluting isomer <b>34a</b> (28%) and slower eluting isomer <b>34b</b> (30%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors in the Treatment of HIV Infections (AIDS)</span>. In  <i>Advances in Pharmacology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>, Ed.;  <i>Antiviral Agents</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Oxford. U.K.</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">67</span>, pp  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-405880-4.00009-3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2FB978-0-12-405880-4.00009-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=317-358&author=E.+De+Clercqauthor=E.+De+Clercq&title=Advances+in+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-405880-4.00009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-405880-4.00009-3%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520Nucleoside%2520Reverse%2520Transcriptase%2520Inhibitors%252C%2520Nonnucleoside%2520Reverse%2520Transcriptase%2520Inhibitors%252C%2520and%2520Protease%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520HIV%2520Infections%2520%2528AIDS%2529%26btitle%3DAdvances%2520in%2520Pharmacology%26aulast%3DDe%2BClercq%26aufirst%3DE.%26btitle%3DAntiviral%2520Agents%26pub%3DAcademic%2520Press%26date%3D2013%26volume%3D67%26spage%3D317%26epage%3D358%26doi%3D10.1016%2FB978-0-12-405880-4.00009-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">A 40-Year Journey in Search of Selective Antiviral Chemotherapy*</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-010510-100228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1146%2Fannurev-pharmtox-010510-100228" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1-24&issue=1&author=E.+De+Clercq&title=A+40-Year+Journey+in+Search+of+Selective+Antiviral+Chemotherapy*&doi=10.1146%2Fannurev-pharmtox-010510-100228"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010510-100228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010510-100228%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DA%252040-Year%2520Journey%2520in%2520Search%2520of%2520Selective%2520Antiviral%2520Chemotherapy%252A%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2011%26volume%3D51%26issue%3D1%26spage%3D1%26epage%3D24%26doi%3D10.1146%2Fannurev-pharmtox-010510-100228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Anusha, N. P.</span></span> <span> </span><span class="NLM_article-title">Antiretroviral Strategies for Treatment of HIV</span>. <i>J. Antivirals Antiretrovirals</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.4172/jaa.1000036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.4172%2Fjaa.1000036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=55-59&author=N.+P.+Anusha&title=Antiretroviral+Strategies+for+Treatment+of+HIV&doi=10.4172%2Fjaa.1000036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.4172%2Fjaa.1000036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252Fjaa.1000036%26sid%3Dliteratum%253Aachs%26aulast%3DAnusha%26aufirst%3DN.%2BP.%26atitle%3DAntiretroviral%2520Strategies%2520for%2520Treatment%2520of%2520HIV%26jtitle%3DJ.%2520Antivirals%2520Antiretrovirals%26date%3D2011%26volume%3D3%26spage%3D55%26epage%3D59%26doi%3D10.4172%2Fjaa.1000036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tressler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godfrey, C.</span></span> <span> </span><span class="NLM_article-title">NRTI Backbone in HIV Treatment</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2051</span>– <span class="NLM_lpage">2062</span>, <span class="refDoi"> DOI: 10.2165/11640830-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.2165%2F11640830-000000000-00000" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2051-2062&issue=16&author=R.+Tresslerauthor=C.+Godfrey&title=NRTI+Backbone+in+HIV+Treatment&doi=10.2165%2F11640830-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.2165%2F11640830-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11640830-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DTressler%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DC.%26atitle%3DNRTI%2520Backbone%2520in%2520HIV%2520Treatment%26jtitle%3DDrugs%26date%3D2012%26volume%3D72%26issue%3D16%26spage%3D2051%26epage%3D2062%26doi%3D10.2165%2F11640830-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudinot, F. D.</span></span> <span> </span><span class="NLM_article-title">Development and Optimization of Anti-HIV Nucleoside Analogs and Prodrugs: A Review of Their Cellular Pharmacology, Structure-Activity Relationships and Pharmacokinetics</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(99)00023-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2FS0169-409X%2899%2900023-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=117-151&issue=1&author=X.+Tanauthor=C.+K.+Chuauthor=F.+D.+Boudinot&title=Development+and+Optimization+of+Anti-HIV+Nucleoside+Analogs+and+Prodrugs%3A+A+Review+of+Their+Cellular+Pharmacology%2C+Structure-Activity+Relationships+and+Pharmacokinetics&doi=10.1016%2FS0169-409X%2899%2900023-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2899%2900023-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252899%252900023-X%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DX.%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DBoudinot%26aufirst%3DF.%2BD.%26atitle%3DDevelopment%2520and%2520Optimization%2520of%2520Anti-HIV%2520Nucleoside%2520Analogs%2520and%2520Prodrugs%253A%2520A%2520Review%2520of%2520Their%2520Cellular%2520Pharmacology%252C%2520Structure-Activity%2520Relationships%2520and%2520Pharmacokinetics%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1999%26volume%3D39%26issue%3D1%26spage%3D117%26epage%3D151%26doi%3D10.1016%2FS0169-409X%2899%2900023-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kukhanova, M. K.</span></span> <span> </span><span class="NLM_article-title">Anti-HIV Nucleoside Drugs: A Retrospective View into the Future</span>. <i>Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">768</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1134/S002689331206012X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1134%2FS002689331206012X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKhur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=768-779&issue=6&author=M.+K.+Kukhanova&title=Anti-HIV+Nucleoside+Drugs%3A+A+Retrospective+View+into+the+Future&doi=10.1134%2FS002689331206012X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HIV nucleoside drugs: A retrospective view into the future</span></div><div class="casAuthors">Kukhanova, M. K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology (Moscow, Russian Federation, English Edition)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">768-779</span>CODEN:
                <span class="NLM_cas:coden">MOLBBJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-8933</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica</span>)
        </div><div class="casAbstract">The review considers the design of antiretroviral drugs based on nucleoside analogs.  Approx. 30 drugs have been approved for treating HIV-infected patients over the past 25 years.  Seven nucleoside drugs act as HIV reverse transcriptase (RT) inhibitors and are clin. used in combination with inhibitors of other viral enzymes, integrase and protease, and nonnucleoside inhibitors of HIV RT.  Toxicity of nucleoside drugs and the possibility to obtain safe anti-HIV drugs by constructing their depot forms are discussed.  The results of developing anti-HIV drugs in Russia are described.  The future prospects of anti-HIV research are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRN48RNKXZwrVg90H21EOLACvtfcHk0lgeLAZ5KqLrGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKhur%252FM&md5=74c46def86147882225a75a6beacd355</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1134%2FS002689331206012X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS002689331206012X%26sid%3Dliteratum%253Aachs%26aulast%3DKukhanova%26aufirst%3DM.%2BK.%26atitle%3DAnti-HIV%2520Nucleoside%2520Drugs%253A%2520A%2520Retrospective%2520View%2520into%2520the%2520Future%26jtitle%3DMol.%2520Biol.%26date%3D2012%26volume%3D46%26issue%3D6%26spage%3D768%26epage%3D779%26doi%3D10.1134%2FS002689331206012X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lionne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, B.</span></span> <span> </span><span class="NLM_article-title">Intracellular Metabolism of Nucleoside/Nucleotide Analogues: a Bottleneck to Reach Active Drugs on HIV Reverse Transcriptase</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.2174/1389200217666151210141903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.2174%2F1389200217666151210141903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=26651972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsVGgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=237-252&author=A.+Vargaauthor=C.+Lionneauthor=B.+Roy&title=Intracellular+Metabolism+of+Nucleoside%2FNucleotide+Analogues%3A+a+Bottleneck+to+Reach+Active+Drugs+on+HIV+Reverse+Transcriptase&doi=10.2174%2F1389200217666151210141903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular Metabolism of Nucleoside/Nucleotide Analogues: a Bottleneck to Reach Active Drugs on HIV Reverse Transcriptase</span></div><div class="casAuthors">Varga, Andrea; Lionne, Corinne; Roy, Beatrice</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-252</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Background: To date, the most effective way to treat HIV is to use a highly active antiretroviral therapy (HAART) that combines three or more different drugs.  The usual regimen consists of two nucleoside reverse transcriptase inhibitors and either a protease inhibitor, a non-nucleoside reverse transcriptase inhibitor, or an integrase strand transfer inhibitor.  Due to the emerging resistance against the nucleoside analogs in use, there is a continuous need for the development of such therapeutic mols. with different structural features.  Objectives: In this review, we would like to summarize the state of knowledge of the antiretroviral nucleoside analogs intracellular metab.  Indeed, these mols. have to be phosphorylated in the cell, a process that is often a bottleneck, to produce their pharmacol. active triphosphorylated forms.  These forms can be used by the HIV reverse transcriptase.  Because they lack a 3'-hydroxyl group, they block further extension of the viral DNA, and finally lead to early chain termination.  Several kinases can act on the phosphorylation of these drugs; most of them have low nucleoside/nucleotide specificity.  On the other hand, there are also nucleotidases in the cell, which can reverse the phosphorylation process, thus shifting the equil. from the active triphosphorylated state to the non-active (not-, mono- or di-phosphorylated) states of these analogs.  Conclusion: Here, we would like to bring to the attention of the medicinal chemists that they have to take into account the limitation of the intracellular phosphorylation machinery when designing new nucleoside analog drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5v8upNgY8grVg90H21EOLACvtfcHk0lgeLAZ5KqLrGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsVGgu7k%253D&md5=589ddeaaf5282d1e27e65842839a8ad1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1389200217666151210141903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200217666151210141903%26sid%3Dliteratum%253Aachs%26aulast%3DVarga%26aufirst%3DA.%26aulast%3DLionne%26aufirst%3DC.%26aulast%3DRoy%26aufirst%3DB.%26atitle%3DIntracellular%2520Metabolism%2520of%2520Nucleoside%252FNucleotide%2520Analogues%253A%2520a%2520Bottleneck%2520to%2520Reach%2520Active%2520Drugs%2520on%2520HIV%2520Reverse%2520Transcriptase%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2016%26volume%3D17%26spage%3D237%26epage%3D252%26doi%3D10.2174%2F1389200217666151210141903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, W. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Toxicity of Nrti Antiviral Drugs: An Integrated Cellular Perspective</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">822</span>, <span class="refDoi"> DOI: 10.1038/nrd1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1038%2Fnrd1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=14526384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslarsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=812-822&issue=10&author=W.+Lewisauthor=B.+J.+Dayauthor=W.+C.+Copeland&title=Mitochondrial+Toxicity+of+Nrti+Antiviral+Drugs%3A+An+Integrated+Cellular+Perspective&doi=10.1038%2Fnrd1201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective</span></div><div class="casAuthors">Lewis, William; Day, Brian J.; Copeland, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">812-822</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral therapy (HAART) regimes based on nucleoside reverse transcriptase inhibitors (NRTIs) have revolutionized the treatment of AIDS in recent years.  Although HAART can successfully suppress viral replication in the long term, it is not without significant toxicity, which can seriously compromise treatment effectiveness.  A major toxicity that has been recognized for more than a decade is NRTI-related mitochondrial toxicity, which manifests as serious side effects such as hepatic failure and lactic acidosis.  However, a lack of understanding of the mechanisms underlying mitochondrial toxicity has hampered efforts to develop novel drugs with better side-effect profiles.  This review characterizes the pharmacol. mechanisms and pathways that are involved in mitochondrial dysfunction caused by NRTIs, and suggests opportunities for future pharmacol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSLd33wOAwYLVg90H21EOLACvtfcHk0lgeLAZ5KqLrGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslarsbo%253D&md5=e027a725c00f135731b9dbb041ae986f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1201%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26aulast%3DCopeland%26aufirst%3DW.%2BC.%26atitle%3DMitochondrial%2520Toxicity%2520of%2520Nrti%2520Antiviral%2520Drugs%253A%2520An%2520Integrated%2520Cellular%2520Perspective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26issue%3D10%26spage%3D812%26epage%3D822%26doi%3D10.1038%2Fnrd1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michailidis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.3390/v2020606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.3390%2Fv2020606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=20376302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFWms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=606-638&issue=2&author=K.+Singhauthor=B.+Marchandauthor=K.+A.+Kirbyauthor=E.+Michailidisauthor=S.+G.+Sarafianos&title=Structural+Aspects+of+Drug+Resistance+and+Inhibition+of+HIV-1+Reverse+Transcriptase&doi=10.3390%2Fv2020606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural aspects of drug resistance and inhibition of HIV-1 Reverse Transcriptase</span></div><div class="casAuthors">Singh, Kamalendra; Marchand, Bruno; Kirby, Karen A.; Michailidis, Eleftherios; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">606-638</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  HIV-1 Reverse Transcriptase (HIV-1 RT) has been the target of numerous approved anti-AIDS drugs that are key components of Highly Active Anti-Retroviral Therapies (HAART).  It remains the target of extensive structural studies that continue unabated for almost twenty years.  The crystal structures of wild-type or drug-resistant mutant HIV RTs in the unliganded form or in complex with substrates and/or drugs have offered valuable glimpses into the enzyme's folding and its interactions with DNA and dNTP substrates, as well as with nucleos(t)ide reverse transcriptase inhibitor (NRTI) and non-nucleoside reverse transcriptase inhibitor (NNRTIs) drugs.  These studies have been used to interpret a large body of biochem. results and have paved the way for innovative biochem. expts. designed to elucidate the mechanisms of catalysis and drug inhibition of polymerase and RNase H functions of RT.  In turn, the combined use of structural biol. and biochem. approaches has led to the discovery of novel mechanisms of drug resistance and has contributed to the design of new drugs with improved potency and ability to suppress multi-drug resistant strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqmEOrS-tfLVg90H21EOLACvtfcHk0lhPSX9iPIjAEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFWms70%253D&md5=315c778aba130ec51e869377a5835009</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.3390%2Fv2020606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv2020606%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520Aspects%2520of%2520Drug%2520Resistance%2520and%2520Inhibition%2520of%2520HIV-1%2520Reverse%2520Transcriptase%26jtitle%3DViruses%26date%3D2010%26volume%3D2%26issue%3D2%26spage%3D606%26epage%3D638%26doi%3D10.3390%2Fv2020606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohrui, H.</span></span> <span> </span><span class="NLM_article-title">A New Paradigm for Developing Antiviral Drugs Exemplified by the Development of Supremely High Anti-HIV Active EFdA</span>. <i>J. Antivirals Antiretrovirals</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.4172/jaa.1000092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.4172%2Fjaa.1000092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=32-39&author=H.+Ohrui&title=A+New+Paradigm+for+Developing+Antiviral+Drugs+Exemplified+by+the+Development+of+Supremely+High+Anti-HIV+Active+EFdA&doi=10.4172%2Fjaa.1000092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A new paradigm for developing antiviral drugs exemplified by the development of supremely high anti-HIV active EFdA</span></div><div class="casAuthors">Ohrui, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antivirals & Antiretrovirals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">032-039, 8</span>CODEN:
                <span class="NLM_cas:coden">JAAOC9</span>;
        ISSN:<span class="NLM_cas:issn">1948-5964</span>.
    
            (<span class="NLM_cas:orgname">OMICS Publishing Group</span>)
        </div><div class="casAbstract">The fundamental concept for developing anti-viral modified nucleoside was proposed.  An idea to use 4'-C-substituted-2'-deoxynucleoside derivs. based on the fundamental concept was also proposed to solve the problems of the existing highly active antiretroviral therapy (HAART).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo_5svxCGj9rVg90H21EOLACvtfcHk0lhPSX9iPIjAEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gtrvJ&md5=7e268939ef2368fb0b324fd4ce6b7029</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.4172%2Fjaa.1000092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252Fjaa.1000092%26sid%3Dliteratum%253Aachs%26aulast%3DOhrui%26aufirst%3DH.%26atitle%3DA%2520New%2520Paradigm%2520for%2520Developing%2520Antiviral%2520Drugs%2520Exemplified%2520by%2520the%2520Development%2520of%2520Supremely%2520High%2520Anti-HIV%2520Active%2520EFdA%26jtitle%3DJ.%2520Antivirals%2520Antiretrovirals%26date%3D2014%26volume%3D6%26spage%3D32%26epage%3D39%26doi%3D10.4172%2Fjaa.1000092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Salie, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michailidis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of HIV Inhibition by Translocation-Defective RT Inhibitor 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine (EFdA)</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">9274</span>– <span class="NLM_lpage">9279</span>, <span class="refDoi"> DOI: 10.1073/pnas.1605223113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1073%2Fpnas.1605223113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=27489345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=9274-9279&author=Z.+L.+Salieauthor=K.+A.+Kirbyauthor=E.+Michailidisauthor=B.+Marchandauthor=K.+Singhauthor=L.+C.+Rohanauthor=E.+N.+Kodamaauthor=H.+Mitsuyaauthor=M.+A.+Parniakauthor=S.+G.+Sarafianos&title=Structural+Basis+of+HIV+Inhibition+by+Translocation-Defective+RT+Inhibitor+4%E2%80%B2-Ethynyl-2-Fluoro-2%E2%80%B2-Deoxyadenosine+%28EFdA%29&doi=10.1073%2Fpnas.1605223113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)</span></div><div class="casAuthors">Salie, Zhe Li; Kirby, Karen A.; Michailidis, Eleftherios; Marchand, Bruno; Singh, Kamalendra; Rohan, Lisa C.; Kodama, Eiichi N.; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">9274-9279</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) is the most potent nucleoside analog inhibitor of HIV reverse transcriptase (RT).  It retains a 3'-OH yet acts as a chain-terminating agent by diminishing translocation from the pretranslocation nucleotide-binding site (N site) to the posttranslocation primer-binding site (P site).  Also, facile misincorporation of EFdA-monophosphate (MP) results in difficult-to-extend mismatched primers.  To understand the high potency and unusual inhibition mechanism of EFdA, we solved RT crystal structures (resolns. from 2.4 to 2.9 Å) that include inhibition intermediates (i) before inhibitor incorporation (catalytic complex, RT/DNA/EFdA-triphosphate), (ii) after incorporation of EFdA-MP followed by dT-MP (RT/DNAEFdA-MPSUP°P/SUP°buldT-MPSUP°N/SUP°), or (iii) after incorporation of two EFdA-MPs (RT/DNAEFdA-MPSUP°P/SUP°bulEFdA-MPSUP°N/SUP°); (iv) the latter was also solved with EFdA-MP mismatched at the N site (RT/DNAEFdA-MPSUP°P/SUP°bulEFdA-MPtSUP°N/SUP°).  We report that the inhibition mechanism and potency of EFdA stem from interactions of its 4'-ethynyl at a previously unexploited conserved hydrophobic pocket in the polymerase active site.  The high resoln. of the catalytic complex structure revealed a network of ordered water mols. at the polymerase active site that stabilize enzyme interactions with nucleotide and DNA substrates.  Finally, decreased translocation results from favorable interactions of primer-terminating EFdA-MP at the pretranslocation site and unfavorable posttranslocation interactions that lead to obsd. localized primer distortions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-6y_9SBl-hbVg90H21EOLACvtfcHk0lhPSX9iPIjAEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygt73K&md5=f3668fe0d312877907006a44549d1520</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1605223113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1605223113%26sid%3Dliteratum%253Aachs%26aulast%3DSalie%26aufirst%3DZ.%2BL.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DRohan%26aufirst%3DL.%2BC.%26aulast%3DKodama%26aufirst%3DE.%2BN.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520Basis%2520of%2520HIV%2520Inhibition%2520by%2520Translocation-Defective%2520RT%2520Inhibitor%25204%25E2%2580%25B2-Ethynyl-2-Fluoro-2%25E2%2580%25B2-Deoxyadenosine%2520%2528EFdA%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D9274%26epage%3D9279%26doi%3D10.1073%2Fpnas.1605223113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Michailidis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawani, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine Triphosphate, a Translocation-Defective Reverse Transcriptase Inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">35681</span>– <span class="NLM_lpage">35691</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.036616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1074%2Fjbc.M109.036616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=19837673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=35681-35691&author=E.+Michailidisauthor=B.+Marchandauthor=E.+N.+Kodamaauthor=K.+Singhauthor=M.+Matsuokaauthor=K.+A.+Kirbyauthor=E.+M.+Ryanauthor=A.+M.+Sawaniauthor=E.+Nagyauthor=N.+Ashidaauthor=H.+Mitsuyaauthor=M.+A.+Parniakauthor=S.+G.+Sarafianos&title=Mechanism+of+Inhibition+of+HIV-1+Reverse+Transcriptase+by+4%E2%80%B2-Ethynyl-2-Fluoro-2%E2%80%B2-Deoxyadenosine+Triphosphate%2C+a+Translocation-Defective+Reverse+Transcriptase+Inhibitor&doi=10.1074%2Fjbc.M109.036616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor</span></div><div class="casAuthors">Michailidis, Eleftherios; Marchand, Bruno; Kodama, Eiichi N.; Singh, Kamlendra; Matsuoka, Masao; Kirby, Karen A.; Ryan, Emily M.; Sawani, Ali M.; Nagy, Eva; Ashida, Noriyuki; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">35681-35691</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleoside reverse transcriptase inhibitors (NRTIs) are employed in first line therapies for the treatment of human immunodeficiency virus (HIV) infection.  They generally lack a 3'-hydroxyl group, and thus when incorporated into the nascent DNA they prevent further elongation.  The authors show that 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA), a nucleoside analog that retains a 3'-hydroxyl moiety, inhibited HIV-1 replication in activated peripheral blood mononuclear cells with an EC50 of 0.05 nM, a potency several orders of magnitude better than any of the current clin. used NRTIs.  This exceptional antiviral activity stems in part from a mechanism of action that is different from approved NRTIs.  Reverse transcriptase (RT) can use EFdA-5'-triphosphate (EFdA-TP) as a substrate more efficiently than the natural substrate, dATP.  Importantly, despite the presence of a 3'-hydroxyl, the incorporated EFdA monophosphate (EFdA-MP) acted mainly as a de facto terminator of further RT-catalyzed DNA synthesis because of the difficulty of RT translocation on the nucleic acid primer possessing 3'-terminal EFdA-MP.  EFdA-TP is thus a translocation-defective RT inhibitor (TDRTI).  This diminished translocation kept the primer 3'-terminal EFdA-MP ideally located to undergo phosphorolytic excision.  However, net phosphorolysis was not substantially increased, because of the apparently facile reincorporation of the newly excised EFdA-TP.  The authors' mol. modeling studies suggest that the 4'-ethynyl fits into a hydrophobic pocket defined by RT residues Ala 114, Tyr-115, Phe 160, and Met 184 and the aliph. chain of Asp 185.  These interactions, which contribute to both enhanced RT utilization of EFdA-TP and difficulty in the translocation of 3'-terminal EFdA-MP primers, underlie the mechanism of action of this potent antiviral nucleoside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSzybzRvJFz7Vg90H21EOLACvtfcHk0lh9bjBVa686HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCqurfI&md5=af4d7c768df0bc42d8a058bd7fd7e993</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.036616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.036616%26sid%3Dliteratum%253Aachs%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DKodama%26aufirst%3DE.%2BN.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DM.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DRyan%26aufirst%3DE.%2BM.%26aulast%3DSawani%26aufirst%3DA.%2BM.%26aulast%3DNagy%26aufirst%3DE.%26aulast%3DAshida%26aufirst%3DN.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DMechanism%2520of%2520Inhibition%2520of%2520HIV-1%2520Reverse%2520Transcriptase%2520by%25204%25E2%2580%25B2-Ethynyl-2-Fluoro-2%25E2%2580%25B2-Deoxyadenosine%2520Triphosphate%252C%2520a%2520Translocation-Defective%2520Reverse%2520Transcriptase%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D35681%26epage%3D35691%26doi%3D10.1074%2Fjbc.M109.036616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohgo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, M.</span></span> <span> </span><span class="NLM_article-title">2′-Deoxy-4′-<i>C</i>-ethynyl-2-halo-adenosines Active against Drug-Resistant Human Immunodeficiency Virus Type 1 Variants</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2410</span>– <span class="NLM_lpage">2420</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2008.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2Fj.biocel.2008.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=18487070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVaguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=2410-2420&author=A.+Kawamotoauthor=E.+Kodamaauthor=S.+G.+Sarafianosauthor=Y.+Sakagamiauthor=S.+Kohgoauthor=K.+Kitanoauthor=N.+Ashidaauthor=Y.+Iwaiauthor=H.+Hayakawaauthor=H.+Nakataauthor=H.+Mitsuyaauthor=E.+Arnoldauthor=M.+Matsuoka&title=2%E2%80%B2-Deoxy-4%E2%80%B2-C-ethynyl-2-halo-adenosines+Active+against+Drug-Resistant+Human+Immunodeficiency+Virus+Type+1+Variants&doi=10.1016%2Fj.biocel.2008.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">2'-Deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants</span></div><div class="casAuthors">Kawamoto, Atsushi; Kodama, Eiichi; Sarafianos, Stefan G.; Sakagami, Yasuko; Kohgo, Satoru; Kitano, Kenji; Ashida, Noriyuki; Iwai, Yuko; Hayakawa, Hiroyuki; Nakata, Hirotomo; Mitsuya, Hiroaki; Arnold, Eddy; Matsuoka, Masao</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2410-2420</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">One of the formidable challenges in therapy of infections by human immunodeficiency virus (HIV) is the emergence of drug-resistant variants that attenuate the efficacy of highly active antiretroviral therapy (HAART).  We have recently introduced 4'-ethynyl-nucleoside analogs as nucleoside reverse transcriptase inhibitors (NRTIs) that could be developed as therapeutics for treatment of HIV infections.  In this study, we present 2'-deoxy-4'-C-ethynyl-2-fluoroadenosine (EFdA), a second generation 4'-ethynyl inhibitor that exerted highly potent activity against wild-type HIV-1 (EC50 ∼ 0.07 nM).  EFdA retains potency toward many HIV-1 resistant strains, including the multi-drug resistant clone HIV-1A62V/V75I/F77L/F116Y/q151M.  The selectivity index of EFdA (cytotoxicity/inhibitory activity) is more favorable than all approved NRTIs used in HIV therapy.  Furthermore, EFdA efficiently inhibited clin. isolates from patients heavily treated with multiple anti-HIV-1 drugs.  EFdA appears to be primarily phosphorylated by the cellular 2'-deoxycytidine kinase (dCK) because: (a) the antiviral activity of EFdA was reduced by the addn. of dC, which competes nucleosides phosphorylated by the dCK pathway, (b) the antiviral activity of EFdA was significantly reduced in dCK-deficient HT-1080/Ara-Cr cells, but restored after dCK transduction.  Further, unlike other dA analogs, EFdA is completely resistant to degrdn. by adenosine deaminase.  Moderate decrease in susceptibility to EFdA is conferred by a combination of three RT mutations (I142V, T165R, and M184V) that result in a significant decrease of viral fitness.  Mol. modeling anal. suggests that the M184V/I substitutions may reduce anti-HIV activity of EFdA through steric hindrance between its 4'-ethynyl moiety and the V/I184 β-branched side chains.  The present data suggest that EFdA, is a promising candidate for developing as a therapeutic agent for the treatment of individuals harboring multi-drug resistant HIV variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1x9Q0xUpKX7Vg90H21EOLACvtfcHk0lh9bjBVa686HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVaguro%253D&md5=69039c735ae8e2f42c73c085f5ba87a3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DA.%26aulast%3DKodama%26aufirst%3DE.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DSakagami%26aufirst%3DY.%26aulast%3DKohgo%26aufirst%3DS.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DAshida%26aufirst%3DN.%26aulast%3DIwai%26aufirst%3DY.%26aulast%3DHayakawa%26aufirst%3DH.%26aulast%3DNakata%26aufirst%3DH.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DMatsuoka%26aufirst%3DM.%26atitle%3D2%25E2%2580%25B2-Deoxy-4%25E2%2580%25B2-C-ethynyl-2-halo-adenosines%2520Active%2520against%2520Drug-Resistant%2520Human%2520Immunodeficiency%2520Virus%2520Type%25201%2520Variants%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2008%26volume%3D40%26spage%3D2410%26epage%3D2420%26doi%3D10.1016%2Fj.biocel.2008.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphey-Corb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyaundi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didier, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span> <span> </span><span class="NLM_article-title">Response of Simian Immunodeficiency Virus to the Novel Nucleoside Reverse Transcriptase Inhibitor 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine in Vitro and in Vivo</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4707</span>– <span class="NLM_lpage">4712</span>, <span class="refDoi"> DOI: 10.1128/AAC.00723-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1128%2FAAC.00723-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=4707-4712&author=M.+Murphey-Corbauthor=P.+Rajakumarauthor=H.+Michaelauthor=J.+Nyaundiauthor=P.+J.+Didierauthor=A.+B.+Reeveauthor=H.+Mitsuyaauthor=S.+G.+Sarafianosauthor=M.+A.+Parniak&title=Response+of+Simian+Immunodeficiency+Virus+to+the+Novel+Nucleoside+Reverse+Transcriptase+Inhibitor+4%E2%80%B2-Ethynyl-2-Fluoro-2%E2%80%B2-Deoxyadenosine+in+Vitro+and+in+Vivo&doi=10.1128%2FAAC.00723-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FAAC.00723-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00723-12%26sid%3Dliteratum%253Aachs%26aulast%3DMurphey-Corb%26aufirst%3DM.%26aulast%3DRajakumar%26aufirst%3DP.%26aulast%3DMichael%26aufirst%3DH.%26aulast%3DNyaundi%26aufirst%3DJ.%26aulast%3DDidier%26aufirst%3DP.%2BJ.%26aulast%3DReeve%26aufirst%3DA.%2BB.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26atitle%3DResponse%2520of%2520Simian%2520Immunodeficiency%2520Virus%2520to%2520the%2520Novel%2520Nucleoside%2520Reverse%2520Transcriptase%2520Inhibitor%25204%25E2%2580%25B2-Ethynyl-2-Fluoro-2%25E2%2580%25B2-Deoxyadenosine%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D4707%26epage%3D4712%26doi%3D10.1128%2FAAC.00723-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> MK-8591 with Doravirine and Lamivudine
in Participants
Infected with Human Immunodeficiency Virus Type 1 (MK-8591-011). <a href="https://clinicaltrials.gov/ct2/show/NCT03272347" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03272347</a> (accessed July 17, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MK-8591+with+Doravirine+and+Lamivudine%0Ain+Participants%0AInfected+with+Human+Immunodeficiency+Virus+Type+1+%28MK-8591-011%29.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03272347+%28accessed+July+17%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Grobler, J.</span>; <span class="NLM_string-name">Friedman, E.</span>; <span class="NLM_string-name">Barrett, S. E.</span>; <span class="NLM_string-name">Wood, S. L.</span>; <span class="NLM_string-name">Ankrom, W.</span>; <span class="NLM_string-name">Fillgrove, K. L.</span>; <span class="NLM_string-name">Lai, M.-T.</span>; <span class="NLM_string-name">Gindy, M.</span>; <span class="NLM_string-name">Iwamoto, M.</span>; <span class="NLM_string-name">Hazuda, D. J.</span></span> <span> </span><span class="NLM_article-title">Long-Acting Oral and Parenteral Dosing of MK-8591 for HIV Treatment or Prophylaxis</span>. Presented at the CROI, Boston, MA, U.S., <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Grobler&author=E.+Friedman&author=S.+E.+Barrett&author=S.+L.+Wood&author=W.+Ankrom&author=K.+L.+Fillgrove&author=M.-T.+Lai&author=M.+Gindy&author=M.+Iwamoto&author=D.+J.+Hazuda&title=Long-Acting+Oral+and+Parenteral+Dosing+of+MK-8591+for+HIV+Treatment+or+Prophylaxis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGrobler%26aufirst%3DJ.%26atitle%3DLong-Acting%2520Oral%2520and%2520Parenteral%2520Dosing%2520of%2520MK-8591%2520for%2520HIV%2520Treatment%2520or%2520Prophylaxis%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, R. P.</span>; <span class="NLM_string-name">Schürmann, D.</span>; <span class="NLM_string-name">Rudd, D. J.</span>; <span class="NLM_string-name">Levine, V.</span>; <span class="NLM_string-name">Fox-Bosetti, S.</span>; <span class="NLM_string-name">Zhang, S.</span>; <span class="NLM_string-name">Robberechts, M.</span>; <span class="NLM_string-name">Huser, A.</span>; <span class="NLM_string-name">Hazuda, D. J.</span>; <span class="NLM_string-name">Iwamoto, M.</span>; <span class="NLM_string-name">Grobler, J. A.</span></span> <span> </span><span class="NLM_article-title">Single Doses as Low as 0.5 mg of the Novel NRTTI MK-8591 Suppress HIV for at Least Seven Days</span>. Presented at the IAS, Paris, France, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=R.+P.+Matthews&author=D.+Sch%C3%BCrmann&author=D.+J.+Rudd&author=V.+Levine&author=S.+Fox-Bosetti&author=S.+Zhang&author=M.+Robberechts&author=A.+Huser&author=D.+J.+Hazuda&author=M.+Iwamoto&author=J.+A.+Grobler&title=Single+Doses+as+Low+as+0.5+mg+of+the+Novel+NRTTI+MK-8591+Suppress+HIV+for+at+Least+Seven+Days"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DR.%2BP.%26atitle%3DSingle%2520Doses%2520as%2520Low%2520as%25200.5%2520mg%2520of%2520the%2520Novel%2520NRTTI%2520MK-8591%2520Suppress%2520HIV%2520for%2520at%2520Least%2520Seven%2520Days%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nyaku, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiwo, B. O.</span></span> <span> </span><span class="NLM_article-title">Long-Acting Antiretrovirals: Where Are We Now?</span>. <i>Curr. HIV/AIDS Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1007/s11904-017-0353-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1007%2Fs11904-017-0353-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=28303548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A280%3ADC%252BC1cznt1Smtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=63-71&author=A.+N.+Nyakuauthor=S.+G.+Kellyauthor=B.+O.+Taiwo&title=Long-Acting+Antiretrovirals%3A+Where+Are+We+Now%3F&doi=10.1007%2Fs11904-017-0353-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Long-Acting Antiretrovirals: Where Are We now?</span></div><div class="casAuthors">Nyaku Amesika N; Kelly Sean G; Taiwo Babafemi O; Taiwo Babafemi O</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV/AIDS reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">63-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Current HIV treatment options require daily use of combination antiretroviral drugs.  Many persons living with HIV experience treatment fatigue and suboptimal adherence as a result.  Long-acting antiretroviral drugs are being developed to expand options for HIV treatment.  Here, we review the agents in development, and evaluate data from recent clinical trials.  In addition, we anticipate challenges to successful widespread use of long-acting antiretrovirals.  RECENT FINDINGS:  Parenteral nanosuspensions of cabotegravir and rilpivirine, and dapivirine vaginal ring are the farthest in clinical development.  Long-acting modalities in earlier development stages employ drug-loaded implants, microparticles, or targeted mutagenesis, among other innovations.  Long-acting antiretroviral drugs promise new options for HIV prevention and treatment, and ways to address poor adherence and treatment fatigue.  Further studies will identify the long-acting agents or combinations that are suitable for routine use.  Creative solutions will be needed for anticipated implementation challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKP8arQFIJ-uRS7coPn-RtfW6udTcc2eYbleWo81r4lrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cznt1Smtg%253D%253D&md5=d78bfa6bd94a1f4df4b5e19062d0ea05</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1007%2Fs11904-017-0353-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11904-017-0353-0%26sid%3Dliteratum%253Aachs%26aulast%3DNyaku%26aufirst%3DA.%2BN.%26aulast%3DKelly%26aufirst%3DS.%2BG.%26aulast%3DTaiwo%26aufirst%3DB.%2BO.%26atitle%3DLong-Acting%2520Antiretrovirals%253A%2520Where%2520Are%2520We%2520Now%253F%26jtitle%3DCurr.%2520HIV%252FAIDS%2520Rep.%26date%3D2017%26volume%3D14%26spage%3D63%26epage%3D71%26doi%3D10.1007%2Fs11904-017-0353-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, C. M.</span></span> <span> </span><span class="NLM_article-title">Abacavir: A Review of its Clinical Potential in Patients with HIV Infection</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.2165/00003495-200060020-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.2165%2F00003495-200060020-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10983741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslWgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=447-479&author=P.+S.+Herveyauthor=C.+M.+Perry&title=Abacavir%3A+A+Review+of+its+Clinical+Potential+in+Patients+with+HIV+Infection&doi=10.2165%2F00003495-200060020-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Abacavir A review of its clinical potential in patients with HIV infection</span></div><div class="casAuthors">Hervey, Pauline S.; Perry, Caroline M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">447-479</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 108 refs.  Abacavir is a carbocyclic 2'-deoxyguanosine nucleoside analog.  It is metabolized intracellularly to a 2'-deoxyguanosine nucleoside analog which competitively inhibits HIV reverse transcriptase and terminates proviral DNA chain extension.  In double-blind trials in antiretroviral therapy-experienced or -naive patients, redns. in HIV RNA levels were greater and more prolonged in patients receiving abacavir in combination with other antiretroviral drugs than in those receiving placebo in combination with the same agents.  Furthermore, abacavir in combination with lamivudine and zidovudine reduced viral load to below detectable levels in a proportion of patients, and to a similar extent to the protease inhibitor indinavir in combination with lamivudine and zidovudine.  Greatest viral load redns. were seen in antiretroviral therapy-naive patients.  Preliminary results suggest that the viral suppression achieved with a protease inhibitor plus 2 nucleoside reverse transcriptase inhibitors (NRTIs) can be maintained as effectively with abacavir in combination with 2 NRTIs as it can be by continuing the protease inhibitor-contg. treatment regimen.  Initial virol. data from studies of combination regimens including abacavir and protease inhibitors appear promising but larger controlled trials are required to confirm these observations.  Nausea is the most frequently reported adverse event in patients receiving abacavir-contg. combination therapy.  Adverse events tend to be reported most frequently soon after starting treatment; the majority of events are mild or moderate in intensity and transient.  Other adverse events reported in >5% of patients include vomiting, malaise and fatigue, headache, diarrhea, sleep disorders, cough, anorexia and rash.  A major cause of abacavir treatment discontinuation is the development of a hypersensitivity reaction which has been reported in 3 to 5% of patients.  The reaction usually occurs within 6 wk of commencing treatment, shows evidence of multiorgan system involvement and typically includes fever and/or rash.  Symptoms resolve rapidly after discontinuation of treatment.  Continuing treatment or rechallenge can result in more severe symptoms, life-threatening hypotension and even death.  Abacavir used in combination with other antiretroviral drugs effectively reduces viral load in both adults and children with HIV infection.  Although these responses are greatest in individuals with little or no previous antiretroviral treatment, useful responses agree still sometimes achieved in heavily pretreated individuals.  Abacavir in combination with lamivudine and zidovudine provides a simple and convenient dosage regimen which is generally well tolerated, able to produce sustained suppression of viral replication and has the advantage of sparing other classes of antiretroviral drugs for subsequent use.  This triple combination represents an alternative antiretroviral regimen for patients intolerant to protease inhibitors or those wishing to retain the option of protease inhibitors for later use.  Further clin. studies are needed to define the activity of abacavir in combination with protease inhibitors and non-nucleoside reverse transcriptase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHo1d2XSPQqLVg90H21EOLACvtfcHk0ljg3oFQLYK7xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslWgurw%253D&md5=062632cb422b7897073fa86cc3874fc8</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.2165%2F00003495-200060020-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200060020-00015%26sid%3Dliteratum%253Aachs%26aulast%3DHervey%26aufirst%3DP.%2BS.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26atitle%3DAbacavir%253A%2520A%2520Review%2520of%2520its%2520Clinical%2520Potential%2520in%2520Patients%2520with%2520HIV%2520Infection%26jtitle%3DDrugs%26date%3D2000%26volume%3D60%26spage%3D447%26epage%3D479%26doi%3D10.2165%2F00003495-200060020-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pakes, G. E.</span></span> <span> </span><span class="NLM_article-title">A Review of the Pharmacokinetis of Abacavir</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.2165/00003088-200847060-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.2165%2F00003088-200847060-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=18479171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1ehsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=351-371&author=G.+J.+Yuenauthor=S.+Wellerauthor=G.+E.+Pakes&title=A+Review+of+the+Pharmacokinetis+of+Abacavir&doi=10.2165%2F00003088-200847060-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the pharmacokinetics of abacavir</span></div><div class="casAuthors">Yuen, Geoffrey J.; Weller, Steve; Pakes, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">351-371</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Abacavir is a carbocyclic 2'-deoxyguanosine nucleoside reverse transcriptase inhibitor that is used as either a 600-mg once-daily or 300-mg twice-daily regimen exclusively in the treatment of HIV infection.  Abacavir is rapidly absorbed after oral administration, with peak concns. occurring 0.63-1 h after dosing.  The abs. bioavailability of abacavir is approx. 83%.  Abacavir pharmacokinetics are linear and dose-proportional over the range of 300-1200 mg/day.  To date, one study has assessed the steady-state pharmacokinetics of abacavir following a 600-mg once-daily regimen, and reported a geometric mean steady-state abacavir peak concn. of 3.85 μg/mL.  Although this concn. is higher than the steady-state abacavir peak concn. reported following a 300-mg twice-daily regimen (0.88-3.19 μg/mL, depending on the study), the geometric mean steady-state abacavir exposure over 24 h was similar following these regimens.  Coadministration with food has no significant effect on abacavir exposure; therefore, abacavir may be administered with or without food.  The apparent vol. of distribution of abacavir after i.v. administration is approx. 0.86 ± 0.15 L/kg, suggesting that abacavir is distributed to extravascular spaces.  Binding to plasma proteins is about 50% and is independent of the plasma abacavir concn.  Abacavir is extensively metabolized by the liver; less than 2% is excreted as unchanged drug in the urine.  Abacavir is primarily metabolized via two pathways, uridine diphosphate glucuronyltransferase and alc. dehydrogenase, resulting in the inactive glucuronide metabolite (361W94, ∼36% of the dose recovered in the urine) and the inactive carboxylate metabolite (2269W93, ∼30% of the dose recovered in the urine).  The remaining 15% of abacavir equiv. found in the urine are minor metabolites, each less than 2% of the total dose.  Faecal elimination accounts for about 16% of the dose.  The terminal elimination half-life of abacavir is approx. 1.5 h.  The antiviral effect of abacavir is due to its intracellular anabolite, carbovir-triphosphate (CBV-TP).  When assessed by validated high-performance liq. chromatog. electrospray ionization tandem mass spectrometry, CBV-TP has been shown to have a long elimination half-life (>20 h), supporting once-daily dosing.  The mean CBV-TP trough concns. do not differ following abacavir 600-mg once-daily and 300-mg twice-daily regimens.  Limited data are available for abacavir in subjects with renal dysfunction or hepatic impairment.  Abacavir pharmacokinetics in HIV-infected subjects with end-stage renal disease were found to be no different from those obsd. in healthy adults; this finding was consistent with the kidney being a minor route of abacavir elimination.  A study of abacavir pharmacokinetics in hepatically impaired adults (Child-Pugh score of 5-6) showed that the abacavir area under the plasma concn.-time curve and elimination half-life were 89% and 58% greater, resp., suggesting that the daily dose of abacavir should be reduced in patients with mild hepatic impairment (Child-Pugh score of 5-6).  Abacavir pharmacokinetics have not been studied in patients with higher Child-Pugh scores.  Abacavir is not significantly metabolized by cytochrome P 450 (CYP) enzymes, nor does it inhibit these enzymes.  Therefore, clin. significant drug interactions between abacavir and drugs metabolized by CYP enzymes are unlikely.  The potential for drug interactions is no different when abacavir is used as a once-daily regimen vs. a twice-daily regimen.  No clin. significant drug interactions have been obsd. between recommended doses of abacavir and lamivudine, zidovudine, alc. (ethanol) or methadone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoqL_LBoD9FbVg90H21EOLACvtfcHk0ljg3oFQLYK7xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1ehsrw%253D&md5=1f8910ab20febad83100819dd725613a</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.2165%2F00003088-200847060-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200847060-00001%26sid%3Dliteratum%253Aachs%26aulast%3DYuen%26aufirst%3DG.%2BJ.%26aulast%3DWeller%26aufirst%3DS.%26aulast%3DPakes%26aufirst%3DG.%2BE.%26atitle%3DA%2520Review%2520of%2520the%2520Pharmacokinetis%2520of%2520Abacavir%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2008%26volume%3D47%26spage%3D351%26epage%3D371%26doi%3D10.2165%2F00003088-200847060-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Rawal, R.
K.</span>; <span class="NLM_string-name">Chu, C. K.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in Carbocyclic Nucleosides: Synthesis and Biological Activity</span>. In  <i>Medicinal Chemistry of Nucleic Acids</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-H.</span>, <span class="NLM_string-name">Xi, Z.</span>, <span class="NLM_string-name">Chattopadhyaya, J.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2011</span>; Chapter 1, pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1002/9781118092804.ch1</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1002%2F9781118092804.ch1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1-100&author=J.+Wang&author=R.%0AK.+Rawal&author=C.+K.+Chuauthor=L.-H.+Zhang&author=Z.+Xi&author=J.+Chattopadhyaya&title=Medicinal+Chemistry+of+Nucleic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2F9781118092804.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118092804.ch1%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DRecent%2520Advances%2520in%2520Carbocyclic%2520Nucleosides%253A%2520Synthesis%2520and%2520Biological%2520Activity%26btitle%3DMedicinal%2520Chemistry%2520of%2520Nucleic%2520Acids%26aulast%3DZhang%26aufirst%3DL.-H.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2011%26spage%3D1%26epage%3D100%26doi%3D10.1002%2F9781118092804.ch1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. K.</span></span> <span> </span><span class="NLM_article-title">Enantiomeric synthesis of carbocyclic D-4′-<i>C</i>-methylribonucleosides as Potential Antiviral Agents</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3304</span>– <span class="NLM_lpage">3314</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2006.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2Fj.tetasy.2006.12.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=3304-3314&author=P.+Liuauthor=A.+Sharonauthor=C.+K.+Chu&title=Enantiomeric+synthesis+of+carbocyclic+D-4%E2%80%B2-C-methylribonucleosides+as+Potential+Antiviral+Agents&doi=10.1016%2Fj.tetasy.2006.12.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2006.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2006.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DSharon%26aufirst%3DA.%26aulast%3DChu%26aufirst%3DC.%2BK.%26atitle%3DEnantiomeric%2520synthesis%2520of%2520carbocyclic%2520D-4%25E2%2580%25B2-C-methylribonucleosides%2520as%2520Potential%2520Antiviral%2520Agents%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2006%26volume%3D17%26spage%3D3304%26epage%3D3314%26doi%3D10.1016%2Fj.tetasy.2006.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, O.
H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. H.</span></span> <span> </span><span class="NLM_article-title">Efficient Synthesis of Novel Carbocyclic Nucleosides via Sequential Claisen Rearrangement and Ring-Closing Metathesis</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">6399</span>– <span class="NLM_lpage">6402</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(02)01384-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2FS0040-4039%2802%2901384-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=6399-6402&author=O.%0AH.+Koauthor=J.+H.+Hong&title=Efficient+Synthesis+of+Novel+Carbocyclic+Nucleosides+via+Sequential+Claisen+Rearrangement+and+Ring-Closing+Metathesis&doi=10.1016%2FS0040-4039%2802%2901384-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2901384-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252901384-9%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DO.%2BH.%26aulast%3DHong%26aufirst%3DJ.%2BH.%26atitle%3DEfficient%2520Synthesis%2520of%2520Novel%2520Carbocyclic%2520Nucleosides%2520via%2520Sequential%2520Claisen%2520Rearrangement%2520and%2520Ring-Closing%2520Metathesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D6399%26epage%3D6402%26doi%3D10.1016%2FS0040-4039%2802%2901384-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antiviral Activity of Novel 2′,4′-Doubly Branched Carbocyclic Nucleosides</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">813</span>– <span class="NLM_lpage">822</span>, <span class="refDoi"> DOI: 10.1081/NCN-120039252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1081%2FNCN-120039252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=15281369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFGntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=813-822&author=A.+Kimauthor=J.+H.+Hong&title=Synthesis+and+Antiviral+Activity+of+Novel+2%E2%80%B2%2C4%E2%80%B2-Doubly+Branched+Carbocyclic+Nucleosides&doi=10.1081%2FNCN-120039252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antiviral Activity of Novel 2',4'-Doubly Branched Carbocyclic Nucleosides</span></div><div class="casAuthors">Kim, Aihong; Hong, Joon Hee</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">813-822</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A series of 2' and 4'-doubly branched carbocyclic nucleosides, e.g. I, were synthesized as antiviral agents starting from simple acyclic ketone derivs.  The required 4'-quaternary carbon was constructed using Claisen rearrangement.  In addn., the installation of a Me group in the 2'-position was accomplished using a Grignard carbonyl addn. of iso-propenyl-magnesium bromide.  Bis-vinyl was successfully cyclized using a Grubbs' catalyst II.  Natural bases (adenine, cytosine) were efficiently coupled by using Pd(0) catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouP1mZul3u27Vg90H21EOLACvtfcHk0lg6VSdWQOKnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFGntbc%253D&md5=a6c27a9b885cdfbde8cf1d3b32c40040</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1081%2FNCN-120039252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-120039252%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%2BH.%26atitle%3DSynthesis%2520and%2520Antiviral%2520Activity%2520of%2520Novel%25202%25E2%2580%25B2%252C4%25E2%2580%25B2-Doubly%2520Branched%2520Carbocyclic%2520Nucleosides%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2004%26volume%3D23%26spage%3D813%26epage%3D822%26doi%3D10.1081%2FNCN-120039252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. H.</span></span> <span> </span><span class="NLM_article-title">Novel Synthesis of 4′C-Aryl-Branched Acyclic Nucleoside Using [3,3]-Sigmatropic Rearrangement</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1781</span>– <span class="NLM_lpage">1788</span>, <span class="refDoi"> DOI: 10.1081/NCN-120023272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1081%2FNCN-120023272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=14533881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFelurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=1781-1788&author=G.+H.+Baikauthor=B.+Y.+Chungauthor=C.-H.+Ohauthor=J.-H.+Choauthor=O.+H.+Koauthor=J.+H.+Hong&title=Novel+Synthesis+of+4%E2%80%B2C-Aryl-Branched+Acyclic+Nucleoside+Using+%5B3%2C3%5D-Sigmatropic+Rearrangement&doi=10.1081%2FNCN-120023272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12dR"><div class="casContent"><span class="casTitleNuber">12d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Synthesis of 4'C-Aryl-Branched Acyclic Nucleoside Using [3,3]-Sigmatropic Rearrangement</span></div><div class="casAuthors">Baik, Gun Ha; Chung, Bong Young; Oh, Chang-Hyun; Cho, Jung-Hyuck; Ko, Ok Hyun; Hong, Joon Hee</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1781-1788</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A very efficient synthetic route for prepg. a novel 4'-C-aryl branched-1',2'-seco-2',3'-dideoxy-2',3'-didehydro-nucleoside is described.  Mesylate I was successfully synthesized via a Horner-Wadsworth-Emmons reaction and a [3,3]sigmatropic rearrangement, with which an adenine base was coupled by nucleophilic substitution conditions (K2CO3, 18-Crown-6, DMF) to give the target nucleoside II.  This study aimed to synthesize novel classes of nucleosides, which are hybrids of branched carbocyclic and 1',2'-seco-acyclic nucleoside analogs showing marginal anti-HIV activity.  An antiviral assay of the synthesized nucleoside II against HIV-1, HSV-1, HSV-2, and HCMV was performed.  However, no significant antiviral activity or cytotoxicity up to 100 pM was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXyXqiyncFtbVg90H21EOLACvtfcHk0lg6VSdWQOKnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFelurg%253D&md5=e3bb8dddf5611b31dedb220e5ad2cf52</span></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1081%2FNCN-120023272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-120023272%26sid%3Dliteratum%253Aachs%26aulast%3DBaik%26aufirst%3DG.%2BH.%26aulast%3DChung%26aufirst%3DB.%2BY.%26aulast%3DOh%26aufirst%3DC.-H.%26aulast%3DCho%26aufirst%3DJ.-H.%26aulast%3DKo%26aufirst%3DO.%2BH.%26aulast%3DHong%26aufirst%3DJ.%2BH.%26atitle%3DNovel%2520Synthesis%2520of%25204%25E2%2580%25B2C-Aryl-Branched%2520Acyclic%2520Nucleoside%2520Using%2520%255B3%252C3%255D-Sigmatropic%2520Rearrangement%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2003%26volume%3D22%26spage%3D1781%26epage%3D1788%26doi%3D10.1081%2FNCN-120023272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kumamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haraguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitanda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutschman, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of (±)-4′-Ethynyl and 4′-Cyano Carbocyclic Analogues of Stavudine (d4T)</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1081/NCN-51900</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1081%2FNCN-51900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=15822615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFWgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=73-83&author=H.+Kumamotoauthor=K.+Haraguchiauthor=H.+Tanakaauthor=T.+Nitandaauthor=M.+Babaauthor=G.+E.+Dutschmanauthor=Y.-C.+Chengauthor=K.+Kato&title=Synthesis+of+%28%C2%B1%29-4%E2%80%B2-Ethynyl+and+4%E2%80%B2-Cyano+Carbocyclic+Analogues+of+Stavudine+%28d4T%29&doi=10.1081%2FNCN-51900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12eR"><div class="casContent"><span class="casTitleNuber">12e</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (±)-4'-ethynyl and 4'-cyano carbocyclic analogs of stavudine (d4T)</span></div><div class="casAuthors">Kumamoto, Hiroki; Haraguchi, Kazuhiro; Tanaka, Hiromichi; Nitanda, Takao; Baba, Masanori; Dutschman, Ginger E.; Cheng, Yung-Chi; Kato, Keisuke</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The synthesis of (±)-4'-ethynyl (I) and 4'-cyano (II) carbocyclic analogs of the anti-HIV agent stavudine (d4T) is reported.  The carbocyclic unit was constructed from readily available β-keto ester.  The ethynyl or cyano group of I and II were prepd., after the introduction of thymine base, by manipulation of the ester function.  Evaluation of the anti-HIV activity of I and II was also carried out, but ultimately did not inhibit the virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxE3RQWy4fgrVg90H21EOLACvtfcHk0lj5ElksivgUpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFWgtrY%253D&md5=6875892c6d555799610e441a67fb81ec</span></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1081%2FNCN-51900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-51900%26sid%3Dliteratum%253Aachs%26aulast%3DKumamoto%26aufirst%3DH.%26aulast%3DHaraguchi%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DNitanda%26aufirst%3DT.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DDutschman%26aufirst%3DG.%2BE.%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DKato%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520%2528%25C2%25B1%2529-4%25E2%2580%25B2-Ethynyl%2520and%25204%25E2%2580%25B2-Cyano%2520Carbocyclic%2520Analogues%2520of%2520Stavudine%2520%2528d4T%2529%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2005%26volume%3D24%26spage%3D73%26epage%3D83%26doi%3D10.1081%2FNCN-51900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyasaka, T.</span></span> <span> </span><span class="NLM_article-title">Enantio- and Diastereoselective Synthesis of 4′-α-Substituted Carbocyclic Nucleosides</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">914</span>, <span class="refDoi"> DOI: 10.1016/S0957-4166(98)00065-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2FS0957-4166%2898%2900065-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=911-914&author=K.+Katoauthor=H.+Suzukiauthor=H.+Tanakaauthor=T.+Miyasaka&title=Enantio-+and+Diastereoselective+Synthesis+of+4%E2%80%B2-%CE%B1-Substituted+Carbocyclic+Nucleosides&doi=10.1016%2FS0957-4166%2898%2900065-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2898%2900065-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252898%252900065-2%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DMiyasaka%26aufirst%3DT.%26atitle%3DEnantio-%2520and%2520Diastereoselective%2520Synthesis%2520of%25204%25E2%2580%25B2-%25CE%25B1-Substituted%2520Carbocyclic%2520Nucleosides%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1998%26volume%3D9%26spage%3D911%26epage%3D914%26doi%3D10.1016%2FS0957-4166%2898%2900065-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a Novel Conformationally Locked Carbocyclic Nucleoside Ring System</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1665</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1021/ol034326z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol034326z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=1665-1668&author=H.+S.+Kimauthor=K.+A.+Jacobson&title=Synthesis+of+a+Novel+Conformationally+Locked+Carbocyclic+Nucleoside+Ring+System&doi=10.1021%2Fol034326z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=10.1021%2Fol034326z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol034326z%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520of%2520a%2520Novel%2520Conformationally%2520Locked%2520Carbocyclic%2520Nucleoside%2520Ring%2520System%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D1665%26epage%3D1668%26doi%3D10.1021%2Fol034326z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneller, S. W.</span></span> <span> </span><span class="NLM_article-title">A Practical Synthetic Route to 4′-Alkylaristeromycin Derivatives: 4′-Methylaristeromycin</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">4057</span>– <span class="NLM_lpage">4059</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.03.188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2Fj.tetlet.2006.03.188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=4057-4059&author=K.-Q.+Yinauthor=S.+W.+Schneller&title=A+Practical+Synthetic+Route+to+4%E2%80%B2-Alkylaristeromycin+Derivatives%3A+4%E2%80%B2-Methylaristeromycin&doi=10.1016%2Fj.tetlet.2006.03.188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12h&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.03.188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.03.188%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DK.-Q.%26aulast%3DSchneller%26aufirst%3DS.%2BW.%26atitle%3DA%2520Practical%2520Synthetic%2520Route%2520to%25204%25E2%2580%25B2-Alkylaristeromycin%2520Derivatives%253A%25204%25E2%2580%25B2-Methylaristeromycin%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D4057%26epage%3D4059%26doi%3D10.1016%2Fj.tetlet.2006.03.188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hřebabecký, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masojídková, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Carba Analogues of Deoxy-4-<i>C</i>-(Hydroxymethyl)-Pentofuranoses, Intermediates in the Synthesis of Carbocyclic Nucleosides</span>. <i>Collect. Czech. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2044</span>– <span class="NLM_lpage">2064</span>, <span class="refDoi"> DOI: 10.1135/cccc19982044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1135%2Fcccc19982044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADyaK1MXislah" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=2044-2064&author=H.+H%C5%99ebabeck%C3%BDauthor=M.+Masoj%C3%ADdkov%C3%A1author=A.+Hol%C3%BD&title=Synthesis+of+Carba+Analogues+of+Deoxy-4-C-%28Hydroxymethyl%29-Pentofuranoses%2C+Intermediates+in+the+Synthesis+of+Carbocyclic+Nucleosides&doi=10.1135%2Fcccc19982044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of carba analogs of deoxy-4-C-(hydroxymethyl)pentofuranoses, intermediates in the synthesis of carbocyclic nucleosides</span></div><div class="casAuthors">Hrebabecky, Hubert; Masojidkova, Milena; Holy, Antonin</div><div class="citationInfo"><span class="NLM_cas:title">Collection of Czechoslovak Chemical Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2044-2064</span>CODEN:
                <span class="NLM_cas:coden">CCCCAK</span>;
        ISSN:<span class="NLM_cas:issn">0010-0765</span>.
    
            (<span class="NLM_cas:orgname">Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic</span>)
        </div><div class="casAbstract">Racemic di-Me 4-methoxy-, diallyl 4-allyloxy- and di-Me 4-(ethylsulfanyl)-2-hydroxycyclopentane-1,1-dicarboxylates were prepd. by base-catalyzed addn. of methanol, allyl alc. and ethylsulfane, resp., to di-Me (4-oxobut-2-en-1-yl)malonate.  Deallylation afforded the 4-hydroxycyclopentanes.  Redn. with lithium aluminum hydride gave the corresponding 4-substituted 2,2-bis(hydroxymethyl)cyclopentanols.  Di-Me (2S,3S,4R)-, (2R,3S,4R)-3-benzyloxy-4-formyloxy-2-hydroxycyclopentane-1,1-dicarboxylates and di-Me (2S,3S,4R)-, (2R,3S,4R)-3-benzyloxy-2-benzoyloxy-4-methoxycyclopentane-1,1-dicarboxylates were synthesized starting from D-glucose.  Redn. of di-Me cyclopentane-1,1-dicarboxylates with lithium aluminum hydride, benzoylation of the formed hydroxy derivs., hydrogenolysis of benzyl groups, conversion of the liberated hydroxy groups into dithiocarbonates and their redn. with tributylstannane afforded, after removal of the protecting groups, (2R,4R)-1,1-bis(hydroxymethyl)-4-methoxycyclopentan-2-ol and (3R,4R)-1,1-bis(hydroxymethyl)-4-methoxycyclopentan-3-ol.  Redn. of a mixt. of esters gave (2R,3R)-2-benzyloxy-5-(hydroxymethyl)hexane-1,3,6-triol as the major product and (2R,3S,4R)-3-benzyloxy-1,1-bis(hydroxymethyl)cyclopentane-2,4-diol as the minor product.  The latter was converted into (3R,4R)-1,1-bis(hydroxymethyl)cyclopentane-3,4-diol.  3-Deoxycarba analogs arose by migration of benzoyl group in the prepn. of the dithiocarbonates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO0ofU6nG-n7Vg90H21EOLACvtfcHk0lj5ElksivgUpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislah&md5=4a018bf0f734229636c47b1861350b52</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1135%2Fcccc19982044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1135%252Fcccc19982044%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C5%2599ebabeck%25C3%25BD%26aufirst%3DH.%26aulast%3DMasoj%25C3%25ADdkov%25C3%25A1%26aufirst%3DM.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520Carba%2520Analogues%2520of%2520Deoxy-4-C-%2528Hydroxymethyl%2529-Pentofuranoses%252C%2520Intermediates%2520in%2520the%2520Synthesis%2520of%2520Carbocyclic%2520Nucleosides%26jtitle%3DCollect.%2520Czech.%2520Chem.%2520Commun.%26date%3D1998%26volume%3D63%26spage%3D2044%26epage%3D2064%26doi%3D10.1135%2Fcccc19982044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, Y.</span></span> <span> </span><span class="NLM_article-title">Remarkable Solvent Effect on Pd(0)-Catalyzed Deprotection of Allyl Ethers Using Barbituric Acid Derivatives: Application to Selective and Successive Removal of Allyl, Methallyl, and Prenyl Ethers</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3132</span>, <span class="refDoi"> DOI: 10.1055/s-2007-992352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1055%2Fs-2007-992352" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=3131-3132&issue=20&author=H.+Tsukamotoauthor=T.+Suzukiauthor=Y.+Kondo&title=Remarkable+Solvent+Effect+on+Pd%280%29-Catalyzed+Deprotection+of+Allyl+Ethers+Using+Barbituric+Acid+Derivatives%3A+Application+to+Selective+and+Successive+Removal+of+Allyl%2C+Methallyl%2C+and+Prenyl+Ethers&doi=10.1055%2Fs-2007-992352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-992352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-992352%26sid%3Dliteratum%253Aachs%26aulast%3DTsukamoto%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKondo%26aufirst%3DY.%26atitle%3DRemarkable%2520Solvent%2520Effect%2520on%2520Pd%25280%2529-Catalyzed%2520Deprotection%2520of%2520Allyl%2520Ethers%2520Using%2520Barbituric%2520Acid%2520Derivatives%253A%2520Application%2520to%2520Selective%2520and%2520Successive%2520Removal%2520of%2520Allyl%252C%2520Methallyl%252C%2520and%2520Prenyl%2520Ethers%26jtitle%3DSynlett%26date%3D2007%26volume%3D2007%26issue%3D20%26spage%3D3131%26epage%3D3132%26doi%3D10.1055%2Fs-2007-992352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>See <span class="NLM_ext-link">Supporting Information</span>. A full manuscript reviewing the details of this
assay is forthcoming (<span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.-T.</span></span>; <span class="NLM_etal"></span> Manuscript in preparation).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Supporting+Information.+A+full+manuscript+reviewing+the+details+of+this%0Aassay+is+forthcoming+%28Lai%2C+M.-T.%3B+Manuscript+in+preparation%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DM.-T." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caton-Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Convenient Synthesis of Nucleoside 5′-Triphosphates for RNA Transcription</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">8142</span>– <span class="NLM_lpage">8144</span>, <span class="refDoi"> DOI: 10.1039/c1cc12201k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1039%2Fc1cc12201k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=8142-8144&author=J.+Caton-Williamsauthor=L.+Linauthor=M.+Smithauthor=Z.+Huang&title=Convenient+Synthesis+of+Nucleoside+5%E2%80%B2-Triphosphates+for+RNA+Transcription&doi=10.1039%2Fc1cc12201k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2Fc1cc12201k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cc12201k%26sid%3Dliteratum%253Aachs%26aulast%3DCaton-Williams%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DConvenient%2520Synthesis%2520of%2520Nucleoside%25205%25E2%2580%25B2-Triphosphates%2520for%2520RNA%2520Transcription%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D8142%26epage%3D8144%26doi%3D10.1039%2Fc1cc12201k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1rtd">1rtd</a> was used as a starting point for modeling efforts. This complex contains HXB2 RT, which was also used for the program’s RT-Pol assay and therefore provided an optimal starting point. Prior to docking ligands of interest, NTP was removed and primer was modified to align with the ligand being modeled. See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>385</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">713</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.10.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1016%2Fj.jmb.2008.10.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=19022262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Sltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=693-713&author=S.+G.+Sarafianosauthor=B.+Marchandauthor=K.+Dasauthor=D.+Himmelauthor=M.+A.+Parniakauthor=S.+H.+Hughesauthor=E.+Arnold&title=Structure+and+Function+of+HIV-1+Reverse+Transcriptase%3A+Molecular+Mechanisms+of+Polymerization+and+Inhibition&doi=10.1016%2Fj.jmb.2008.10.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of HIV-1 reverse transcriptase: Molecular mechanisms of polymerization and inhibition</span></div><div class="casAuthors">Sarafianos, Stefan G.; Marchand, Bruno; Das, Kalyan; Himmel, Daniel M.; Parniak, Michael A.; Hughes, Stephen H.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-713</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The rapid replication of the HIV-1 virus and errors made during viral replication cause the virus to evolve rapidly in patients, making the problems of vaccine development and drug therapy particularly challenging.  In the absence of an effective vaccine, drugs are the only useful treatment.  Anti-HIV drugs work; so far drug therapy has saved more than 3 × 106 yr of life.  Unfortunately, HIV-1 virus develops resistance to all of the available drugs.  Although a no. of useful anti-HIV drugs have been approved for use in patients, the problems assocd. with drug toxicity and the development of resistance means that the search for new drugs is an ongoing process.  The 3 viral enzymes, reverse transcriptase (RT), integrase (IN), and protease (PR) are all good drug targets.  Two distinct types of RT inhibitors, both of which block the polymerase activity of RT, have been approved to treat HIV-1 infections, nucleoside analogs (NRTIs) and non-nucleosides (NNRTIs), and there are promising leads for compds. that either block the RNase H activity or block the polymerase in other ways.  A better understanding of the structure and function(s) of RT and of the mechanism(s) of inhibition can be used to generate better drugs; in particular, drugs that are effective against the current drug-resistant strains of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTrnqshyZtC7Vg90H21EOLACvtfcHk0lgEt1vhkDhzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Sltw%253D%253D&md5=e26f178e629a36f6e248a879057021a2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.10.071%26sid%3Dliteratum%253Aachs%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DHimmel%26aufirst%3DD.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructure%2520and%2520Function%2520of%2520HIV-1%2520Reverse%2520Transcriptase%253A%2520Molecular%2520Mechanisms%2520of%2520Polymerization%2520and%2520Inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D385%26spage%3D693%26epage%3D713%26doi%3D10.1016%2Fj.jmb.2008.10.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaix, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Périgaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyrottes, S.</span></span> <span> </span><span class="NLM_article-title">Recent Trends in Nucleotide Synthesis</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">7854</span>– <span class="NLM_lpage">7897</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSju77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=7854-7897&author=B.+Royauthor=A.+Depaixauthor=C.+P%C3%A9rigaudauthor=S.+Peyrottes&title=Recent+Trends+in+Nucleotide+Synthesis&doi=10.1021%2Facs.chemrev.6b00174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Trends in Nucleotide Synthesis</span></div><div class="casAuthors">Roy, Beatrice; Depaix, Anais; Perigaud, Christian; Peyrottes, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7854-7897</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Focusing on the recent literature (since 2000), this review outlines the main synthetic approaches for the prepn. of 5'-mono-, 5'-di-, and 5'-triphosphorylated nucleosides, also known as nucleotides, as well as several derivs., namely, cyclic nucleotides and dinucleotides, dinucleoside 5',5'-polyphosphates, sugar nucleotides, and nucleolipids.  Endogenous nucleotides and their analogs can be obtained enzymically, which is often restricted to natural substrates, or chem.  In chem. synthesis, protected or unprotected nucleosides can be used as the starting material, depending on the nature of the reagents selected from P(III) or P(V) species.  Both soln.-phase and solid-support syntheses have been developed and are reported here.  Although a considerable amt. of research has been conducted in this field, further work is required because chemists are still faced with the challenge of developing a universal methodol. that is compatible with a large variety of nucleoside analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsGkv8t1I_7bVg90H21EOLACvtfcHk0lgEt1vhkDhzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSju77E&md5=b193e68126504cd6442f532aead446e2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00174%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DB.%26aulast%3DDepaix%26aufirst%3DA.%26aulast%3DP%25C3%25A9rigaud%26aufirst%3DC.%26aulast%3DPeyrottes%26aufirst%3DS.%26atitle%3DRecent%2520Trends%2520in%2520Nucleotide%2520Synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D7854%26epage%3D7897%26doi%3D10.1021%2Facs.chemrev.6b00174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolstykh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micolochick Steuer, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espiritu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Activation of PSI-7851 and its Diastereoisomer PSI-7977</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">34337</span>– <span class="NLM_lpage">34347</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.161802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1074%2Fjbc.M110.161802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=20801890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGktb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=34337-34347&author=E.+Murakamiauthor=T.+Tolstykhauthor=H.+Baoauthor=C.+Niuauthor=H.+M.+Micolochick+Steuerauthor=D.+Baoauthor=W.+Changauthor=C.+Espirituauthor=S.+Bansalauthor=A.+M.+Lamauthor=M.+J.+Ottoauthor=M.+J.+Sofiaauthor=P.+A.+Furman&title=Mechanism+of+Activation+of+PSI-7851+and+its+Diastereoisomer+PSI-7977&doi=10.1074%2Fjbc.M110.161802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977</span></div><div class="casAuthors">Murakami, Eisuke; Tolstykh, Tatiana; Bao, Haiying; Niu, Congrong; Steuer, Holly M. Micolochick; Bao, Donghui; Chang, Wonsuk; Espiritu, Christine; Bansal, Shalini; Lam, Angela M.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">34337-34347</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A phosphoramidate prodrug of 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate, PSI-7851, demonstrates potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo.  PSI-7851 is a mixt. of two diastereoisomers, PSI-7976 and PSI-7977, with PSI-7977 being the more active inhibitor of HCV RNA replication in the HCV replicon assay.  To inhibit the HCV NS5B RNA-dependent RNA polymerase, PSI-7851 must be metabolized to the active triphosphate form.  The first step, hydrolysis of the carboxyl ester by human cathepsin A (CatA) and/or carboxylesterase 1 (CES1), is a stereospecific reaction.  Western blot anal. showed that CatA and CES1 are both expressed in primary human hepatocytes.  However, expression of CES1 is undetectable in clone A replicon cells.  Studies with inhibitors of CatA and/or CES1 indicated that CatA is primarily responsible for hydrolysis of the carboxyl ester in clone A cells, although in primary human hepatocytes, both CatA and CES1 contribute to the hydrolysis.  Hydrolysis of the ester is followed by a putative nucleophilic attack on the phosphorus by the carboxyl group resulting in the spontaneous elimination of phenol and the prodn. of an alaninyl phosphate metabolite, PSI-352707, which is common to both isomers.  The removal of the amino acid moiety of PSI-352707 is catalyzed by histidine triad nucleotide-binding protein 1 (Hint1) to give the 5'-monophosphate form, PSI-7411.  SiRNA-mediated Hint1 knockdown studies further indicate that Hint1 is, at least in part, responsible for converting PSI-352707 to PSI-7411.  PSI-7411 is then consecutively phosphorylated to the diphosphate, PSI-7410, and to the active triphosphate metabolite, PSI-7409, by UMP-CMP kinase and nucleoside diphosphate kinase, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3SPaB9Whp17Vg90H21EOLACvtfcHk0lgEt1vhkDhzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGktb7O&md5=28287a5f7547ab85158f594cd5fb1cd0</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.161802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.161802%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DMechanism%2520of%2520Activation%2520of%2520PSI-7851%2520and%2520its%2520Diastereoisomer%2520PSI-7977%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D34337%26epage%3D34347%26doi%3D10.1074%2Fjbc.M110.161802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Derudas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanpouille, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuigan, C.</span></span> <span> </span><span class="NLM_article-title">The Application of Phosphoramidate Protide Technology to Acyclovir Confers Anti-HIV Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5520</span>– <span class="NLM_lpage">5530</span>, <span class="refDoi"> DOI: 10.1021/jm9007856</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9007856" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlSgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5520-5530&author=M.+Derudasauthor=D.+Cartaauthor=A.+Brancaleauthor=C.+Vanpouilleauthor=A.+Liscoauthor=L.+Margolisauthor=J.+Balzariniauthor=C.+McGuigan&title=The+Application+of+Phosphoramidate+Protide+Technology+to+Acyclovir+Confers+Anti-HIV+Inhibition&doi=10.1021%2Fjm9007856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">The Application of Phosphoramidate Protide Technology to Acyclovir Confers Anti-HIV Inhibition</span></div><div class="casAuthors">Derudas, Marco; Carta, Davide; Brancale, Andrea; Vanpouille, Christophe; Lisco, Andrea; Margolis, Leonid; Balzarini, Jan; McGuigan, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5520-5530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, it has been reported that phosphorylated acyclovir (ACV) inhibits human immunodeficiency virus type 1 (HIV-1) reverse transcriptase in a cell-free system.  To deliver phosphorylated ACV inside cells, ACV monophosphorylated derivs., i.e. I, using ProTide technol. were designed.  It was found that the L-alanine derived ProTides show anti-HIV activity at noncytotoxic concns.; ester and aryl variation was tolerated.  ACV ProTides with other amino acids, other than L-phenylalanine, showed no detectable activity against HIV in cell culture.  The inhibitory activity of the prodrugs against herpes simplex virus (HSV) types -1 and -2 and thymidine kinase-deficient HSV-1 revealed different structure-activity relationships but was again consistent with successful nucleoside kinase bypass.  Enzymic and mol. modeling studies have been performed in order to better understand the antiviral behavior of these compds.  ProTides showing diminished carboxypeptidase lability translated to poor anti-HIV agents and vice versa, so the assay became predictive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOQcvyBNhrB7Vg90H21EOLACvtfcHk0lhUrGszW9rryA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlSgtbc%253D&md5=164dd951a4a2234895cb4da8b01fdaa1</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm9007856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9007856%26sid%3Dliteratum%253Aachs%26aulast%3DDerudas%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DD.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DVanpouille%26aufirst%3DC.%26aulast%3DLisco%26aufirst%3DA.%26aulast%3DMargolis%26aufirst%3DL.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DThe%2520Application%2520of%2520Phosphoramidate%2520Protide%2520Technology%2520to%2520Acyclovir%2520Confers%2520Anti-HIV%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5520%26epage%3D5530%26doi%3D10.1021%2Fjm9007856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolstykh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, E.</span></span> <span> </span><span class="NLM_article-title">Metabolic Activation of the Anti-Hepatitis C Virus Nucleotide Prodrug PSI-352938</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3767</span>– <span class="NLM_lpage">3775</span>, <span class="refDoi"> DOI: 10.1128/AAC.00530-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=10.1128%2FAAC.00530-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=22526308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2isLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3767-3775&author=C.+Niuauthor=T.+Tolstykhauthor=H.+Baoauthor=Y.+Parkauthor=D.+Babusisauthor=A.+M.+Lamauthor=S.+Bansalauthor=J.+Duauthor=W.+Changauthor=P.+G.+Reddyauthor=H.-R.+Zhangauthor=J.+Woolleyauthor=L.-Q.+Wangauthor=P.+B.+Chaoauthor=A.+S.+Rayauthor=M.+J.+Ottoauthor=M.+J.+Sofiaauthor=P.+A.+Furmanauthor=E.+Murakami&title=Metabolic+Activation+of+the+Anti-Hepatitis+C+Virus+Nucleotide+Prodrug+PSI-352938&doi=10.1128%2FAAC.00530-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938</span></div><div class="casAuthors">Niu, Congrong; Tolstykh, Tatiana; Bao, Haiying; Park, Yeojin; Babusis, Darius; Lam, Angela M.; Bansal, Shalini; Du, Jinfa; Chang, Wonsuk; Reddy, P. Ganapati; Zhang, Hai-Ren; Woolley, Joseph; Wang, Li-Quan; Chao, Piyun B.; Ray, Adrian S.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.; Murakami, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3767-3775</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">PSI-352938 is a novel cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine-5'-monophosphate with potent anti-HCV activity.  In order to inhibit the NS5B RNA-dependent RNA polymerase, PSI-352938 must be metabolized to the active triphosphate form, PSI-352666.  During in vitro incubations with PSI-352938, significantly larger amts. of PSI-352666 were formed in primary hepatocytes than in clone A hepatitis C virus (HCV) replicon cells.  Metab. and biochem. assays were performed to define the mol. mechanism of PSI-352938 activation.  The first step, removal of the iso-Pr group on the 3',5'-cyclic phosphate moiety, was found to be cytochrome P 450 (CYP) 3A4 dependent, with other CYP isoforms unable to catalyze the reaction.  The second step, opening of the cyclic phosphate ring, was catalyzed by phosphodiesterases (PDEs) 2A1, 5A, 9A, and 11A4, all known to be expressed in the liver.  The role of these enzymes in the activation of PSI-352938 was confirmed in primary human hepatocytes, where prodrug activation was reduced by inhibitors of CYP3A4 and PDEs.  The third step, removal of the O6-Et group on the nucleobase, was shown to be catalyzed by adenosine deaminase-like protein 1.  The resulting monophosphate was consecutively phosphorylated to the diphosphate and to the triphosphate PSI-352666 by guanylate kinase 1 and nucleoside diphosphate kinase, resp.  In addn., formation of nucleoside metabolites was obsd. in primary hepatocytes, and ecto-5'-nucleotidase was able to dephosphorylate the monophosphate metabolites.  Since CYP3A4 is highly expressed in the liver, the CYP3A4-dependent metab. of PSI-352938 makes it an effective liver-targeted prodrug, in part accounting for the potent antiviral activity obsd. clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNZgd5L-S6a7Vg90H21EOLACvtfcHk0lhUrGszW9rryA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2isLk%253D&md5=368e11bad1e84484953d392df3e9aaa5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FAAC.00530-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00530-12%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DWoolley%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.-Q.%26aulast%3DChao%26aufirst%3DP.%2BB.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DMurakami%26aufirst%3DE.%26atitle%3DMetabolic%2520Activation%2520of%2520the%2520Anti-Hepatitis%2520C%2520Virus%2520Nucleotide%2520Prodrug%2520PSI-352938%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3767%26epage%3D3775%26doi%3D10.1128%2FAAC.00530-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganapati Reddy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachakonda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofia, M. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">8311</span>– <span class="NLM_lpage">8319</span>, <span class="refDoi"> DOI: 10.1021/jo201492m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo201492m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ags77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=8311-8319&author=B.+S.+Rossauthor=P.+Ganapati+Reddyauthor=H.-R.+Zhangauthor=S.+Rachakondaauthor=M.+J.+Sofia&title=Synthesis+of+Diastereomerically+Pure+Nucleotide+Phosphoramidates&doi=10.1021%2Fjo201492m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates</span></div><div class="casAuthors">Ross, Bruce S.; Ganapati Reddy, P.; Zhang, Hai-Ren; Rachakonda, Suguna; Sofia, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8311-8319</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prodrugs of therapeutic nucleoside monophosphates masked as phosphoramidate derivs. have become an increasingly important class of antiviral drugs in pharmaceutical research for delivering nucleotides in vitro and in vivo.  Conventionally, phosphoramidate derivs. are prepd. as a mixt. of two diastereomers.  We report a class of stable phosphoramidate reagents contg. an amino acid ester and two phenolic groups, one unsubstituted and the other with electron-withdrawing substituents.  The reagents can be isolated as single diastereomers and reacted with the 5'-hydroxyl group of nucleosides through selective nucleophilic displacement of the substituted phenol to prep. single diastereomer phosphoramidate products.  This method has been used to prep. the HCV clin. candidate PSI-7977 I in high yield and high diastereomeric purity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgDGdlH3gLa7Vg90H21EOLACvtfcHk0lhUrGszW9rryA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ags77F&md5=747a893daa7d9c4784cc29619d05ab81</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo201492m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo201492m%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DGanapati%2BReddy%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520of%2520Diastereomerically%2520Pure%2520Nucleotide%2520Phosphoramidates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2011%26volume%3D76%26spage%3D8311%26epage%3D8319%26doi%3D10.1021%2Fjo201492m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1rtd" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1rtd','PDB','1rtd'); return false;">PDB: 1rtd</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i33"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00141">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_32360"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00141">10.1021/acs.jmedchem.8b00141</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">All experimental procedures, characterization data for new compounds, in vitro experimental protocols, and details on computational modeling (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for compounds <b>19</b>, <b>20</b>, <b>24</b>–<b>26</b>, <b>29b</b>, <b>30</b>, <b>34a</b>, and <b>34b</b> and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_001.pdf">jm8b00141_si_001.pdf (441.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00141/suppl_file/jm8b00141_si_002.csv">jm8b00141_si_002.csv (0.7 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00141&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-20%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00141%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00141" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997d86bc1a3cd6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
